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I a vegades se’ns baixa la verge 
i de sobte ens revela que ens en sortim. 
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Introducció 
El complex de Golgi és l’orgànul encarregat d’organitzar el transport de la via 
secretora. Aquest es dóna mitjançant elements de transport, com vesícules o túbuls, 
per a la formació  dels quals és necessària l’acció coordinada de moltes proteïnes i 
una composició lipídica determinada. El diacilglicerol (DAG) és un lípid senyalitzador 
necessari per al transport des del complex de Golgi a la membrana plasmàtica  i per la 
formació de vesícules COPI, responsables del transport retrògrad del complex de 
Golgi al reticle endoplasmàtic. En principi, els nivells de DAG podrien ser regulats tan 
per les seves vies de producció com les de consum. El DAG necessari per al transport 
al complex de Golgi podria ser produït per tres vies diferents: mitjançant la fosfolipasa 
D (PLD), que converteix fosfatidilcolina (PC) en àcid fosfatídic (PA), acoblada a l’acció 
de les fosfatases del PA (PAPs) ; per acció de la fosfolipasa C (PLC), que produeix 
DAG a partir de fosfatidilinositol bifosfat (PIP2) i, com també s’ha proposat, de 
fosfatidilinositol fosfat (PIP); i per acció de l’esfingomielina sintasa (SMS) a partir de 
PC i ceramida. Els nivells de DAG també podrien ser regulats pel seu consum, 
mitjançant la síntesi de fosfolípids com la PC, a través de la via de la CDP-colina; o el 
fosfatidilinositol (PI), per la via que comença amb la fosforilació del DAG per la DAG 
quinasa.  
Existeixen treballs que suggereixen que la producció de DAG mitjançant la SMS així 
com l’acció combinada de la PLD i les PAPs pot regular el transport a nivell del 
complex de Golgi. En canvi, no hi ha evidències que les vies que consumeixen DAG o 
la hidròlisi de polifosfoinosítids per part de la PLC participin en la regulació de la 
formació d’intermediaris de transport. A més a més, es desconeix quina de les vies 
metabolitzadores de DAG, ja sigui de producció o de consum, és regulada de forma 
específica dins de la cèl·lula i en condicions fisiològiques per estimular la formació 
d’intermediaris de transport.  
Objectius 
El primer objectiu d’aquesta tesi és determinar si les vies de consum de DAG, les vies 
de síntesi de fosfolípids, poden regular els nivells de DAG al complex de Golgi i si 
aquestes tenen algun paper en la regulació del transport intracel·lular. Per això 
necessitem confirmar la localització de les reaccions que consumeixen DAG de les 
vies de síntesi de PI i PC al complex de Golgi, determinar si canvis en la seva activitat 
poden variar els nivells de DAG en aquest orgànul i si aquestes variacions es 
tradueixen en una alteració del transport intracel·lular des del complex de Golgi.  
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El segon objectiu és estudiar la possible participació de la PLC en la regulació dels 
nivells de DAG del complex de Golgi, i la seva possible implicació en el transport 
intracel·lular a nivell d’aquest orgànul. Per a això, hem d’estudiar la presència 
d’activitat PLC al complex de Golgi, així com els efectes del seu silenciament en la 
dinàmica funcional i estructural d’aquest orgànul. Com que la PLC és una molècula 
senyalitzadora, estudiarem els possibles senyals activadors de la seva activitat al 
complex de Golgi. 
Resultats 
De cara al primer objectiu, primer vam voler confirmar la localització al complex de 
Golgi de les reaccions consumidores de DAG de les vies de síntesi de PI i PC. Per 
això, vam determinar l’activitat enzimàtica d’aquests enzims en fraccions de membrana 
enriquides en Golgi provinents de cèl·lules Vero i de fetge de rata. Aquestes van ser 
incubades durant 20 minuts en presència o no de CMP. En els dos casos, els nivells 
de DAG van augmentar en presència de CMP, com a conseqüència de la reversió de 
la CDP-colina:diacilglicerol transferasa (CPT), l’últim enzim de la síntesi de 
fosfatidilcolina. A aquesta pujada dels nivells de DAG en presència de CMP també hi 
pot contribuir la reacció reversa de la fosfatidilinositol sintasa, encara que el principal 
producte d’aquesta reacció seria el CDP-DAG. Aquests resultats suggereixen que els 
enzims responsables de les reaccions consumidores de DAG es troben localitzats al 
complex de Golgi. 
Posteriorment, vam determinar que canvis en l’activitat de les vies de síntesi de PI i PC 
poden regular els nivells de DAG del complex de Golgi en un context cel·lular. Per 
això, vam posar a punt dues estratègies experimentals per a modificar els nivells de 
DAG regulant aquestes rutes metabòliques. La primera consisteix en l’ús de la línia 
cel·lular CHO-MT58, amb l’enzim regulador de la síntesi de fosfatidilcolina, la 
CTP:fosfocolina citidililtransferasa (CTT), termosensible. Vam observar que 
incubacions en temps curts a 40ºC, la temperatura restrictiva, de la línia CHO-MT58 es 
tradueixen en un augment dels nivells  de DAG, respecte als de les CHO-K1 wt, que 
es mantenen constants. Aquest augment de DAG ja és visible als 30 minuts i dura 
almenys fins a les 3 hores. L’altra estratègia per a modular l’activitat de les vies de 
síntesi de PC i PI consisteix en controlar la presència o l’absència de colina i inositol, 
substrats necessaris per el consum de DAG mitjançant aquestes rutes. En absència de 
substrats, vam afegir liti per reduir la presència d’inositol endogen. Els nivells de DAG 
observats són més alts tant en cèl·lules NRK com en CHO-K1 incubades durant 1 hora 
en absència d’aquests substrats que no en presència d’ells. Per assegurar que la 
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inhibició de la síntesi de fosfolípids produïda en les nostres condicions experimentals 
només varia els nivells de DAG, vam mesurar els nivells dels principals fosfolípids així 
com de triacilglicerols. En les dues condicions experimentals descrites no veiem canvis 
en els nivells de PC, PI, fosfatidiletanolamina, esfingomileina, fosfatidilserina, àcid 
fosfatídic  (PA), ni en els nivells de triacilglicèrids. 
Per a determinar si aquest augment en els nivells de DAG causats per la inhibició de la 
síntesi de fosfolípids podien tenir lloc al complex de Golgi, vam estudiar la 
ultraestructura d’aquest orgànul en cèl·lules CHO-K1 i CHO-MT58 a 33ºC i 40ºC en 
presència o no de propanolol. Estudis previs del grup havien indicat que el propanolol, 
un inhibidor de les PAPs, reduïa el DAG del complex de Golgi, augmentant els perfils 
de budding, fet que reflectia un bloqueig en la fissió de vesícules. L’augment de perfils 
de budding associats al complex de Golgi causat pel propanolol va ser revertit en 
cèl·lules CHO-MT58 incubades a 40ºC, suggerint que la augment de DAG causat per 
la inhibició de la síntesi de PC pot contrarestar la inhibició de la formació de DAG al 
complex de Golgi per acció del propanolol. 
Per determinar si l’augment de DAG produït per la inhibició de les vies de síntesi de 
fosfolípids tenia un efecte en el transport a través de la via secretora, vam analitzar 
primer la distribució del receptor KDEL en cèl·lules NRK i CHO-K1. Vam observar que 
la inhibició de la síntesi de fosfolípids per absència de colina i inositol es tradueix en un 
augment en el número de partícules amb receptor KDEL. Aquest també es dóna en 
incubar la línia MT-58 a 40ºC durant 1 hora a la temperatura no permissiva. Vam 
analitzar el transport del VSVG des del complex de Golgi a la membrana plasmàtica, i 
aquest es veia frenat quan es consumia DAG en presència de colina i inositol, ja que el 
VSVG està més temps al complex de Golgi i arriba més lentament a la membrana 
plasmàtica que en absència d’aquests substrats. Vam observar un efecte similar en la 
secreció de la proteïna soluble ssHRP, que és menor quan es consumeix DAG en 
presència dels substrats colina i inositol que en la seva absència, quan el DAG no és 
consumit. 
De cara al segon objectiu, estudiar la possible implicació de la PLC en el transport al 
complex de Golgi, primer vam voler determinar si hi podia haver activitat PLC en 
fraccions enriquides en membranes de Golgi. Per a això, vam incubar membranes de 
Golgi amb [32P]ATP i vam mesurar la producció de[32P] PA, com a reflex de la 
producció de DAG. L’addició de citosol (les PLCs són proteïnes citoplasmàtiques) va 
augmentar la producció de [32P]PA i els nivells d’aquest eren molt més alts en afegir 
PLC recombinant. A més, la depleció de Ca2+ i GTPS, activadors de l’activitat PLC, 
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produeix una inhibició de la producció de [32P]PA. A continuació vam voler determinar 
si els nivells de PIP, el fosfoinosítid majoritari al complex de Golgi, es veien disminuïts 
en afegir citosol, per confirmar la presència d’activitat PLC. En presència de citosol, el 
nivells de [32P]PIP es veien disminuïts, i aquest consum era depenent de Ca2+, però no 
de GTPS. Aquests resultats suggereixen que si la PLC actua al complex de Golgi, 
aquesta podria ser la PLC, ja que l’activitat d’aquesta, és sensible al Ca2+, però no és 
regulada per proteïnes G. 
Per això, vam estudiar la dinàmica funcional i estructural del complex de Golgi en 
cèl·lules silenciades per la isoforma expressada de forma ubiqua PLC1. Vam 
observar que l’arribada del VSVG a la membrana plasmàtica és més lenta en cèl·lules 
HeLa silenciades per la PLC1, comparades amb les cèl·lules control. En la mateixa 
línia, la secreció de proteïnes marcades amb [35S] també es troba significativament 
disminuïda en silenciar la PLC1. Aquests resultats mostren que la PLC1 participa en 
el transport anterògrad a nivell del complex de Golgi. Per contra, la internalització de la 
toxina B de Shigella amb la seqüència de retenció al reticle KDEL (STxB-KDEL) no es 
veu alterada en silenciar la PLC1, suggerint que aquesta no intervé en el transport 
retrògrad. 
També vam analitzar per immunofluorescència la morfologia del complex de Golgi de 
les cèl·lules silenciades per la PLC1. Aquestes mostraven una morfologia 
lleugerament més compacta que les cèl·lules control. Vam quantificar aquesta 
morfologia mitjançant l’índex de compactació del complex de Golgi, on vam trobar que 
les cèl·lules silenciades per la PLC1 presentaven un valor de compactació més elevat 
que les cèl·lules control. En concordança amb aquest resultat, cèl·lules que 
sobreexpressen la PLC1, però no de la seva forma catalíticament inactiva 
PLC1(H335Q), presenten una morfologia del complex de Golgi més fragmentada. 
Posteriorment, vam analitzar si la PLC1 podia estar regulant els nivells de DAG al 
complex de Golgi. Per això, vam mesurar la localització del sensor de DAG C1-PKC-
GFP al complex de Golgi en cèl·lules silenciades per la PLC1. La localització del C1-
PKC-GFP a aquest orgànul era lleugerament menor en les cèl·lules silenciades per la 
PLC1 que en les control, i en afegir PMA per desplaçar el C1-PKC-GFP a la 
membrana, vam veure que la presència d’aquest sensor de DAG al complex de Golgi 
era significativament menor en cèl·lules silenciades per la PLC1 que en les control, 
indicant així la implicació de la PLC1 en la regulació dels nivells de DAG al complex 
de Golgi. 
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Com que la PLC1 és un enzim que participa en la senyalització intracel·lular, vam 
buscar quin podria ser un dels seus activadors al complex de Golgi. Recentment, s’ha 
descrit que l’arribada de cargo al complex de Golgi inicia una senyal necessària pel 
correcte funcionament de la via secretora  Vam analitzar la hipòtesi de que aquesta 
mateixa senyal, l'arribada de cargo, podia controlar la producció de DAG al complex de 
Golgi i que aquest procés era depenent de la PLC1. Per a això, vam analitzar la 
localització del sensor de DAG C1-PKC-GFP al complex de Golgi abans i després de 
l’arribada de VSVG, com a model d’arribada de cargo. Vam observar que els nivells de 
C1-PKC-GFP al complex de Golgi es trobaven augmentats després de l’arribada de 
cargo, i que aquest increment no tenia lloc en cèl·lules que no expressaven el VSVG.  
Aquests resultat ens indica que l’arribada de cargo augmenta els nivells de DAG al 
complex de Golgi. Per estudiar si aquesta producció de DAG és deguda a la PLC1, 
vam fer el mateix experiment en cèl·lules silenciades per la PLC1, on vam observar 
que l’arribada de cargo provocava un menor augment en la localització del C1-PKC-
GFP al complex de Golgi en les cèl·lules silenciades per la PLC1 que en les cèl·lules 
control. Aquests resultats ens indiquen que la PLC1 pot participar en la producció de 
DAG induïda per l’arribada de cargo. 
Com que el mecanisme d’activació descrit més comú de la PLC1 és la fosforil·lació 
de la seva tirosina 783, vam analitzar els nivells d’aquesta fosforil·lació després d’una 
arribada de cargo. Contràriament al que esperàvem, els nivells de la fosforil·lació de la 
tirosina 783 de la PLC1 no es veien modificats per una arribada massiva de VSVG. 
Aquest resultat ens indica que si la PLC1 actua al complex de Golgi després d’una 
arribada de cargo, tal com suggereixen els nostres resultats, el seu mecanisme 
d’activació ha de ser diferent a la fosforil·lació.
Discussió 
En conjunt, els resultats obtinguts a la primera part de la tesi indiquen que la síntesi de 
fosfolípids, a part de tenir lloc al reticle endoplasmàtic, també pot tenir lloc al complex 
de Golgi. Aquestes vies de síntesi de PC i PI, que són consumidores de DAG, poden 
regular els nivells d’aquest metabòlit al complex de Golgi. A més a més, una inhibició 
de l’activitat d’aquestes vies consumidores de DAG pot accelerar el transport tant 
retrògrad com anterògrad al complex de Golgi. D’aquesta manera, podem concloure 
que les vies de síntesi de fosfolípids participen en la regulació del DAG necessari per 
al transport, tan retrògrad com anterògrad, al complex de Golgi.  
Per altra banda, els resultats obtinguts en la segona part de la tesi ens indiquen que la 
PLC1 pot participar al complex de Golgi en el control del pool de DAG d’aquest 
RESUM 
20 

orgànul, regular el transport post-Golgi i la morfologia d’aquest orgànul. A més, el fet 
que la PLC1 participi en la producció de DAG induïda per l’arribada de cargo situa la 
PLC1 en un punt clau de la cascada de senyalització per al correcte funcionament del 
complex de Golgi, ja que la converteix en un dels nexes entre l’arribada de cargo a 
aquest orgànul i la producció de DAG per la sortida d’aquest cargo al seu destí 
cel·lular. 
Conclusions 
1.- Les vies metabòliques per a la síntesi de fosfolípids que són consumidores de DAG 
regulen els nivells d’aquest al complex de Golgi.
2.- La síntesi de fosfolípids controla els nivells de DAG necessaris per al transport tan 
retrògrad com anterògrad al complex de Golgi. 
3.- L’arribada de cargo al complex de Golgi estimula la producció de DAG. 
4.- La PLC1 està involucrada en la producció de DAG estimulada per l’arribada de
cargo al complex de Golgi. 
5.- La PLC1 és necessària per al transport post-Golgi i pel manteniment de 
l’estructura del complex de Golgi. 
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1.- INTRACELLULAR MEMBRANE TRAFFICKING 
Along evolution, the eukaryotic cell increased its complexity by acquiring intracellular 
membranes, which allowed the segregation of the cell in different subunits, known as 
cell organelles. This compartmentalization into different organelles vastly improves the 
efficiency of many cellular functions and prevents potentially dangerous molecules from 
roaming freely within the cell. But when distinct cellular processes are 
compartmentalized, a new problem arises: these different compartments need to 
communicate with each other and exchange specific molecules or need to be exported 
them to the cell exterior (Zierath and Lendahl, 2013). All intracellular membranes are 
interconnected by bidirectional traffic, yet each maintains a unique lipid and protein 
composition (Van Meer, 2010). This intracellular traffic is achieved by vesicular or 
tubulovesicular structures known as transport carriers, which detach from one 
intracellular membrane to fuse to another one, thus allowing the communication and 
exchange of material between different organelles. 
1.1.- The composition of cellular membranes 
Cellular membranes are composed by a bilayer of amphipathic lipid molecules. The 
propensity of the hydrophobic moieties to self-associate in an aqueous environment 
and the tendency of the hydrophilic moieties to interact with it and with each other is 
the basis of the spontaneous formation of a membrane. The major structural lipids in 
eukaryotic membranes are the glycerophospholipids (Fig. 1A); phosphatidylcholine 
(PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylinositol 
(PI) and phosphatidic acid (PA). Their backbone is diacylglycerol (DAG), which 
contains a glycerol with two saturated or cis-unsaturated acyl chains of varying lengths 
esterified to its first and second alcohol groups. PC is the most abundant phospholipid 
of eukaryotic cells, accounting for more than 50% of the total phospholipid mass. PC, in 
an aqueous environment, is self-organized as a planar bilayer, where it has a nearly 
cylindrical molecular geometry. Most PC molecules have one cis-unsaturated fatty acyl 
chain, which renders them fluid at room temperature and increases the diamater of the 
hydrophobic part of the molecule. The shape of each phospholipid class in the 
membrane bilayer depends not only on the nature of its acyl chains, but also on the 
size of their polar group. For example, PE has a more conical shape than PC, since its 
polar headgroup it is relatively small compared to PC (Van Meer, 2008). 
Although PI and its derivates, known as phosphoinositides, account for less than 15% 
of the total phospholipids, they play a key role in organizing cellular membranes. 
Inositol, the PI polar headgroup, can be phosphorylated in different positions. PI 
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kinases specifically modify the D-3, D-4 and D-5 positions of the inositol ring in all of 
the possible combinations, generating up to seven different classes of 
phosphoinositides. These different classes of phosphoinositides are specifically 
segregated in different organelles and in different amounts. For example, 
phosphatidylinositol 4-phosphate (PI(4)P) is the major phosphoinositide of the Golgi 
complex, while phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) is mainly localized at 
the plasma membrane. Moreover, phosphoinositides also are important in cell 
signalling and in the recruitment of specific proteins for each phosphoinositide class to 
cellular membranes (Di Paolo and De Camilli, 2006).
In addition to the glycerol-based phospholipids, the eukaryotic cell membranes also 
possesses sphingolipids and sterols (Fig. 1B,C). Having ceramide as their backbone, 
sphingolipids constitute another class of structural lipids. The major sphingolipids in 
mammal cells are sphingomyelin (SM) and the glycosphingolipids (GSLs), which 
contain mono-, di- or oligosaccharides based on glucosylceramide (GlcCer) and 
sometimes galacotosylceramide. Sphingolipids have saturated or trans-unsaturated 
acyl chains so they are able to form taller, narrower cylinder than PC lipids of the same 
chain length. Sphingolipids pack more tightly, and are self-assembled in a more 
ordered membrane and can be fluidized by sterols, the major non-polar lipids of cell 
membranes. Cholesterol is the major sterol in mammals (Van Meer, 2008, Pruett, 
2008; Hannich, 2011).  
Figure 1. The three main classes of 
eukaryotic membrane lipids. 
Structure of glycerophospholipids, 
sphingolipids and sterols, which are 
based in glycerol, sphingosine and 
cholesterol, respectively (blue 
shading).  P stands for a phosphate 
group and R for a head group, which 
can be either neutral, as for PS and 
PI; or basic, as for PE and PC. 
(Adapted from Holthuis and Levine, 
2005) 
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The main lipid biosynthetic organelle is the endoplasmic reticulum (ER), which 
produces the bulk of the structural lipids and cholesterol (Bell, 1981). However, 
significant levels of lipid synthesis also occur in the Golgi complex. Synthesis of SM 
and complex sphingolipid occurs at the Golgi complex, although the synthesis of their 
precursor ceramide also takes place at the ER (Bartke and Hannun, 2009). Moreover, 
the Golgi complex also possesses the capacity of synthesis of glycerophospholipids as 
PC and PI (Jelsema and Morré, 1978). 
Cellular membranes are also loaded with proteins, which can account for roughly half 
the mass of most cell membranes. Some of these proteins are transmembrane 
proteins, which are inserted into the membrane bilayer and stick out on both sides. 
Other proteins are found associated with the membrane, usually bound to other 
proteins (Van Meer, 2008). 
1.2.- Intracellular trafficking pathways 
Since the eukaryotic cell is compartmentalized in different organelles, exchange of 
material as proteins or lipids between compartments is necessary to maintain the 
integrity and function of the cell. This exchange of material is achieved by trafficking 
pathways that communicate the different organelles. These trafficking pathways are 
responsible to deliver specific molecules, known as cargo, which could be lipid, protein, 
carbohydrate or inorganic substances; from one compartment to another. Intracellular 
trafficking is mediated by transport carriers that could be vesicles or tubulovesicular 
structures, which are detached from the donor organelle, moved by motor proteins 
using the cytoskeleton as a structural platform for their movement and finally fused to 
its target organelle. The different intracellular trafficking pathways can be classified by 
a functional criterion (Fig. 2). 
1.2.1.- Endocytosis and the recycling pathway 
Endocytosis is the pathway that is used to incorporate exogenous soluble molecules 
and membrane components inside the cell. Cargo is internalized to the early 
endosomes, from where it is delivered to late endosomes and then to the lysosomes, 
the trans-Golgi network (TGN) or to recycling endosomes (Jones, 2007). Endocytosis 
can be classified into phagocytosis or pinocytosis, depending on the size and the 
nature of the internalized cargo (Conner and Schmid, 2004). Phagocytosis is used by 
specialized cells, as macrophages, to internalize large objects as viruses, bacteria or 
other intracellular parasites, which are then digested in the lysosomes. Pinocytosis is 
used to internalize macromolecules and fluids, and also is responsible of the constant  
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Figure 2. Membrane trafficking pathways. In the secretory pathway, cargo synthesised at the ER is first 
sent to the ERGIC by COPII transport carriers and then to the Golgi complex. Once at the TGN, cargo 
sorted and sent to the plasma membrane, to the endo/lysosomal system, to secretory granules in 
specialized cells or sent back to the ER in COPI transport carriers. In the endocytic pathway, cargo is 
internalised at the plasma membrane and sent to the endosomal compartments and to the Golgi complex 
or the lysosomes. The recycling pathway delivers part of the endocyted cargo to the cell surface by the 
action of the recycling endosomes. The unconventional secretion pathway transport proteins to the cell 
surface without entering the Golgi complex (De Matteis and Luini, 2011).  
exchange of material on the plasma membrane. On the other hand, pinocytosis can be 
classified into different subclasses: macropinocytosis, clathrin-mediated endocytosis, 
and clathrin- independent endocytosis. In micropinocytosis the plasma membrane is 
deformed in order to internalize the exogenous element. In clathrin-mediated 
endocytosis the transport carriers of this kind of endocytosis are coated with clathrin, a 
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molecule that after ligand recognition by the receptor is assembled into polygonal 
structures that deform the plasma membrane in its inner side (Robinson and 
Bonifacino, 2001). Clathrin-independent endocytosis could be divided in processes 
dependent on RhoA and Cdc42, flotillin-mediated endocytosis and Arf6-associated 
uptake of cargo (Sandvig, 2011). Caveolin-mediated endocytosis was proposed to be 
another mechanism of clathrin-independent endocytosis (Van Deurs, 2003), but 
nowadays the role for caveolae in endocytosis is questioned (Doherty and McMahon, 
2009; Sandvig, 2011). 
After endocytosis, some molecules are selected and sent back to the plasma 
membrane, where they will exert their function again. The responsible of this process is 
the recycling pathway, which is followed in part by most membrane receptors, which 
after interacting with their ligand are endocyted.  Once internalized, they split from their 
ligand and are sent back to the plasma membrane through the recycling endosomes 
(Maxfield and McGraw, 2004). 
1.2.2.- The secretory pathway  
Newly synthesized components are transported from their site of synthesis to their final 
destination by the secretory pathway. This trafficking pathway begins at the ER, where 
cargo is synthesized and folded if necessary. After that, cargo enters the exit sites of 
the ER (ERES), where it is sorted into either small or large vesicles that are generated 
through the membrane bending properties of coat protein complex II (COPII). Once 
detached from the ER, these vesicles move cargo to the endoplasmic reticulum-Golgi 
intermediate compartment (ERGIC) and after this it reaches the Golgi complex. Once 
at the cis side of the Golgi, cargo can be sent back to the ER, in a process known as 
retrograde trafficking, or can continue forward to the trans pole until reaching the TGN. 
At the TGN, cargo is sorted and packaged in different vesicles, which then carry them 
to their final destinations, such as lysosomes, plasma membrane or secretory granules 
in specialized cells (De Matteis and Luini, 2011). Recently, another secretory pathway 
has been described, known as unconventional secretion, in which cargo is not packed 
in transport carriers and does not enter the Golgi complex. Proteins that follow this 
pathway exit the ER directly to the cytoplasm to finally reach the extracellular media, 
(Malhotra, 2013). 
1.3- The Golgi complex: structure and function 
The Golgi complex is an organelle present in all eukaryotes that acts as a central 
station of the secretory pathway and its main function is to organize most of the 
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intracellular trafficking of this pathway (Egea, 2001). It is localized at the perinuclear 
region, associated to the centrosome and the microtubule cytoskeleton (Fig. 3A; Ríos 
and Bornens, 2003). The Golgi complex has a characteristic structure that is conserved 
amongst nearly all eukaryotes, comprising flattened membrane discs called cisternae 
that are layered on top of each other to generate the Golgi stack (Lowe, 2011). Each 
stack is morphologically and functionally polarized, where it can be distinguished an 
entrance face, the cis-Golgi, where cargo synthesised at the ER is received; and an 
exit zone, the trans-Golgi, where processed cargo is sorted and released (Fig. 3B). The 
group of cisternae between the cis and the trans pole form the mid-Golgi region. Both 
cis- and trans-Golgi are associated to a highly dynamic network of tubulovesicular 
structures that act as an interface between the Golgi complex and other compartments 
of the secretory pathway. Thus, the cis-Golgi network is found between the ER and the 
cis side of the Golgi complex, while the TGN is localized between the trans pole and 
the plasma membrane or other compartments of the secretory pathway (Rambourg 
and Clermont, 1990). 
Figure 3. Localization and organization of the 
Golgi complex. A) Immunofluorescence images 
showing the microtubules and the Golgi complex. 
Scale bar 200 nM. B) Electron tomographic modelof 
the Golgi complex. The Golgi stacks are laterally 
arranged within the Golgi ribbon and each cisterna is 
deifferently colored. Numerous transport vesicles that 
surround the Golgi stacks are shown in white.  
(Adapted from Rios and Egea, 2008; and Marsh and 
Howell, 2002) 
The Golgi complex provides a spatial compartmentalization for post-translational 
modifications of cargo synthesised at the ER. Glycosylation of proteins is the most 
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common of these modifications and is a fundamental process for the final function and 
the correct sorting of cargo, but other processes as phosphorylation also take place in 
this organelle. One example of protein post-translational modifications is the 
phosphorylation of mannose residues to produce mannose-6-phosphate residues, a 
signal that is recognized by the sorting machinery to send lysosomal enzymes to the 
lysosome (Hille-Rehfeld, 1995). As mentioned before, the Golgi complex is also 
fundamental for lipid metabolism, since is the place for sphingolipid synthesis (Van 
Meer, 2008) and phospholipid synthesis also occurs at this organelle (Jelsema and 
Morré, 1978).  
Recently, the Golgi complex has also been proposed to be a central hub for 
intracellular signalling (Cancino and Luini, 2013), since numerous components of 
signalling pathways, such as kinases and G proteins, are found associated with this 
organelle. The signalling events at the Golgi can either control the secretory pathway or 
other cellular functions (see below, chapter III). 
 1.4.- Golgi-associated membrane trafficking 
The molecular components of the Golgi complex are constantly renewed. Cargo 
synthesised at the ER, together with membrane and other components of the transport 
carriers, is constantly arriving and fusing with the Golgi complex (Cancino, 2013). 
Moreover, the Golgi complex also receives cargo and membrane from the endosomes. 
On the other hand, a large of proportion membrane also moves out from the Golgi 
complex by fission of transport carriers that are sent to other cell organelles. This high 
and constant flux of membrane makes the Golgi complex a very dynamic organelle. IN 
order to maintain its structure and function, the net gain of the membrane flux should 
be null. These highly regulated membrane fluxes to and from the Golgi complex are 
described below.  
1.4.1.- Membrane trafficking at the ER-Golgi interface 
Membrane traffic between the ER and the Golgi complex is bidirectional. The 
membrane flux that moves from the ER to the Golgi complex is called anterograde 
transport, while retrograde transport drives the movement of membrane in the opposite 
direction, from the Golgi complex to the ER. Distinct machineries facilitate the formation 
of carriers for anterograde and retrograde transport, which are thought to ensure fidelity 
and directionality of trafficking (Fig. 4). COPII operates in the anterograde pathway 
from the ER to the Golgi complex, and COPI functions in the retrograde route from the 
Golgi complex to the ER (Brandizzi and Barlowe, 2013), although COPI has also been 
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proposed to participate in the anterograde transport from the ERGIC to the Golgi 
complex (Orci, 1997). 
Figure 4. Membrane trafficking at the ER-Golgi interface. Transport between the ER and the Golgi 
complex occurs in different steps. Cargo is loaded to COPII vesicles, which bud at the ERES and are sent 
to the ERGIC and next to the Golgi complex. ER resident proteins that have reached the ERGIC or the 
Golgi complex are sent back to the ER in COPI vesicles (adapted from Bonifacino and Glick, 2004). 
1.4.1.1.- Anterograde transport 
Most proteins and lipids synthesised at the ER are transported to the Golgi complex. 
To exit the ER, fully folded soluble and membrane cargos are packaged into COPII-
coated transport carriers. The generation of these COPII transport carriers is localized 
at specialized, long-lived subdomains of the ER, termed ERES, which are enriched in 
COPII coat proteins. In addition to the core COPII components, large multidomain 
Sec16 localizes at the ERES and is required for export site assembly and function. The 
core components of COPII complex are the proteins Sec23/24, Sec 13/31 and the Sar1 
GTPase (Kirchhausen, 2007; Barlowe 1994). Sar1 and Sec23/24 form the inner layer 
of the COPII complex, which binds and selects specific cargo for packaging into ER-
derived transport vesicles, while Sec13/31 is found in the outer layer and their 
polymerization leads to deformation of ER membranes to drive transport vesicle 
formation (Brandizzi and Barlowe, 2013). 
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COPII coated vesicles do not travel directly to the Golgi complex. These vesicles fuse 
with themselves and generate a tubulovesicular structure between the ER and Golgi 
complex, known as the ER/Golgi intermediate compartment (ERGIC), which 
concentrates and sorts cargo (Bannykh, 1998; Hauri and Schweizer, 1992). Transport 
from the ERGIC to the cis-Golgi can be explained by two models. The first one 
suggests that the ERGIC is a transient organelle that fuses to generate the first Golgi 
cisternae. The second one suggests that the ERGIC is a stable compartment and that 
COPI vesicles deliver cargo from the ERGIC the first Golgi cisternae (Rabouille and 
Klumperman, 2005). 
1.4.1.2.- Retrograde transport 
ER resident proteins possess signals for its retention in this organelle; however some 
of them reach the Golgi complex, either for post-translational modification or for miss-
sorting at the ERES. Retrograde transport is used to send back to the ER these soluble 
or transmembrane ER resident proteins. Proteins that cycle between these organelles, 
as the KDEL receptor (KDELR), also use this trafficking pathway to travel from the 
Golgi complex to the ER. Retrograde membrane trafficking also compensates the large 
amount of membrane that arrives at the Golgi complex from the ER, which could lead 
to disruption of Golgi structure and function if not compensated. 
Retrograde transport is mainly driven by coat protein complex I (COPI) vesicles, which 
are formed by the protein complex coatomer (Kreis and Pepperkok, 1994). The most 
accepted model postulates that COPI vesicle function is to accumulate, sort and 
transport cargo in a retrograde manner (Bethune, 2006; Lippincott-Schwartz and Liu, 
2006). However, the prominent presence of COPI vesicles around the cisternae of the 
Golgi also suggests a role of these carriers in intra-Golgi trafficking (Duden 1991; 
Serafini 1991a). Soluble ER resident proteins possess a four aminoacid sequence 
(KDEL, where K stands for lysine, D for aspartic acid, E for glutamic acid and L for 
leucine) at its carboxyl end, which is recognized by a seven transmembrane protein 
that cycles between the ER and the Golgi complex, the KDEL receptor (KDELR; Lewis 
and Pelham, 1990; Capitani and Sallese, 2009). When KDELR binds a protein with the 
KDEL tag at the Golgi complex, it sends it back to the ER through COPI vesicles. 
Transmembrane ER resident proteins also possess a four aminoacidic tag at its 
carboxyl end, KKXX (where K stands for lysine and X for any other aminoacid). This 
aminoacidic sequence interacts with proteins of the COPI coat and acts as a recovery 
signal that stimulates retrograde transport of these proteins from the Golgi complex or 
the ERGIC back to the ER (Nilsson, 1989). 
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Retrograde transport is not limited by COPI vesicles. First evidences of COPI 
independent retrograde transport rose with the identification the Golgi GTPase Rab6. 
Overexpression of a constitutively active form of Rab6-GTP leads to a retrograde flux 
of membrane (Martínez, 1997). Studies with bacterial toxins as the Shigella toxin B 
(StxB), showed that inhibition of COPI transport did not alter the transport of the STxB 
from the Golgi complex to the ER and that this transport was dependent of Rab6 
(Girod, 1999). 
1.4.2.- Intra-Golgi transport 
Once the cargo has arrived at the cis-Golgi, it must go through all Golgi compartments, 
where it will be modified, and after reaching the trans face of the organelle will be finally 
sent to its final destination. Cargo, either small as the vesicular stomatitis virus G 
protein (VSVG) or large as procollagen, traverse the Golgi within COPI vesicles and/or 
through tubular connections that communicate different compartments (Mironov, 2001). 
However, there is lots of controversy about how the cargo goes through the Golgi, and 
debate between two classical models for intra-Golgi transport is not just still open, but 
some other models are arising (Glick and Luini, 2011). The vesicular transport model 
views the Golgi complex as a set of stable compartments where cargo is delivered to 
its cis side and would then move from one compartment to the next in COPI vesicles 
(Rothman and Wieland, 1996). On the other hand, in the cisternal 
progression/maturation model the Golgi cisternae are viewed as transient carriers, 
formed by homotypic fusion of COPII vesicles or other ER-derived carriers, which 
nucleate to form a new cis-Golgi cisterna (Bannykh and Bach, 1997, Mironov 2003). As 
the cisterna carry the secretory cargo forward, COPI vesicles would recycle Golgi 
proteins from older to younger cisternae (Glick and Malhotra, 1998; Rabouille and 
Klumperman, 2005). This model can be extended to incorporate tubular connections 
between cisterna. These tubular connections have been shown (Marsh, 2004; Trucco 
2004) and enzymes of phospholipid metabolism as phospholipase A2 may be 
implicated in its formation (San Pietro, 2009). These connections would allow cargo to 
move faster through cisternae and also allow the retrograde trafficking of resident Golgi 
proteins (San Pietro, 2009). Another model, known as rapid partitioning model, 
suggests that the Golgi operates as a single compartment that contains processing 
domains and export domains, and that cargo would partition between these domains 
and exit the Golgi from every level to its final destination (Patterson, 2008; Lippincott-
Schwartz and Phair, 2010). Finally, the cisternal progenitor model proposes that the 
Golgi complex is a set of stable compartments that are segregated into domains 
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defined by Rab GTPases, where cargo transport would involve continual fusion of 
fission of these stable compartments (Pfeffer, 2010). 
1.4.3.- Post-Golgi transport 
After crossing the Golgi complex, cargo finally reaches the TGN, a tubulovesicular 
network where last post-translational modifications are done and cargo is sorted and 
sent to its final cellular destination as endosomes, lysosomes, the plasma membrane 
or the extracellular media. In polarized cells different molecular machineries regulate 
the transport to the basolateral plasma membrane and to the apical membrane (De 
Matteis and Luini, 2008). Proteins that are destined for basolateral domains possess a 
cytoplasmic tag that consists of the aminoacidic sequence YXX0 (where Y stands for 
tyrosine, X for any aminoacid and 0 for a hydrophobic one), which is recognized by 
coat or adaptor proteins (Bonifacino and Traub, 2003).  Sorting of apical cargoes 
occurs by lipid-lipid or lipid-protein interactins within transmembrane or luminal 
domains, being the latter a process mediated by N- and O-glycans (Potter, 2004), or by 
interactions with the tethering domain GPI of the lipid rafts (Schuck and Simons, 2004). 
Once cargo is correctly sorted, this is retained in specific membrane domains of the 
TGN, in which cargoes with other destination and resident proteins are excluded. 
Finally, this cargo is embedded into a transport carrier that will bud and fission from the 
TGN (De Matteis and Luini, 2008). 
1.5.- Biogenesis of transport carriers at the Golgi complex 
When a membrane export domain is ready for export, it interacts with a suitable motor, 
it is extruded from the Golgi area and is followed by the detachment of these tubular 
precursors into transport carriers (De Matteis and Luini, 2008). These steps are also 
common in the biogenesis of COPI transport carriers for retrograde transport. The first 
step for the formation of the transport carrier is its budding, where a region of the 
membrane loaded with cargo will protrude into the cytoplasmic face. After the budding 
of the transport carrier, this must be detached from the membrane in a process called 
fission. Membrane fission requires local distortion and remodelling of the lipid bilayer to 
create a separate membrane-bound compartment without compromise the integrity of 
the maternal bilayer and avoiding any exposure of the vesicle lumen with the external 
milieu (Campelo and Malhotra, 2012). Membrane fission has been proposed to 
proceed via hemifusion-like pathway (Kozlovsky and Kozlov, 2003). Briefly, membrane 
fission starts with the formation a constricted neck, where membranes of the fission 
neck come into close proximity. Then contacting monolayers merge in a fission stalk 
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intermediate and the decay of this fission stalk leads to the completion of the fission 
reaction (Campelo and Malhotra, 2012; Fig. 5). 
Figure 5. The steps of the fission of a vesicular transport carrier. 1) Membrane budding, 2) formation 
of a hemifission intermediate and 3) the eventual separation of the carrier . (Campelo and Malhotra, 2012) 
The process of membrane remodelling required for fission must be energetically 
favourable. The system free energy before remodeling has to be higher than after 
fission, which means that membrane remodeling must result in relaxation of the free 
energy. In other words, the fission process must go energetically “downhill” (Kozlov, 
2010). Then, a large energy barrier has to be overcome to prevent the arrest of the 
system in a bud/tube configuration. The energy requirement for this late step can be 
reduced by changes in membrane curvature that promote fission, which can be driven 
by protein insertions into the bilayer or changes in the lipid composition of the 
membrane (Campelo and Malhotra, 2012). 
1.5.1.- Membrane curvature for transport carrier formation 
Both budding and fusion require changes in membrane curvature, which can be 
positive or negative.Conventionally, the curvature of a monolayer is defined as positive 
if the monolayer bulges in the direction of the polar heads, and negative for the 
opposite direction of bending (Semesh, 2003). Transport carrier budding needs the 
generation of both positive and negative curvature and their fission is highly dependent 
of negative curvature. In the formation of a membrane bud, positive curvature is 
required at the outer bilayer, while negative is needed at the inner. In the neck, there is 
a “saddle” geometry, which means that at any point both positive and negative 
curvatures are needed (Fig. 6). To proceed, the membrane bud needs to promote 
negative curvature to destabilize this “saddle” structure to finally achieve the fission of 
the transport carrier from the membrane of the donor organelle. 
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Figure 6. Membrane curvature in transport carrier formation. A) Membrane curvatures found in the A) 
budding and B) scission of a transport carrier. C)Detailed view of the different curvatures at the neck of a 
membrane bud, where is shown that both negative and positive curvature are needed for membrane 
fission. The cytosolic and luminal leaflets of the membrane are depicted in blue and orange, respectively. 
(Adapted from McMahon and Gallop, 2005; and Campelo and Malhotra, 2012).
The changes in membrane curvature that makes fission energetically favourable can 
be driven by different mechanisms (Fig. 7): changes in cytoskeletal polymerization and 
pulling of tubules by motor proteins, interaction of proteins with the membrane and/or 
changes in the lipid composition of the bilayer (McMahon and Gallop, 2005). First, the 
external force required to expand a piece of membrane for budding can be done by the 
combined action of the cytoskeleton and its motor proteins (De Matteis and Luini, 
2008). Second, the interaction of proteins with the membrane bilayer can modify its 
curvature by three different ways. Transmembrane proteins can deform the membrane 
bilayer, since some of them have intrinsic curvature or present curvature on 
oligomerization. Peripheral membrane proteins can also modify the membrane by 
direct or indirect scaffolding. One example of this bending of the membrane by protein 
scaffolding is the oligomerization of the COPI coat proteins, which leads to the budding 
of COPI vesicles. Third, the insertion of the amphipathic helix into the membrane can 
also increase positive membrane curvature (McMahon and Gallop, 2005). 
Finally, the lipid composition also plays a role in the generation of membrane curvature. 
The structure of their polar head and the nature of their acyl chains can influence the 
shape of the membranes. Depending on these parameters, three groups of lipids can 
be distinguished: cylindrical, inverted cones and conical lipids. Membrane lipids with a  
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Figure 7. Mechanisms of membrane deformation. The phospholipid bilayer can be deformed causing 
positive or negative membrane curvature. There are three main categories: 1, changes in lipid 
composition; 2, changes in cytoskeletal polymerization and pulling of tubules by motor proteins;  and 3, by 
protein interaction , which can be by integral membrane proteins that have intrinsic curvature or have 
curvature on oligomerization; by direct and indirect scaffolding of the bilayer; or by active amphipathic helix 
insertion into one leaflet of the bilayer (adapted from McMahon and Gallop, 2005).
polar head size similar to its hydrophobic moiety are known as cylindrical lipids, which 
spontaneously form a planar bilayer, without membrane curvature. PC, the most 
abundant lipid on cell membranes is a cylindrical lipid. The second group of lipids, the 
inverted cones, possess a polar head thicker than their hydrophobic part, which adopt 
a convex structure and promote positive curvature. Lysophospholids, as 
lysophospahtidic acid (LPA), are examples of inverted cones. The structure of conical 
lipids is opposite to the inverted cones, with a polar group smaller than its hydrophobic 
part. DAG and PA are examples of conical lipids, which adopt a concave structure and 
promote negative curvature of the membrane (Fig. 8; Voet and Voet, 1995). However, 
the negative charge of the polar headgroup of PA prevents that several PA molecules 
are localized together in order to promote negative curvature. 
Therefore, changes in the lipid composition of the membrane can promote its 
curvature. It has been reported that an increase of DAG concentration increased the 
negative curvature of PC monolayers in vitro (Szule, 2002). The conversion of one kind 
of lipid to another can promote membrane curvature, as it does phospholipase A, which  
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Figure 8. Classes of lipids and its 
spontaneous curvature. Conical lipids (in 
red) as PC or PE  do not induce membrane 
curvature. Inverted cone lipids (in blue) as 
LPA induce positive curvature, while 
conical lipids as DAG and PA promote 
negative curvature of the membrane.The 
line represents the curvature induced by 
each class of lipid. 
transforms PA (a conical lipid with two acyl chains) to LPA (an inverted cone with one 
acyl chain); which favour opposite curvature (Kooijman, 2005). Enzymes that change 
lipid headgroup size also can influence the area occupied by the lipids, affecting 
membrane curvature. DAG formation by phospholipase C (PLC) also promoted the 
increase of negative curvature of liposomes (Riske and Döbereiner, 2003). The action 
of flippases, which transfer lipids from one leaflet to the other, could generate 
membrane asymmetry, which could lead to membrane bending; or disrupt it. Thus, the 
metabolism of membrane lipids can play an important role in the generation or 
stabilization of membrane curvature and its particular distribution in the shape of a 
membrane, since most of the headgroups and acyl groups of different membrane lipids 
can be changed, going from the cylindrical PC to the highly conical DAG (McMahon 
and Gallop, 2005). 
1.5.2.- Biogenesis of COPI-coated vesicles 
The generation of COPI vesicles can be conceptually subdivided into different steps: 
coat recruitment, uptake of cargo, budding, membrane separation or scission and 
uncoating (Fig. 9; Popoff, 2011). The COPI, also called coatomer, consists of 
heptameric (
, , , , , , ) complex, with two main subcomplexes: the -COP–-
COP–-COP–-COP tetrameric complex, which constitutes the inner layer core; and 
the 
-COP–-COP–-COP trimeric complex, which forms the outer layer of the COPI 
coat (Waters, 1991; Eugster, 2000). Recruitment of the coatomer to Golgi membranes 
is tightly correlated to ADP-ribosylation factor 1 (Arf1) activation (Donaldson, 1991; 
Serafini, 1991b; Palmer, 1993). Arf1 contains Golgi localization signals encoded in its 
sequence, and, once at this organelle can bind to dimeric complexes of the p24 family 
of Golgi-resident transmembrane proteins (Gommel, 2001). In contrast to clathrin1 and 
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COPII, which are composed of two successively recruited layers of protein, the 
coatomer is recruited en bloc (Hara-Kuge, 1994). 
Figure 9.Scheme of the individual steps of the formation of a COPI vesicle. See detailed information 
in the text (Popoff, 2011.) 
Cargo proteins are directed into COPI vesicles by different mechanisms based on 
direct or indirect binding to the coat. The KDELR interacts at the luminal side of soluble 
proteins with the C-terminal KDEL-sequence and its cytosolic tail interacts with 
coatomer and, as a result, KDEL-proteins are included into COPI vesicles and retrieved 
to the ER (Pelham 1991, Majoul 1998). Membrane proteins to be included into COPI 
vesicles can also be recognized directly by coatomer through sorting motifs present in 
their sequence (Popoff, 2011). It has also been proposed that ArfGAP1 can mediate 
cargo concentration at the center of a growing bud (Liu, 2005). 
During the formation of a COPI bud, two different mechanisms have the potential to 
deform membrane into a curved bud. These are the polymerization of coatomer and 
the activity of Arf. Coatomer and Arf-GTP alone are sufficient to form COPI vesicles in 
vitro (Spang, 1998). Coatomer forms multiple protein-protein interfaces that result in 
conformational changes in -COP and 
-COP subunits (Reinhard, 1999; Bethune, 
2006; Langer, 2008). The spatial rearrangement of these subunits causes aggregation 
of the complex and is likely to initiate coatomer polymerization (Reinhard, 1999) 
providing the energy to bend the membrane to form a COPI-coated bud (Popoff, 2011). 
Other proteins as Brefeldin-A ADP-ribosylated Substrate (BARS), endophilin and 
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ArfGAP1 are thought to play a role in membrane scission of COPI-coated buds (Popoff, 
2011). However, scission of COPI vesicles is a process still poorly understood. 
Once a COPI vesicle is formed, it needs to be uncoated in order to allow fusion with its 
target membrane. This process is coupled to hydrolysis of GTP by Arf1 (Tanigawa 
1993), triggered by ArfGAPs (Cukierman, 1995), which can be regulated by membrane 
curvature (Bigay, 2003). 
In addition to the protein machinery involved in COPI vesicle formation, it has been 
shown that lipids as PA, DAG and PI also have active roles in the generation of these 
transport carriers. Our group showed that pharmacological inhibition of DAG production 
impaired the fission of COPI vesicles and the recruitment of ArfGAP1 at the Golgi 
complex (Fernández-Ulibarri, 2007). These results were confirmed by another study, 
where it was proposed that DAG was needed for bud formation (Asp, 2009). It has also 
been proposed that PA participates in COPI vesicle formation, since it has been shown 
that BARS requires PA to induce tubulation in vitro (Yang, 2008). Moreover, 
knockdown of PI transfer protein  (PITP) leads to an impairment of COPI-mediated 
retrograde transport (Carvou, 2010), suggesting that PI is required for COPI vesicle 
formation, since it is the substrate of PI(4)P. 
1.5.3.- Biogenesis of TGN-to-plasma membrane transport carriers 
In contrast to COPI-, COP-II and clathrin-coated vesicles, thus far there is no specific 
coat protein identified for the formation of transport carriers that drive the trafficking of 
cargo from the TGN to the plasma membrane (Campelo and Malhotra, 2012). 
However, it is well known that a serine/threonine kinase termed protein kinase D (PKD) 
plays a critical role in the formation of these transport carriers (Bard and Malhotra, 
2006; Malhotra and Campelo, 2011). 
Early studies with the sponge metabolite ilimaquinone (IQ) suggested the existence of 
regulated membrane fission machinery at the Golgi complex. IQ addition led to a 
complete vesiculation of the Golgi complex and after IQ removal the Golgi complex 
assembled into a normal, fully functional, organelle (Takizawa, 1993). Further studies 
showed that trimeric G protein subunits  and PKD were involved in the IQ-mediated 
fragmentation of the Golgi (Jamora, 1997; Jamora 1999; Díaz-Añel and Malhotra, 
2005). Chemical inactivation of PKD or expression of an inactive form inhibited 
trafficking of proteins from the Golgi to the cell surface, retaining cargo into large 
tubules attached to the TGN (Liljedahl, 2001). Overexpression of a constitutive active 
PKD caused extensive vesiculation of the TGN, while PKD depletion by small 
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interference siRNA (siRNA) led to cargo accumulation in tubular membranes at the 
TGN (Bossard, 2007). These results led to the proposal that PKD was required for 
events leading to membrane fission specifically of carriers that transport cargo to the 
cell surface. 
DAG has a critical role in the generation of TGN-to-plasma membrane transport 
carriers. The first cysteine rich domain of PKD, known as C1a, binds DAG at the TGN  
(Maeda, 2001) and depletion of cellular pools of DAG inhibits the binding of PKD to the 
TGN and blocks protein trafficking to the cell surface (Baron and Malhotra, 2002). In 
addition to recruiting PKD, DAG in the TGN is required for protein kinase C 	 (PKC	) 
activation, which in turn phosphorylates and activates the DAG-associated PKD (Díaz-
Añel and Malhotra, 2005). Moreover, the local increase of DAG should promote the 
negative curvature needed for the fission of these transport carriers (Bard and 
Malhotra, 2006). In a proposed model, Golgi-associated DAG recruits PKD, which in 
turn indirectly increases DAG production by the action of shingomyelin synthase to 
promote fission of transport carriers at this organelle (Malhotra and Campelo, 2011, 
see below chapter III). 
2.- DIACYLGLYCEROL AT THE GOLGI COMPLEX 
2.1.- Structure and function of diacylglycerol  
Diacylglycerol (DAG) is a lipid consisting of a glycerol molecule linked through ester 
bonds to two fatty acids. This composition confer exceptional properties on DAG as a 
lipid intermediate in metabolism, as a component of biological membranes and as a 
second messenger (Fig. 10; Carrasco and Mérida, 2007). 
Based on its acyl chain nature, more than 50 DAG species have been identified in 
mammals, which differ in the length and the number of insaturations of acyl chains 
(Pettitt and Wakelam, 1993).  Palmitic acid (16:0; 16 carbon length: 0 double bonds), 
estearic acid (18:0), and arachidic acid (20:0) are the most common saturated fatty 
acids in cell membranes.  Oleic acid (18:1) is the most common monounsaturated acyl 
chain while linoleic acid (18:2) and arachidonic acid (20:4) are the most abundant 
poliinsaturated fatty acids.  
DAG has an important role as a precursor for phospholipid synthesis. Although DAG is 
found in small amounts, its presence is a requisite for most phospholipid synthesis. 
DAG is a precursor for PC and PE, whose synthesis requires the incorporation of the 
activated alcohols CDP-choline and CDP-ethanolamine into DAG (Henneberry, 2002). 
In addition, DAG can be phosphorylated by DAG kinases (DAGK) to produce PA,  
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which is essential for the synthesis of PI and cardiolipin. Moreover, DAG can be 
metabolized into triacylglycerol (TAG) by esterification of a new fatty acid in the free 
alcohol group of the glycerol moiety (Carrasco and Mérida, 2007). 
DAG also acts as a second messenger. One of the most known producers of DAG as a 
second messenger PLC, a family of phospholipases that classically, after extracellular 
stimuli, hydrolyses PI(4,5)P2 producing DAG and IP3, a soluble second messenger that 
is essential for Ca2+ exit from the intracellular Ca2+ stores (Gresset, 2012, Khadamur 
and Ross, 2012). DAG is able to bind and activate different signalling proteins, which 
have at least one sequence of 50 amino acids known as C1 domain (Yang and 
Kazanietz, 2003). C1 are conserved domains rich in cysteine that were first described 
in the PKC family, but that are also found in other five protein families as chimaerins, 
DGKs, PKD, Munc13, Ras guanine-realising protein (RasGRP) and myotonic 
dystrophy kinase-related Cdc42-binding kinase (Carrasco and Mérida, 2007). C1 
domains were initially described as domains that bind DAG analogues as phorbol 
esters, and their capacity to bind DAG and other related compounds was confirmed 
later (Kazanietz, 2000). 
Compared to other membrane phospholipids, DAG possesses a small polar 
headgroup, comprising only an alcohol group of the glycerol moiety. This makes DAG 
the lipid with the most spontaneous negative curvature, involving it in events that 
require high membrane curvature as fission of transport carriers (Shemesh, 2003). If 
membrane curvature is impaired, the presence of DAG in a bilayer induces the 
generation of small areas in which the apolar regions of neighbouring lipids are partially 
exposed (Goñi 1999). By promoting the hydrophobic interaction of proteins with these 
membrane areas, DAG can affect the activity of some proteins that are integrated or 
Figure 10. Functions of DAG as a component of biological membranes. DAG (highlighted in yellow) 
can participate in different events at the biological membrane. A) Some proteins are recruited to the 
membrane by the binding of its C1 domain to DAG. B) DAG can interfere to some protein activities by 
facilitates the insertion of amphipathic helixes of proteins into the bilayer. C) DAG, as a conical lipid, 
promotes negative membrane curvature. 
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interact with cell membranes (Lee, 2004; Bigay, 2005; Ahyayauch 2005). Moreover, 
DAG molecules with saturated fatty acids adopt a more conical structure than those 
with unsaturated ones, thus promoting membrane curvature or interaction of proteins 
with hydrophobic tails. One example of this is found in ArfGAP1, which is more active 
in membranes enriched DAG molecules with one monounsaturated acyl chain 
(Antonny, 1997), which are the most common fatty acids of the hydrophobic backbone 
of PC.   
2.2.-DAG in the fission of transport carriers at the Golgi complex 
DAG has a critical role at the Golgi complex, where is needed for the generation of 
transport carriers. First evidences were shown in yeast, where DAG depletion by 
overexpression of a DAGK impaired protein transport from the Golgi complex (Kearns, 
1997). DAG requirement for transport to the plasma membrane was confirmed in 
mammals, where pharmacological reduction of DAG levels impaired the recruitment of 
PKD to the Golgi complex and blocked protein trafficking from the TGN to the plasma 
membrane (Baron and Malhotra, 2002). A theoretical model suggested that DAG was 
not only needed for PKD recruitment, but also for generating the membrane curvature 
needed for fission of transport carriers (Semesh, 2003). Reduction of Golgi DAG levels 
after Nir2 inhibition impaired Golgi secretory function, which can be recovered by PC 
synthesis inhibition (Litvak, 2005). By pharmacological inhibition of DAG production, 
our group demonstrated the need of DAG for fission of COPI vesicles at the Golgi 
complex (Fernández-Ulibarri, 2007), a result confirmed by others, where DAG was 
proposed to be needed for vesicle budding (Asp, 2009). In this context, inhibition of 
sphingomyelin synthase (SMS), which also produces DAG; by pharmacological and 
siRNA approaches also impaired protein secretion (Subathra, 2011) 
These results showed the involvement of DAG in transport carrier formation and led to 
models of transport carrier formation where DAG has a pivotal role in both PKD 
recruitment and vesicle fission (Bard and Malhotra, 2006, Campelo and Malhotra, 
2011). They also showed the enzymatic pathways that may be targeted by cells to 
control DAG at the Golgi compelx. However, how cells regulate DAG for the generation 
of transport carriers is unknown. It has been postulated that, cargo arrival could be the 
more straightforward activator of DAG production at the Golgi complex for transport 
carrier formation (Bard and Malhotra, 2007), but this issue has not been experimentally 
adressed. 
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2.3. DAG metabolism at the Golgi complex 
DAG is an intermediate metabolite that is involved in different metabolic pathways (Fig. 
11). At the Golgi complex DAG can be produced by at least three different 
mechanisms: 1) by SMS (Holthuis and Luberto, 2010), 2) the coupled reactions of 
phospholipase D (PLD) and lipid phosphate phosphatases (LPPs; Sciorra and Morris, 
1999), and 3) by PLC (Bard and Malhotra, 2005). However, DAG concentration not 
only depends on these mechanisms that produce it, but also on metabolic pathways 
that consume DAG. These pathways are the ones involved in phospholipid synthesis, 
which are the synthesis of PC by the CDP-choline pathway or PI synthesis. The key 
enzymes of DAG-consuming reactions are also localized at the Golgi complex 
(Jelsema and Morré, 1978). This way, an increase of DAG for the generation of 
transport carriers at the Golgi complex could be caused, theoretically, by a stimulation 
of mechanisms that produce DAG, by an inhibition of the ones that consume it or by 
both. 
Figure 11. Metabolic pathways that can 
regulate DAG at the Golgi complex. The 
name of the enzyme or pathway that produces 
or consumes DAG is written in bold and italic. 
2.3.1.- DAG production by the sphingomyelin synthase 
Production of DAG by SMS is one of the mechanisms that can regulate DAG 
homeostasis at the Golgi complex, since it is well established that SMS is found at the 
trans-Golgi (Holthuis and Luberto, 2010). SMS, also named phosphatidylcholine: 
ceramide cholinephosphotransferase; transfers phosphocholine from PC to ceramide 
to yield SM and DAG. SM synthesis is initiated by the production of ceramide, the key
intermediate for the biosynthesis of most sphingolipids. Briefly, L-serine and palmitoyl 
CoA are condensated to generate 3-ketodihydrosphingosine, which is rapidly reducted 
and N-acylated to generate dihydroceramide, which is desaturated to finally generate 
ceramide.These reactions that produce ceramide have been described to occur in the 
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cytosolic leaflet of the ER bilayer (Hanada, 2009). Then, ceramide is delivered to the 
luminal side of the Golgi complex by the ceramide transfer protein (CERT; Hanada, 
2003), and converted to SM by SMS. 
Mammals express two isoforms of SMS (SMS1 and SMS2), both localized at the Golgi 
complex, although SMS2 is also found at the plasma membrane (Villani, 2008; 
Huitema 2004). Availability of ceramide seems to be the limiting step for SM synthesis. 
LY-A, a cell line that expresses a mutated CERT, has an impaired SM synthesis that 
can be restored with addition of functional CERT (Hanada, 2003).  
There are evidences that DAG production by SMS at the TGN has a role in secretory 
function. Treatment with fumonisin B1, which inhibits ceramide synthase and thus 
deprives SMS of its substrate, lowers DAG levels in the Golgi complex, and this 
inhibition also results in block of Golgi-to-cell-surface transport (Baron and Malhotra 
2002). Addition of short chain ceramide leads to an increase of DAG at the Golgi 
complex, suggesting that SMS can regulate the Golgi-associated DAG pool (Villani, 
2008). Pharmacological inhibition of SMS leads to tubulation of the TGN and silencing 
of both SMS1 and SMS2 reduces the trafficking of VSVG to the plasma membrane and 
insulin secretion (Subathra, 2011), suggesting a role for SMS in the TGN secretory 
function. Moreover, a recent study suggests that a regulated production and 
organization of SM is necessary for transport carrier formation (Duran, 2012), showing 
that both products of SMS are needed for Golgi secretory function. However, if SMS is 
regulated to control the amount of DAG in order to promote fission at the Golgi and/or 
SMS is activated after cargo arrival is not known. 
2.3.2.- DAG production by phospholipase D and lipid phosphate phosphatases 
DAG can also be produced by the combined action of PLD and LPPs. PLD converts 
PC into PA, which can be dephosphorylated to DAG by LPPs. 
Two mammalian PLD enzymes that convert PC to PA have been identified: PLD1 and 
PLD2.  Both enzymes have been reported on the plasma membrane and on internal 
vesicles, although PLD2 appears less abundant at internal sites than PLD1. However, 
their precise localization is controversial. Both enzymes have been reported to be 
localized at the Golgi complex (Freyberg 2001, Freyberg 2002), but this localization 
has not been confirmed by other studies (Sarri 2003, Du 2004). 
LPPs are members of a larger family of proteins, the phoshpatidic acid phosphatases 
(PAP) that hydrolyze PA. LPPs were formerly known as Mg2+-independent and N-
ethylmaleimideinsensitive phosphatidate phosphatases (PAP2). There are three LPPs 
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(LPP1, LPP2, and LPP3 and a splice variant, LPP1a), which hydrolyze lipid 
phosphates, including PA, LPA, sphingosine1-phosphate, ceramide 1-phosphate and 
diacylglycerol pyrophosphate (Brindely 2009). All LPPs are present to some extent in 
the plasma membrane, while LPP2 and LPP3 have been variably localized in 
endomembranes such as ER, endosomes, vesicular structures and the Golgi complex 
(Alderton, 2001). In a recent study from our group, LPP3 was found in early 
compartments of the secretory pathway including the Golgi complex, and particularly 
enriched at the ERGIC (Gutiérrez-Martínez, 2013). 
PLD has been suggested to be involved in membrane traffic since it was discovered 
that Arf1, an important regulator of membrane traffic localized at the Golgi complex, 
was an activator of PLD activity (Brown 1993, Cockcroft 1994). Studies that revealed a 
role for PLD in formation of Golgi coated vesicle (Ktistakis 1996), transport from the ER 
to the Golgi (Bi, 1997) or in regulation of Golgi structure and protein secretion in 
endocrine cells (Siddhanta, 2000) have not been confirmed by siRNA experiments that 
knockdown PLD (Roth, 2008). PA, the product of PLD, has also been suggested to be 
necessary for COPI vesicle formation (Yang, 2008) and if metabolized by LPPs can 
generate DAG. There are some evidences that inhibition of LPPs causes defects on 
the Golgi function. Treatment with propanolol, an inhibitor of general PAP activity, leads 
to a lesser recruitment of PKD in the Golgi complex and alters anterograde transport 
(Baron, 2002), lowers DAG levels in this organelle and impairs COPI vesicle fission 
(Fernández-Ulibarri, 2007) and budding (Asp, 2009), with the subsequent alteration of 
retrograde transport from the Golgi complex to the ER. Moreover, the depletion of 
LPP3 impairs the Rab6-dependent retrograde transport of STxB from the Golgi to the 
ER and induces a high accumulation of Golgi-associated membrane buds (Gutiérrez-
Martínez, 2013). However, none of these studies show evidence that LPPs or PLD may 
be regulated by the presence of cargo or specifically stimulated during DAG production 
for transport carrier formation at the Golgi complex. 
Nevertheless, the structure of PA and DAG produced by PLD activity also support the 
idea that PLD could be involved in transport carrier formation. As explained before, the 
most abundant forms of PC, the substrate for PLD in mammalian cells, have one 
saturated and one unsaturated acyl chain. Membrane lipids with an unsaturated acyl 
chain have a relative bigger hydrophobic part than those with two saturated acyl 
chains. PA and DAG derived from PLD activity would conserve this unsaturated acyl 
chain, being even more conical than PA and DAG with two saturated acyl chains, 
promoting negative membrane curvature and, on the other hand, facilitating the 
insertion of hydrophobic amino acids into the membrane (Roth, 2008).  
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2.3.3.- DAG consuming pathways 
2.3.3.1.- DAG consumption by PC synthesis: the CDP-choline or Kennedy pathway 
DAG can be consumed by the synthesis of PC in the CDP-choline or Kennedy 
pathway. PC is the most abundant phospholipid of eukaryotic membranes, generally 
comprising more than 50% of the total phospholipid mass. In mammalian cells, PC is 
mainly synthesised de novo by the CDP-choline or Kennedy pathway. 
Choline is an essential nutrient provided by the diet. Choline is internalized by gradient-
driven choline transporters. Once inside the cell, choline is phosphorylated by the 
choline kinase (CK) producing phosphocholine. Because CK has a high affinity for 
choline, choline taken up into cells is readily trapped as phosphocholine, which 
constitutes the largest pool of intermediates in the CDP-choline pathway (Fagone and 
Jackowski, 2013), and it also maintains the choline gradient that allows its 
internalization to the cell. Phosphocholine can be also supplied as a result of 
sphingomyelin degradation by a lysosomal sphyngomyelinase (Jansen, 2001).  
Phosphocholine and CTP give CDP-choline and pyrophosphate, in a reaction 
catalyzed by the CTP:phosphocholine cytidylyltransfarase (CCT). CCT is the key 
regulatory enzyme in the CDP-choline pathway. Moreover, CDP-choline, the product of 
the reaction, is present in extremely small amounts in cells, indicating that newly 
synthesized CDP-choline is readily incorporated to PC. CCT presents a biochemical 
regulation that enables its response to local changes in membrane lipid. This 
mechanism relies on the insertion of the hydrophobic face of its 
-helix into membranes 
with lipid packaging stress. This way, CCT has low affinity with membranes that are 
made up of a large fraction of PC; and introduction of DAG or free fatty acids into these 
membranes introduces negative elastic stress and enhances CCT association and 
activity (Yang, 1995; Johnson, 1998). Thus, CCT can sense changes on membrane 
composition in order to increase PC synthesis when this is depleted (Fagone and 
Jackowski, 2013). 
DAG is consumed in the last step of the CDP-choline pathway, a reaction catalysed by 
the enzyme CDP-choline: diacylglycerol phosphotransferase (CPT). In this reaction, 
phosphocholine is transferred from CDP-choline to DAG, producing the end product 
PC and CMP. This last, DAG-consuming step of the CDP-choline pathway can also be 
physiologically regulatory, since it has been reported that NMDA overactivation inhibits 
PC synthesis at the level of CPT (Gasull, 2003). 
INTRODUCTION 
59 

Although PC synthesis is mainly localized at the ER, evidences of its presence at the 
Golgi complex have been shown. Fractionation of subcellular organelles reveals that 
CPT activity in the Golgi complex is 37 % of that in the ER, the organelle where CPT 
activity is higher (Jelsema and Morré, 1978). Overexpression studies showed that CPT, 
the enzyme that incorporates DAG in the CDP-choline pathway, is localized at the 
Golgi complex (Henneberry 2002). 
Some studies point that Golgi-specific CPT may have a role in regulating secretory 
processes by controlling DAG levels in this organelle. The yeast PITP Sec14p is 
essential for protein trafficking at the Golgi complex (Bankaitis, 1989). Sec14p 
requirement for yeast Golgi function can be bypassed by mutations in the yeast CK 
gene that impair PC synthesis (Cleves, 1991), suggesting a role for the CDP-choline 
pathway in the regulation of Golgi secretory function. Sec14p was proposed to act as a 
dynamic sensor of PI and PC content in Golgi membranes, regulating the CDP-choline 
biosynthetic pathway in this organelle (McGee, 1994). Defects on Sac1p that led to an 
increase of the DAG pool at the Golgi complex also bypassed Sec14p requirement for 
secretory function (Kearns, 1997). The CDP-choline pathway is not the primary route 
for PC synthesis in yeast, where is not essential (Fagone 2012). This observation 
suggests that, in yeast, one of the functions of this metabolic pathway, instead of being 
the main producer of PC, is to control the secretory function of the Golgi complex. 
Similar results were obtained with Nir2, the mammalian homologue of Sec14 (Litvak, 
2005).  
2.3.3.2.- DAG consumption by PI synthesis 
DAG can also be consumed for PI synthesis. PI is a structural lipid and also the 
precursor of all polyphosphoinositides, which have critical roles in organelle identity, 
vesicular trafficking and signalling. DAG is consumed in this pathway by DAGKs, which 
phosphorylate DAG to produce PA. Then, PA is activated by CTP to CDP-DAG, which 
condensates with inositol to produce PI by the action of phosphatidylinositol synthase 
(PIS; Antonsson, 1997). 
PIS is a membrane-bound enzyme that requires Mg2+ and has a high specificity for its 
substrate myo-inositol. Myo-inositol is an essential substrate and its availability could 
control PIS activity. It has also been suggested that PIS activity might be inhibited by its 
product, PI (Antonsson, 1997). 
The substrate for PI synthesis CDP-DAG is formed in very low amounts by cytidine 
diphosphate-diacylglycerol synthase (CDS). The low levels of CDP-DAG reported 
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suggest that CDS activity may be the rate-limiting step for PI synthesis (Heacock and 
Agranoff, 1997), as CTT for the CDP-choline pathway; indicating that newly 
synthesised CDP-DAG is rapidly converted to PI or to phosphatidylglycerophosphate. 
DAG is consumed for PI synthesis by DAGKs. DAGKs are members of a family of 
cytosolic lipid kinases, currently with ten members classified into five different 
subtypes. Most of its members are cytosolic proteins that translocate to the membrane, 
are regulated by phosphorylation and have tissue specificity. The main function 
attributed to DAGKs is the depletion of DAG, but also controls the levels of PA. DAGKs 
have been found to be crucial components for PI resynthesis, since some studies have 
shown that PA generation controls the PI cycle (Mérida, 2008). 
It is well known that PI synthesis takes place at the ER. However, some PIS and CDS 
activity have been found in Golgi-enriched membrane fractions (Jelsema and Morré, 
1978). A recent study showed that PIS is found in a mobile compartment of ER origin 
that makes ample contact with other organelles, while CDS resides in the Golgi 
complex. Moreover, catalytically inactive PIS is not found in this mobile compartment, 
suggesting that PI synthesis is needed for the generation of this mobile compartment 
where active PIS is found (Kim, 2011). 
DAG consumption for PI synthesis takes place at the beginning of this metabolic 
pathway. However, regulation of PIS can also affect, theoretically, the Golgi-associated 
DAG pool, because changes on the rate of this enzyme can affect the rate of other 
steps of the pathway and, therefore, the amount of all the metabolic intermediates of 
this pathway, as DAG. Thus, changes in PIS and CDS activity could modify the activity 
of the other enzymes of the pathway, as the DAG consumption by DAGK. This step 
can also be taking place at the Golgi complex, since DAGK are cytosolic enzymes that 
can act on different cellular membranes. 
On the other hand, PI is necessary for membrane trafficking and Golgi function, since it 
is the precursor of all polyphosphoinositides, which have critical roles in these 
processes (Mayinger, 2011). However, if regulation of PI synthesis can modulate DAG 
levels at the Golgi complex and the secretory function of this organelle has not been 
addressed. 
2.3.4.- Phospholipase C 
Another possible mechanism to produce DAG in the Golgi complex is by the action of 
PLC.  Mammal PLC enzymes comprise 13 isozymes distributed in 6 different families 
(Fig. 12; Bunney and Katan, 2011). PLCs are calcium-dependent phosphodiesterases 
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that preferentially hydrolyze PI(4,5)P2 into DAG and inositol(1,4,5)triphosphate (IP3), 
but they also hydrolyse PI(4)P (Claro, 1993). 
All PLCs share a conserved core structure in addition to a variety of other domains 
specific for each family. The core enzyme is composed of a pleckstrin homology (PH) 
domain, four tandem EF hand domains, a split catalytic triose phosphate isomerase 
(TIM) barrel and a C2 domain. The active site, all catalytic residues and a Ca2+ binding 
site are contributed by the TIM barrel (Katan and Williams, 1997). This domain has an 
autoinhibitory insert that leads to the naming of the N- and C- terminal halves of the 
TIM barrel as X and Y domains. This insert, known as the X-Y linker, differs among 
families in sequence and size, and is central to the regulation of PLC activity (Hicks, 
2008).  
All PLC isoforms can be found in soluble form, while their substrate is an integral part 
of the membrane. Therefore, PLC has to be, at least, in close proximity to the 
membrane to hydrolyse its substrate. Another requirement for PLC activity is Ca2+, 
which facilitates the deprotonation of the inositol-phosphate moiety for subsequent PIP2
hydrolysis. This essential Ca2+ is ligated by four acidic residues, and mutation of them 
impairs PLC activity or increases the concentration of Ca2+ required for catalysis. PLCs 
initially form a weakly enzyme-bound cyclic intermediate, inositol 1,2-cyclic 
phosphodiester, which is then hydrolysed to form IP3. All the residues in the active site 
participating in substrate specificity, Ca2+ coordination and the catalytic activity are 
highly conserved across the PLC family (Hicks, 2008; Jezyk, 2006; Waldo, 2010). 
Regulation of PLC activity depends on each isozyme, but all families share a common 
mechanism of autoinhibition. PLCs are autoinhibited by the X-Y linker of the TIM barrel 
(Hicks, 2008), which it apparently occludes the active site. Removal of this X-Y linker is 
needed for activation of PLC isozymes, although regulation of this step may be 
different in each family. Both proteolysis and genetic deletion of sections of the X-Y 
linker increase PLC activity in most of the PLC families (Kadamur and Ross, 2013). 
Two compounds have been proposed as general PLC inhibitors. 1-(6-((17-3-
methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122) is an 
aminosteroid first reported as an inhibitor of PLC-dependent processes (Bleasdale, 
1989). Many studies have used U73122 as a direct and general PLC inhibitor, in 
combination with (1-[6-((17-3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl]-2,5-
pyrrolidinedione) (U73343) a close structural analog of U73122 containing N-
alkylsuccinimide moiety in place of N-alkylmaleimide, which is supposed to not inhibit  
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Figure 12. Domain structures of mammalian PLC isozymes. Different domains are abbreviated as 
follows: PH, pleckstrin homology; EF, EF hands; CC, coiled coil; SH2/SH3, Src homology 2/3; RA, Ras 
association; Ras GEF, Ras GDP/GTP exchange factor; X and Y, N- and C-terminal portions of the TIM 
barrel (Kadamur and Ross, 2013). 
 PLC. U73122 has been used to involve PLC in different cellular process, although its 
mechanism is not known. Recently it has been reported that U73122, but not U73343, 
can stimulate PLC and PLC in vitro (Klein, 2011). The other compound frequently 
used as a PLC inhibitor is the ether lipid analogue 1-octadecyl-2-methyl-rac-glycero-3-
phosphocholine, also known as edelfosine (Powis, 1992). Although its exact 
mechanism of inhibition is also not known, it has been proposed that edelfosine may be 
a more selective inhibitor than U73122 (Horowitz, 2005). 
2.3.4.1.- PLC families and their regulation 
2.3.4.1.1.- PLC
The three PLC proteins (numbered 1, 3 and 4) appear to be the progenitor animal 
PLCs, since they are already found in early eukaryotes. PLCs consist of only the core 
domain and their only well regulatory ligands are PI(4,5)P2 and Ca2+. The PH domain of 
PLC binds tightly PI(4,5)P2 and this binding drives membrane association and 
promotes PLC activity. The residues of the PH domain that ligate PI(4,5)P2 in PLC
are not conserved in other PLC isozymes, and mutation of them impair PLC activity. 
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However, PI(4,5)P2-mediated membrane binding is not sufficient to activate PLC and 
Ca2+ is required for maximal activation (Gresset, 2012). Ca2+ binding to the C2 domain, 
in addition to Ca2+ at the active site, is the only known regulator that enhances the 
activity of PLC isoforms and is sufficient to promote its activity (Allen, 1997; Kim, 
1999). 
All PLC isozymes are expressed widely. PLC1 is mainly cytosolic, although it 
shuttles between the nucleus and the cytosol depending on the phase of the cell cycle. 
PLC3 has been detected in membrane fractions and PLC4 localizes at the nucleus. 
It has been proposed that the role of PLC is to intensify and prolong Ca2+ signals by 
responding to elevated cytosolic Ca2+ that has been evoked by the action of other PLC 
isoforms (Gresset, 2012). 
2.3.4.1.2.- PLC
The structure of all four PLC isozymes is unique in having, in addition to the whole 
core of PLCs described in PLC isoforms, a C-terminal three-stranded coiled coil 
domain, which is required for stimulation by heterotrimeric G-proteins. PLC isozymes 
are effectors of heterotrimeric G-proteins downstream of G-protein coupled receptors 
(GPCR) that activate G
 subunits of the Gq family. The Gq family consists of four 
different G
 subunits (G
q, G
11, G
14, G
16) and all of them can strongly activate 
PLC in both intact cells or in vitro.  Although individual PLC can be regulated by 
other factors as Rac, PA or phosphorylation, all isozymes are also stimulated by 
subunits G
 and Ca2+ (Kadamur and Ross, 2013). All PLC also are GTPase-
activating proteins (GAPs) for G
q, promoting the hydrolysis of GTP and consequent 
G
q inactivation (Biddlecome 1996; Ross 2008).  
All PLC isozymes are cytosolic but they can be found associated with the plasma 
membrane. PLC1 can also be found in the nucleus, where it can hydrolyse PI(4)P. 
The four PLC differ in expression pattern and only PLC3 is broadly expressed. The 
main physiological role of the PLC family is to mediate the actions of many 
extracellular stimuli, through activation of GPCR and consequent activation of G

subunits of the Gq family that regulate their activity (Kadamur and Ross, 2013). 
2.3.4.1.3.- PLC
PLC has a single isoform that, in addition to the core lipase domains contains an N-
terminal cysteine-rich domain, an N-terminal CDC25 domain and two C-terminal Ras-
associating domains. PLC is a direct target of Ras, Rap and Rho. The GTP-bound 
forms of Rap and Ras stimulate PLC by binding to the second of its C-terminal Ras-
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associating domain. Therefore, PLC can respond to all imputs that regulate these 
GTP-binding proteins, as GPCR coupled to G proteins or tyrosin kinase receptors. 
Moreover, Ras and Rap also participate in recruiting PLC to specific organelles, as the 
cell periphery or to the perinuclear area, respectively (Gresset, 2012; Kadamur and 
Ross, 2013). Recently, it has been described that PLC can generate DAG from PI(4)P 
in the Golgi complex in response to hypertrophic stimuli in mouse cardiac myocytes  
(Zhang, 2013).  
2.3.4.1.4.- PLC
PLC is found only in vertebrate sperm and is structurally characterized for lacking an 
N-terminal PH domain. PLC is the smallest PLC isozyme and has the highest 
sensitivity to Ca2+, its only known regulatory ligand. PLC contains two nuclear 
localization signals, one localized at the X-Y that can promote its shuttling in and out of 
the nucleus coinciding with Ca2+ oscillations (Gresset, 2012; Kadamur and Ross, 
2013). 
2.3.4.1.5.- PLC	
A novel class of PLC isozymes that includes two isozymes, PLC	1 and PLC	2, was 
discovered in 2005. Its expression is enriched in the brain. PLC	 structure is similar to 
PLC, with the addition of an extended C-terminus after the C2 domain. To date, only 
Ca2+ has been reported to stimulate PLC	, and some data suggest that PLC	2 can be 
activated also by G subunits (Gresset, 2012; Kadamur and Ross, 2013). 
2.3.4.1.6.- PLC
The two PLC isoforms are structurally characterized by a large insertion in the X-Y 
linker that is central to its regulation. This insertion consists of a split PH domain, two 
SH2 domains and a SH3 domain. Phosphorylation is a key step of removal of 
autoinhibition of this enlarged X-Y linker. Phosphorylation of Tyr783 PLC1 promotes 
conformational changes that remove autoinhibition of the X-Y linker and increases 
lipase activity (Gresset, 2010). This mechanism is likely to be analogous for PLC2 in 
its tyrosine Tyr759. PLC isoforms can be phosphorylated by receptors with intrinsic 
tyrosine kinase or by other cytosolic tyrosine kinases, both forming large signalling 
complexes in the plasma membrane (Gresset, 2012; Kadamur and Ross, 2013). 
Although phosphorylation is the most acceped activator of PLC, other mechanisms 
can stimulate its activity. PI(3,4,5)P3 can act as a specific ligand for PLC isozymes 
and can mediate their translocation to the plasma membrane. PLC2, but not PLC1, is 
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directly activated by Rac GTPases (Gresset, 2012). Moreover, activity of both isoforms 
is stimulated by increasing concentrations of Ca2+ (Piechulek, 2005). 
PLC1 is found ubiquitously, while PLC2 expression is restricted to cells of the 
haematopoietic system. PLC, as PLC, responds to different extracellular stimuli, as 
almost all growth factors, and its main function is the transduction of extracellular 
stimuli (Gresset, 2012). 
2.3.4.2.- PLC at the Golgi complex 
The hypothesis of DAG production at the Golgi complex by PLC has the advantage 
that this DAG production can be activated by a signal cascade triggered at the Golgi 
complex. Since DAG is needed for vesicle budding for cargo exiting the Golgi complex, 
it is plausible that PLC could be activated by cargo to promote DAG formation. 
However, this particular role of PLC isozymes at the Golgi complex has not been 
widely addressed. 
Our group found that incubation of U73122 led to a decrease of DAG at the Golgi and 
to a reduced number of particles of KDELR at the cytosol, suggesting that incubation 
with this PLC inhibitor was impairing retrograde transport (Fernández-Ulibarri, 2007). 
PLC activation by Ca2+ ionophores deplete the PI(4)P pool of the Golgi complex, 
showing that PLC can be acting at this organelle (Balla, 2005), but without resolving 
the PLC isozyme involved in this PI(4)P consumption. 
Few PLC isozymes have been reported to be acting at or influence the Golgi complex. 
The localization of G protein signalling at the Golgi complex, where they can regulate 
vesicular transport, structure and secretion (Denker, 1996; Pimplikar and Simons, 
1993; Stow, 1991) suggests that PLC could be acting at this organelle. In this context, 
a study shows that G could activate PLC3 at the Golgi complex and this PLC 
isozyme is a key component of generation of transport carriers (Diaz-Añel, 2007). 
Recently, as mentioned before, it has been described that PLC could act at the Golgi 
complex in response to hypertrophic stimuli in mouse cardiac myocytes (Zhang, 2013). 
PLC1 has been reported to mediate Ras activation at the Golgi complex. Activation of 
protein kinase receptors at the plasma membrane activates PLC1 in a Src dependent 
manner, which in turn promotes RasGRP1 translocation to the Golgi complex, where it 
activates H-Ras (Bivona, 2003). In this context, although PLC1 is controlling a Golgi 
event, its action is localized at the plasma membrane but not at the Golgi complex. 
However, direct evidences of stimulation of any PLC isozyme at the Golgi in order to 
generate DAG for transport carrier formation have not been described yet. 
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3.- SIGNALING AT THE GOLGI COMPLEX 
Historically, the Golgi complex has been seen as one of the key regulators of the 
secretory pathway, where last post-transcriptional modification take place and cargo is 
sorted to its final destination. However, Golgi function may be wider than that and may 
be involved in more cellular processes. The Golgi complex may represent a new hub 
for cell signalling (Cancino and Luini, 2013), not only for its central position, but 
because a variety of cell-signalling molecules have been shown to be physically 
associated with this organelle, including G-proteins, kinases, phosphatases and 
phospholipases (Farhan and Rabouille, 2011; Wilson, 2010; Cancino and Luini, 2013).  
This recent focus in the signalling function of the Golgi complex can be seen in the 
literature, in the increase in the number of papers of this field (Tillmann, 2013). In order 
to identify and study the relationship between the Golgi complex and signalling events, 
recent studies have used high throughput RNAi strategies to identify regulatory 
proteins involved in secretion and signalling proteins controlling Golgi structure and/or 
function. In these studies, 122 kinases/phosphatases were found to affect ER export 
and/or morphology of the Golgi (Farhan, 2010); secretion was influenced by 554 
proteins (Simpson, 2012) and 159 signaling genes induced perturbations in the Golgi 
morphology (Chia, 2012). Signalling proteins that affected secretion or Golgi 
morphology were related with growth factor signalling, the Raf-MEK-ERK cascade, 
phosphoinositides regulation, acto-myosin dynamics and mitogen activated protein 
kinase signalling (Farhan, 2010; Simpson, 2012; Chia, 2012). These studies showed a 
strong relationship between the Golgi complex and signalling, and opened future 
directions in order to understand how these signals control the Golgi or the Golgi 
controls signalling. 
Signaling cascades can regulate Golgi function and structure, and this signal can be 
generated at the Golgi complex itself or in other cellular locations. Moreover, the Golgi 
complex can be part of other transduction signals. In other words, as proposed 
recently, the Golgi complex can participate in the modulation of cell signalling in at least 
three different ways (Cancino and Luini, 2013). First, signalling might be generated at 
the Golgi complex itself, which will thus participate in the self-coordination of 
intracellular transport. Second, the Golgi complex might modulate an input generated 
at the plasma membrane that has an impact upon Golgi function. Finally, the Golgi 
complex can act as a modulator of cell signalling generated at the plasma membrane 
for the regulation of other cellular processes that do not specifically Golgi function or 
structure (Fig. 13; Cancino and Luini, 2013). 
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Figure 13. The Golgi complex as a signaling platform. Golgi modulation of cell signaling: A) signaling 
might be generated by the Golgi complex itself, which will thus participate in the self-coordination of 
intracellular transport; B) cell signaling generated at the PM might be modulated at the Golgi complex, for 
the regulation of other cellular processes that do not specifically involve Golgi function or structure and C) 
the Golgi complex might modulate input initiated at the PM that has an impact upon Golgi function.
(Cancino and Luini, 2013). 
One example of how the Golgi complex can act as a regulator for signalling initiated at 
the plasma membrane is the compartment-specific regulation of Ras (Bivona and 
Phillips 2003). Briefly, dimerization of protein tyrosine kinase receptors at the cell 
surface activates Ras on the PM through recruitment of Grb2/Sos complexes. In 
addition to Grb2/Sos, PLC and Src are also recruited and activated at the plasma 
membrane.  PLC activation by Src generates the second messengers DAG and IP3, 
which can then promote intracellular Ca2+ signaling. The Ras guanine nucleotide 
exchange factor (GEF) RasGRP1 responds to DAG and Ca2+ by translocation to the 
Golgi complex, where it activates H-Ras. Elevated Ca2+ also activates the RasGAP 
CAPRI, directing it to the plasma membrane, where it deactivates Ras. In this model, 
the Golgi complex provides selective activation of H-Ras, while plasma membrane Ras 
is deactivated (Bivona, 2003; Bivona and Phillips 2003). 
3.1.- Control of Golgi function and structure by signalling events 
As described before, multiple signalling molecules and signalling pathways are 
associated with Golgi function and structure. Some of them are well known to be 
localized at the Golgi complex and/or control the morphology and function of this 
organelle. Next, some of these signalling events that control the Golgi complex function 
and structure are described. As other cellular responses to signalling events, Golgi 
function and structure will be a result of the balance of all the signalling that controls it. 
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3.1.1.- Regulation of Golgi function by extracellular signals 
The secretory function of the Golgi function is dependent on extracellular stimuli that 
influence the overall state of the cell. First evidences that extracellular stimuli can 
modulate membrane trafficking was based on the effects of the activation of IgE 
receptors and PKC, which was shown to regulate GTP-dependent binding of two COPI 
coat components, Arf and -COP; and at the same time enhance secretory trafficking 
(De Matteis, 1993). 
A more recent example of how secretory function can be influenced by extracellular 
stimuli is the regulation of PI(4)P by Sac1 in response to growth factors.  Sac1 is a 
transmembrane phosphatase that is responsible for PI(4)P turnover at the ER and the 
Golgi (Foti, 2001; Schorr 2001; Rohde, 2003). In quiescent cells, Sac1 accumulates at 
the Golgi complex and down-regulates anterograde trafficking by depleting Golgi 
PI(4)P. When quiescent cells are stimulated by serum addition, the p38 mitogen-
activated protein kinase (MAPK) pathway induces the COPI-mediated retrieval of Sc1 
to the ER, thus releasing the break on Golgi secretory function by enabling the 
restoration of PI(4)P (Blagoveschenskaya, 2008).  
3.1.2.- Regulation of Golgi function by a signal triggered by cargo 
Golgi function and morphology can be controlled by other stimuli than extracellular 
ones. To prevent structural and functional disruption, the Golgi complex must regulate 
its high membrane fluxes. Thus, it must not only react to external stimuli as part of the 
integrated cellular response, but should also sense and generate a response to the 
passage of variable amounts of membranes and cargo. In other words, should respond 
to the passage of the traffic itself (Cancino and Luini, 2013). The ability of the Golgi 
complex to generate autonomous signalling in response to the arrival of cargo from the 
ER has been experimentally addressed only in the last few years (Pulvirenti, 2008; 
Giannotta, 2012). These studies show that cargo arrival from the ER can be sensed by 
a receptor in the Golgi complex, which initiates signalling pathways that can 
compensate the arrival of new membrane at the Golgi (Cancino and Luini, 2013). 
It has been proposed that cargo arrival at the Golgi complex can be sensed by the 
KDELR, a seven transmembrane domain protein that cycles between the ER and Golgi 
complex and mediates the return of ER-resident proteins to the ER. The KDELR has 
structural similarities with GPCRs (Giannotta, 2012). The KDELR, upon binding to a 
KDEL-containing ligand, can activate Gq, and presumibily Gs, that in turn initiates a 
cascade that leads to the activation of a Golgi pool of the tyrosine kinase Src (Fig. 14; 
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Pulvirenti, 2008; Giannotta, 2012). Src activation is fundamental for Golgi function, 
since Src inhibition blocks intra-Golgi and post-Golgi traffic (Pulvirenti, 2008; Giannotta, 
2012). One of the mechanisms by which Src can control secretion is by 
phosphorylation of dynamin 2, a protein required for the fission of transport carriers at 
the Golgi complex; which was found to be phosphorylated by Src family kinases 
(Weller, 2010). Moreover, Src has been also proposed to regulate Golgi structure and 
KDELR-dependent retrograde transport (Bard, 2003). It has been shown that after 
cargo arrival, Src promotes an increase of tyrosine phosphorylation at the Golgi 
complex, which is necessary for cargo exit from this organelle (Pulvirenti, 2008). These 
results are in accordance to a previous study that showed that reversible protein 
tyrosine phosphorylation at the trans-Golgi is required for albumin secretion. Moreover, 
the inhibition of tyrosine phosphatases led to a redistribution of trans-Golgi proteins 
(Webb, 2005), suggesting that the cycle of tyrosine phosphorylation and 
dephosphorylation is also required for maintenance of the trans-Golgi structure. 
In addition to Src activation, cargo arrival at the Golgi complex also induces other 
signalling effetcts. Cargo arrival promotes the release of Ca2+ from the Golgi complex 
(Micaroni, 2010) and the recruitment of phospholipase A2 (PLA2) to this organelle, 
where is necessary for the formation inter-cisternal continuities for intra-Golgi trafficking 
(San Pietro, 2009). It is not known if these processes are independent or dependent of 
the KDELR activation, and/or if act upstream or downstream of Src or other signaling 
events at the Golgi complex.  
3.1.3.- PKD signalling for TGN-to-plasma membrane transport carrier formation 
As previously described, the generation of TGN-to-plasma membrane transport carriers 
depends on PKD (Bard and Malhotra, 2006). PKD activation requires production of 
DAG and the action of Arf1 for proper recruitment, but its activity can also be positively 
regulated by heterotrimeric G proteins (Saini, 2010) and inhibited by the MAPK p38
(Sumara, 2009). Moreover, an increase of Ca2+ promotes the translocation of PKD at 
the TGN (Kunkel and Newton, 2010). Recruitment of PKD to the TGN is proposed to 
initiate the events that create and regulate the growth of export domains at the TGN for 
generation of transport carriers (Malhotra and Campelo, 2011). In the proposed model 
(Fig. 15), PKD phosphorylates and activates the enzyme PIKIII (Hausser, 2005), thus  
promoting the production of PI(4)P at the outer leaflet of the TGN, where it binds, 
among others, oxysterol binding protein (OSBP) and CERT (Nishikawa, 1998; Levine 
and Munro, 2002). CERT dependent transfer of ceramide leads to the generation of 
SM and DAG from PC and ceramide at the TGN (Hanada, 2009). SM and cholesterol  
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Figure 14. KDELR interacts with two major G proteins, Gq and Gs, and activates Gq at the Golgi.
When chaperones reach the Golgi complex via transport carriers, they can bind to the KDELR and return 
with it to the ER. Structural modeling predicts that KDELR has a three-dimensional fold that is similar to 
that of the GPCRs. Remarkably, the KDELR interacts with two major G proteins, Gq and Gs at the Golgi. 
Thus, upon binding to a KDEL-containing ligand (a chaperone), this can activate Gq (and presumably also 
Gs). Gq, in turn, initiates a phosphorylation cascade that leads to the activation of a Golgi pool of the 
tyrosine kinase Src. Through this Src activation, there is acceleration of anterograde intra-Golgi 
trafficking, which helps to maintain Golgi homeostasis (Cancino and Luini, 2013) 
. 
 transferred by OSBP segregate from DAG creating non-overlapping domains at the 
TGN: one rich in SM and cholesterol and the other in DAG, where more PKD is 
recruited. This high recruitment of PKD by binding to DAG is proposed to prevent DAG 
from flipping across the membrane, thus concentrating DAG on the outer leaflet 
(Malhotra and Campelo, 2011). PKD then phosphorylates OSBP and CERT to release 
them from the TGN. At the same time, PKD binds Arf1, which can activate PLD to 
produce PA from PC, which is converted to LPA by PLA2 (San Pietro, 2009). This 
accumulation of different modified lipids leads to the fission of TGN-to-plasma 
membrane transport carriers. After fission, DAG will be consumed, thus dissociating 
PKD form the TGN membrane and resetting the system for another round of transport 
carriers in a cargo-dependent manner (Malhotra and Campelo, 2011). However, 
although it has been often proposed that cargo arrival could be the activator of this 
INTRODUCTION 
71 

PKD signalling pathway at the TGN (Bard and Malhotra, 2006; Malhotra and Campelo, 
2011), there are no experimental evidences that cargo arrival is triggering PKD 
activation and/or DAG production at the TGN. 
Figure 15. The effectors of PKD at the TGN. A) PKD is recruited to the TGN by DAG and ARF1. 
Activated PKD phosphorylates to activate PI4KIIIß thus promoting the production of PI(4)P in the outer 
leaflet of the TGN. B) PI(4)P OSBP and CERT to the TGN. C) OSBP and CERT regulate the SM and 
sterol levels in the TGN and this is suggested to be required for separating the PI4P containing domain 
from the SM and sterol rich domain. CERT dependent ceramide transport to the TGN is required to 
generate and concentrate DAG at the TGN. D) This DAG in turn recruits more PKD to generate more 
DAG. PKD then phosphorylates OSBP and CERT to release them from the TGN. E) Arf1 mediated 
activation of PLD1 generates PA from the PC pool, which eventually is converted to LPA by the action of 
PLA2. The accumulation of these different modified lipids leads to fission of TGN to cell surface transport 
carriers. F) DAG is consumed thus dissociating PKD from the membrane thus resetting the TGN to 
generate another round of transport carriers in a cargo-dependent manner (Malhotra and Campelo, 
2011). 
3.1.4.- Heterotrimeric G proteins signalling at the Golgi complex 
The heterotrimeric G proteins are activated by the GPCRs and are made up of 
 and 
 subunits (Oldham and Hamm, 2008). Heterotrimeric G protein signals occur on the 
Golgi complex, where it has been shown to regulate its structure (Jamora, 1997; Saini, 
2010) and secretion (Irannejad and Wedegaertner 2010; Saini, 2010). Heterotrimeric G 
proteins can translocate from the plasma membrane to the Golgi complex (Saini, 2010) 
or can be located in this organelle. In particular, G
s, G
i3, G
q/11 have been shown to 
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be located at the Golgi complex (Denker, 1996; Stow, 1991; Stow and Heimann, 1998), 
where they can control vesicle formation and secretion (Stow, 1991; Stow and 
Heimann, 1998). On the other hand, Golgi vesiculation occurs through the activity of 
the free  subunits (Jamora, 1997), which interact with PKD (Jamora, 1999, Díaz-Añel 
and Malhotra, 2005) after its translocation from the plasma membrane (Saini, 2010). 
G
q/11 has been proposed to participate in the signalling cascade initiated by cargo 
arrival at the Golgi complex and to be necessary for Src activation and regulation of 
anterograde transport (Giannotta, 2012). 
3.1.5.- Protein kinase A and the Golgi complex 
Protein kinase A (PKA) is a Ser/Thr kinase activated by the second messenger cAMP 
(Edelman, 1987). First evidences for the requirement of PKA for Golgi function were 
shown by pharmacological inhibition of PKA, which altered intra-Golgi trafficking and 
blocked the transport of VSVG from the TGN to the plasma membrane (Muñiz, 1996, 
Muñiz 1997). This inhibition of PKA altered secretion at the TGN level, where it blocked 
vesicle budding (Muñiz, 1997). PKA was also found to be required for retrograde 
transport, since PKA-mediated phosphorylation of the KDELR is needed for its retrieval 
from the Golgi complex to the ER (Cabrera, 2003). The mechanisms through which 
PKA exerts these effects on the secretory pathway have been identified in part. All 
components of the cAMP-PKA pathway have been located at the secretory pathway, 
and particularly on the Golgi complex (Cancino, 2013). However, Golgi-resident PKA 
can respond to extracellular signals to regulate Golgi structure and function (Mavillard, 
2010). Moreover, it has been shown that the interaction between PKA and Golgi 
membranes is sensitive to modulators of heterotrimeric G proteins (Martin, 1999). 
3.1.6.- Ca2+ and the Golgi complex 
Ca2+ is the most ubiquitous second messenger in vertebrates, and even slight 
variations in its levels can greatly affect cell behaviour. The extracellular Ca2+ is usually 
in the low millimolar range, while the concentration of resting free cytosolic Ca2+ is in 
the order of 100 nM. According to the classical model, activation of some signalling 
pathways at the plasma membrane that produce IP3 induce the release of Ca2+ from 
the ER, the main Ca2+ store of the cell (Micaroni, 2012). More recently, the Golgi 
complex has also been considered as a part of the intracellular Ca2+ response that can 
be triggered by extracellular stimuli (Pinton, 1998). Ca2+ release from the Golgi 
complex, as well from the ER, is mediated by activation of the IP3 receptors (IP3Rs); 
while Golgi Ca2+ uptake involves two classes of Ca2+-ATPase pumps, the sarcoplasmic 
and ER Ca2+ ATPase (SERCA), present in the ER and the cis-Golgi, and the Golgi 
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specific secretory pathway Ca2+-ATPase (SPCA) (Missiaen, 2007; Micaroni, 2012). 
Ca2+ can be monitored by the Ca2+-receptor (CaR), a GPCR that is coupled to various 
heterotrimeric G proteins (Ward, 2004). CaR is also present at the TGN, where it can 
sense the luminal concentration of Ca2+ of the Golgi complex and regulate Ca2+ uptake 
into this organelle by acting in concert with PLC1 and SPCA (Tu, 2007). 
Ca2+ also participates in the control of membrane trafficking. After cargo arrival at the 
Golgi complex, the cytosolic concentration of Ca2+ is increased, and this temporary 
fluctuation of Ca2+ was shown to be necessary to allow the intra-Golgi trafficking of 
cargo and this Ca2+ was found to come within the Golgi complex (Micaroni, 2010). It 
has been proposed that the increase of cytosolic Ca2+ around the Golgi can affect the 
activities of Golgi-localized Ca2+-dependant proteins and/or result in the recruitment of 
cytosolic signalling proteins that are involved in the initiation of signalling cascades 
similar to those seen at the plasma membrane (Micaroni, 2012). In accordance to this 
hypothesis, Ca2+ may allow intra-Golgi transport by activating cPLA2, a cytoplasmic 
phospholipase that requires Ca2+, which is recruited to the Golgi complex after cargo 
arrival and is involved in the formation of intra-cisternal tubules for intra-Golgi transport 
(San Pietro, 2009).  
Ca2+ requirement for membrane trafficking was demonstrated by the use of the Ca2+ 
chelator BAPTA, which impaired VSVG transport from the ERGIC to the Golgi complex 
and from the Golgi complex to the plasma membrane; and also promoted the 
detachment of the coatomer from membranes (Chen, 2002). Moreover, Ca2+ signalling 
from the plasma membrane promotes the increase of DAG at the Golgi complex and 
the recruitment of PKD to this organelle (Kunkel and Newton, 2010), steps needed for 
the transport of TGN-to-plasma membrane transport carriers. 
  
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Previous studies have demonstrated that DAG is essential for protein transport at the 
Golgi complex in both yeast (Kearns, 1997) and mammals (Baron and Malhotra, 2002). 
It has been proposed that DAG may be playing a dual role in the generation of TGN-to-
plasma membrane transport carriers. First, DAG acts as a signalling molecule that 
recruits PKD at the TGN (Baron and Malhotra, 2002), a kinase needed for TGN-to-
plasma membrane transport carrier formation (Liljedahl, 2001). Second, the structure of 
DAG promotes the negative curvature needed for membrane fission (Semesh, 2003). 
Our group demonstrated that DAG is also required for the generation of COPI vesicles 
at the fission step (Fernández-Ulibarri, 2007). Another study confirmed our results, but 
suggested that DAG may be participating in the budding of these transport carriers 
(Asp, 2009). These two studies were based on pharmacological inhibition of the 
formation of DAG by PAPs using propanolol (Fernández-Ulibarri, 2007; Asp, 2009). 
Other studies confirmed the requirement of DAG for proper Golgi function also by 
pharmacological inhibition of other metabolic pathways that produce DAG, as the SMS 
(Baron and Malhotra, 2002; Subathra, 2011) or PLC (Díaz-Añel, 2007). Silencing 
studies showed that the DAG-producing enzymes SMS1 and SMS2 are involved in 
anterograde trafficking at the Golgi complex (Subathra, 2011) and that LPP3 
participates in the retrograde transport (Gutiérrez-Martínez, 2013).  
However, the role of DAG-consuming pathways in the regulation of transport carrier 
formation at the Golgi complex remains unknown. PC and PI synthesis, which 
consume DAG, could be taking place at the Golgi complex, since their key enzymes 
are also localised at this organelle or associated with it (Jelsema and Morré, 1978; 
Hennerberry, 2002; Kim, 2011). In yeast, PC synthesis by the CDP-choline pathway is 
highly associated with Golgi secretory function (Cleves, 1991; McGee, 1994). In 
mammals, Nir2, a PITP protein that regulates the rate of the CDP-choline pathway at 
the Golgi complex, is also required for maintenance of the Golgi-associated DAG pool 
required for protein transport (Litvak, 2005). 
On the other hand, neither of all the studies that show the requirement of DAG for Golgi 
function demonstrates which specific metabolic pathway is activated to produce DAG 
for the generation of transport carriers. All these studies show that the reduction of the 
Golgi-associated DAG pool, either by pharmacological agents or siRNA, leads to an 
impairment of transport carrier formation at the Golgi complex  (Baron and Malhotra, 
2002; Litvak, 2005; Díaz-Añel, 2007; Fernández-Ulibarri, 2007; Asp, 2009; Subathra, 
2011). However, these works do not demonstrate that the inhibited metabolic pathways 
may be regulated in response to any stimulus and the effects described may derive 
AIMS 
78 

from an overall imbalance in DAG metabolism on Golgi membranes (Bard and 
Malhotra, 2005). 
The potential stimulus that could trigger DAG production at the Golgi complex for the 
formation of transport carriers is the arrival of cargo. The main function of transport 
carriers is to transport cargo from one organelle to the other, thus it is plausible that 
cargo stimulates DAG production for transport carrier formation. Moreover, it has been 
recently described that the arrival of cargo at the Golgi complex triggers a signalling 
circuit that coordinates the secretory pathway (Pulvirenti, 2008). Cargo arrival at the 
Golgi complex activates G proteins (Giannotta, 2012), stimulates Src activity and 
increases the phospho-tyrosine levels at this organelle (Pulvirenti, 2008). Moreover, it 
also induces the release of Ca2+ from the Golgi complex, increasing the cytosolic Ca2+
concentration around this organelle (Micaroni, 2010). These events triggered by cargo 
arrival present the Golgi complex as a perfect site for PLC activation, a signalling 
protein that produces DAG. PLC and PLC isoforms have been related to the Golgi 
complex previously (Díaz-Añel, 2007; Bivona, 2003; Tu, 2007) All PLCs require Ca2+, 
PLC isoforms respond to G protein signalling (Gresset, 2012; Khadamur and Ross, 
2013) and PLC isoforms are activated by phosphorylation in one of their tyrosines 
(Gresset, 2010).  
With all this background, the aims of this work are: 
AIM 1.- To determine the implication of PC and PI synthesis in the regulation of 
diacylglycerol required for membrane trafficking at the Golgi complex.  
1.1.- To design experimental approaches that, by tuning PC and PI synthesis, 
regulate the amount of DAG at the Golgi complex. 
1.2.- To analyse membrane trafficking at the Golgi complex in conditions where 
DAG is altered by the regulation of PC and PI synthesis. 
AIM 2.- To study the involvement of PLC in DAG production after cargo arrival at the 
Golgi complex.  
2.1.- To determine which PLC isoform acts at the Golgi complex. 
2.2.- To analyse  DAG production at the Golgi complex after cargo arrival at this 
organelle and the involvement of PLC in this process. 

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1.- MATERIALS 
1.1- Reagents 
In this table are found the different reagents used, a brief description of them and their 
use, their concentration of use and source. 
Reagent Description Concentration
of use 
Source
Cicloheximide Antibiotic that inhibits 
protein synthesis 
100 g/mL Sigma-Aldrich 
(St. Louis, 
USA) 
EGF (Epidermal 
Growth Factor) 
Small mitogenic 
polypeptide which is 
present in many 
mammalian species. Used 
as an activator of PLC1 
100 ng/mL Invitrogen 
(Carlsbad, 
USA) 
Phalloidin-TRITC Fluorescent phallotoxin 
which may be used to 
identify filamentous actin 
. 
0,5 g/mL Sigma-Aldrich 
Phospholipase C, 
Phosphatidylinositol-
specific, from 
B.cereus. 
Recombinant 
phospholipase C 
0,3 U/ml Sigma-Aldrich 
PMA (Phorbol 12-
myristate 13-
acetate) 
Phorbol ester analogue of 
DAG. 
100 nM Sigma-Aldrich  
Propanolol Inhibitor of the lipid 
phosphate phosphatase 
(PAP/LPP) 
60 M Calbiochem  
STxBKDEL Bacterial toxin that is 
internalized and travels 
from the plasma 
membrane to the ER. It is 
used as a model of 
retrograde transport 
0,5 g/mL Dr. Ludger 
Johannes 
(Institute Marie 
Curie, Paris, 
France) 
U73122 Inhibitor of agonist-
induced phospholipase C 
activation in human 
platelets and neutrophils. 
6 M Calbiochem 
(San Diego, 
USA) 
U73343  A cell-permeable analog of 
U-73122 that acts as a 
very weak inhibitor of 
phospholipase C, used as 
a negative control. 
6 M Calbiochem  
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1.2.- Antibodies 
In the following tables are found the primary and secondary antibodies used for 
immunofluorescence (IF) and Western Blot (WB), showing their host specie, working 
dilution, concentration of use, if available (N.A. stands for not available) and source. 
Primary 
antibody 
Host 
specie 
Working Dilution Concentration 
of use (g/mL) 
Source
IF WB IF WB
GFP Rabbit - 1:25000 - 0,008 Molecular Probes, 
Invitrogen 
Actin Rabbit - 1:20000 - 0,02  
Calnexin Mouse - 1:1000 -  BD 
Flag Rabbit - 1:1000 - 2 Sigma 
GM130 Mouse 1:1000 1:10000 0,25 0,025 Transduction 
Laboratories 
(Lexington, KY, 
USA) 
Golgin97 Mouse 1:500 - 0,002 - Molecular Probes 
(Invitrogen) 
KDELR Rabbit 1:500 - N.A. - Dr. H.D. Söling 
(University of 
Göttingen) 
PentaHis Mouse 1:200 1.2000 0,005 0,0005 Qiagen 
PLC1 Rabbit 1:100 1:2000 N.A. N.A. Cell Signaling 
PLC2 Rabbit - 1:2000 - N.A. Cell Signaling 
pPLC1 Rabbit 1:100 1:2000 N.A. N.A. Cell Signaling 
RhoGDI Rabbit - 1:1000 - 0,2 Santa Cruz 
(Delaware, CA, 
USA) 
TGN46 Sheep 1:500 - 0,5 - Serotech (Oxford, 
UK) 
VSVG 
Ectodomain
Mouse 1:500 - N.A - Sigma-Aldrich 
Secondary antibody Working 
Dilution 
Concentration 
of use (g/mL) 
Source
Alexa Fluor 488 Anti-Mouse 1:400 0,005 Invitrogen  
Alexa Fluor 488 Anti-Rabbit 1:400 0,005 Invitrogen 
Alexa Fluor 488 Anti-Sheep 1:400 0,005 Invitrogen 
Alexa Fluor 546 Anti-Sheep 1:400 0,005 Invitrogen 
Alexa Fluor 647 Anti-Mouse 1:250 0,008 Invitrogen  
Cy3 Anti-Mouse 1:250 0,008 Jackson Laboratoties 
Cy3 Anti-Rabbit 1:250 0,008 Jackson Laboratories 
HRP Anti-Mouse 1:3000 0,0003 Promega (Eugene, USA) 
HRP Anti-Rabbit 1:3000 0,0003 Promega  
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1.3.- Plasmids 
In this table are described the plasmids used, together with their vectors of expression 
and its source. 
Plasmid Vector Source
C1-PKC-GFP pEGFP Dr. I. Mérida (Consejo Superior de 
Investigaciones Científicas, Madrid) 
FLAG-ssHRP pEGFP Dr. V. Malhotra (Centre de Regulació 
Genòmica, Barcelona) 
PH-OSBP-GFP pEGFP Dr. T. Levine (University College London, 
London, UK) 
PLC1 wt full length pTriEx4 Dr. M. Katan 
  
PLC1(H335Q) full length pTriEx4 Dr. M. Katan 
PLC2 (H327Q)(2-1198) pTriEx4 Dr. M. Katan 
PLC2 wt (2-1198) pTriEx4 Dr. M. Katan 
ts045VSVG-cherry pEGFP Dr. E.L. Snapp (Albert Einstein College of 
Medicine, NY, USA) 
ts045VSVG-YFP pEGFP Dr. K. Simons (Max Planck Instiutute, 
Dresden, Germany) 
1.4.- Radiolabelled molecules 
In this table we find the radiolabeled molecules used and its specific activity. All of them 
were purchased from Perkinelmer Life Sciences. 
Molecule Isotope 
Specific activity 
(mCi/mmol) 
Choline chloride 3H 50-62 
Myo-inositol 3H 10-25 
Acetate 14C 45-62 
ATP 32P 10 
Ortho-phosphoric acid 32P 850-912 
EasyTag™ EXPRESS Protein Labeling Mix 35S 1000 
2.- METHODS 
2.1.- Cell lines and cell culture 
Chinese hamster ovary cells wild type (CHO-K1) and with a termosensitive CT (CHO-
MT58) were grown at 33 ºC in F-12 media, while NRK, Vero, HeLa and HeLa 
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constitutively expressing VSVG-GFP were grown at 37 ºC in Dulbecco’s modified 
medium nutrient mixture (DMEM) at 37 ºC. All of them were supplemented with 10 % 
inactivated foetal bovine serum, penicillin (100 U/ml), streptavidin (100 mg/ml), sodic 
pyruvate (100 mM) and L-glutamine (10 mM). Both F-12 and DMEM were from Gibco. 
All cells were grown in a humidified incubator at 5 % CO2. 
2.2.-Protein analysis, silencing and overexpression
2.2.1.- Cellular extracts and Western Blot 
Cellular extracts were obtained from confluent cell culture dishes washed once with 
phosphate buffered saline (PBS; 137 mM NaCl, 2,7 mM KCl, 10 mM Na2HPO4 • 
2H2O, 10 mM KH2PO4, pH 7.4) before addition of cold lysis buffer (50 mM Tris-HCl, 
150 mM NaCl2, 2mM EDTA, 50 mM NaF, 1% NP-40; pH 7,4) in the presence of 
protease inhibitors (1 g/mL aprotinin, 1 g/ mLleupeptin, 5M pepstatin A, 2 mM 
sodium orthovanadate). Cells were scrapped, frozen, thawed and centrifuged at 1000 g
for 10 minutes, and supernatant was collected and quantified for protein concentration 
by the Lowry method (Lowry, 1951) using the DC protein assay kit from Bio-Rad. 
Western blot analysis was performed following a standard protocol. Protein were 
denatured in loading buffer 5x (62,5 mM Tris-HCl (pH 6,8), 2% (w/v) SDS, 10% 
glycerol, 140 mM -mercaptoethanol and 0,1% (w/v) bromophenol blue) and heated at 
100 ºC for 5 minutes. Electrophoresis was performed in denaturing polyacrylamide gels 
(SDS-PAGE) at different polyacrylamide concentrations at 35 mA. Proteins were then 
transferred to a nitrocellulose membrane (Whatman Maidstone, Kent, United Kingdom) 
during 1,5 hours at 100 V at 4 ºC. Nitrocellulose membranes were blocked in Tris-
buffered saline (TBS, 50 mM Tris, 150 mM NaCl, pH 7,4) containing 1 % Tween-20 
(TBS-T) solution with the addition of 5% skimmed milk or 5% bovine albumin serum 
(BSA) for 1 hour at room temperature. After 3 washes of 10 minutes in TBS-T, 
membranes were blotted overnight at 4 ºC in the presence of the primary antibody 
diluted in TBS 1% BSA 0,002% sodium azide. After primary antibody incubation, 
membranes were washed 3 times for 10 minutes with TBS-T and incubated for 1 hour 
at room temperature with the appropriated secondary antibody in TBS-T with 2,5% 
skimmed milk or 2,5% BSA. Membranes were washed again three times for 10 minutes 
with TBS-Tto remove secondary antibody remains and the reaction, and they were 
incubated for 1 minute with the Western Blotting Luminal Reagent (Santa Cruz 
Biotechnology, Santa Cruz, USA) to finally be visualized by exposition on Hyperfilm 
(Amersham Pharmacia Biotec, Uppsala, Sweden). Actin, tubulin and RhoGDI 
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antibodies were used as loading controls. The film was scanned and the intensity of the 
bands was quantified using the GelPro analyser software version 4.0. 
2.2.2.- Immunoprecipitation 
Cellular extracts were obtained as described previously and 500 g of protein in 
volume of 300 L of lysis buffer were added to 50 l of protein A sepharose beads 
(Santa Cruz) and 6 L of PLC1 antibody and incubated overnight at 4 ºC on a rotary 
mixer. The next day, beads were centrifuged and washed with RIPLA2 buffer (20 mM 
Tris, 137 mM NaCl, 10 % glycerol, 0,05% SDS, 0,5% Triton X-100, 0,1% sodium 
deoxycholate, 2 mM EDTA; pH 7,5) three times. 20 L of loading buffer were added to 
the final immune complexes and were denatured boiling them for 10 minutes. Samples 
were then processed for western blot as previously described. 
2.2.3.- DNA transfection 
Plasmids were transfected using FuGene HD (Promega) for morphological analysis, as 
immunofluorescence and protein localization; or Lipofectamine (Invitrogene) for 
biochemical studies; as ssHRP secretion. For FuGene HD mediated transfection, the 
plasmid mixtures contained 1 g of DNA per 1L of FuGene HD, mixed in 100 L of 
OptiMEM (Gibco). Lipofectamine transfection was prepared by mixing 2 g of DNA and 
3L of Lipofictamine in 100 L of OptiMEM and incubated for 20 min at room 
temperature. Plasmid mixtures were applied in cells in suspension, and then cells were 
plated onto glass coverslips or cell culture plates. If not specified, overexpression 
experiments lasted 12-16 hours of expression. 
2.2.4.- siRNA transfection 
20nM small interference RNA (siRNA) were transfected in cells in suspension using 
Lipofectamine, following manufacturer’s instructions. In brief, siRNA mixtures were 
prepared by adding 100 pmols siRNA and 5L of Lipofectamine in 100 L of OptiMEM 
and incubated for 20 min at room temperature. Then, the siRNA mixture was added to 
a p6 well containg cells in suspension in 2 mL of DMEM. After 5-6 hours, media 
containing the siRNA mixture was washed with DMEM and cells were grown overnight. 
After 24 hour of transfection, cells were subcultured and grown in coverslips or cell 
culture plates. Experiments were performed 72 hours after siRNA transfection. siRNA 
pools for PLC1, PLC2 and non-targeting siRNA (siRNA control) were purchased from 
Dharmacon. The sequences of siRNA pools for PLC1 and PLC2 are found in the 
following table: 
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 PLC1 PLC2 
Se
qu
en
ce
 
fro
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3’
 CCAACCAGCUUAAGAGGAA GCAGAUGAAUCACGCAUUG
GAAGUGAACAUGUGGAUCA CCAAGUUCCUUAAAGAUAA 
GAGCAGUGCCUUUGAAGAA GGAAAUAGGAGCACACAAA 
CCAAGAAGGACUCGGGUCA GGGAAGAACUCCAAAGAUU 
2.3.- Isolation of Golgi-enriched Fractions 
2.3.1.- Preparation of Golgi-enriched fractions from Vero cells 
Golgi fractions from Vero cells were prepared at 4 °C following a modification of a 
method reported previously (Balch, 1984). Cells were harvested, washed twice in PBS 
and twice in homogenization buffer (250 mM sucrose in 10 mm Tris-HCl, pH 7.4), and 
pelleted at 1500 g for 10 min. Cells were then resuspended in 4 volumes of 
homogenization buffer and homogenized using the Ball-Balch device. The homogenate 
was brought to a sucrose concentration of 37% by the addition of 62% sucrose in 10 
mM Tris-HCl, pH 7.4, and EDTA (1 mM final concentration). Twelve millilitres of this 
solution were placed at the bottom of a centrifuge tube and carefully overlaid with 15 ml 
of sucrose at 35% and 9 ml of 29% sucrose in 10 mm Tris-HCl (pH 7.4). Gradients 
were centrifuged at 100,000 × g (25000 rpm) for 2.5 h with the swing rotor SW28 on a 
L7–55 Beckmann ultracentrifuge. The Golgi-enriched fraction was recovered at the 
35%/29% sucrose interface and subsequently frozen in liquid nitrogen and stored in 
aliquots at −80 °C until use.  
2.3.2.- Preparation of Golgi-enriched fractions from rat liver 
For preparation of Golgi-enriched fractions from rat liver, adult female Wistar rats were 
starved for 24 hours. After being killed, livers were removed and placed into 200 mL of 
cold 0,5 M phosphate buffer pH 6,7 with 0,5 M sucrose. Livers were swirled, squeezed 
and cut to several pieces in order to remove as much as blood as possible. Excess 
buffer was removed and liver pieces were minced into small pieces and homogenized 
and sieved by gently pressing through a 150-m-mesh stainless sieve with the aid 
bottom of a conical flask in grinding action. 13 mL of this homogenate were added to a 
discontinuous gradient and centrifuged in an SW-28 rotor at 28.000 rpm for 1 hour at 
4ºC. 2-3 mL of the Golgi fractions were collected from between the 0,5 and 0,86 M 
sucrose fractions using a Pasteur pipette. Golgi fractions were then diluted to 0,25 M 
sucrose and centrifuged at 7000 rpm for 30 min at 4ºC in the SW-28 rotor. 
Supernatants were discarded and pellets were resuspended in 2mL of phosphate 
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buffer with 0,25 M sucrose and centrifuged again at 7000 rpm for 30 min at 4ºC. 
Supernatants were again discarded and the final pellet was resuspended in 4,5 mL of 
phosphate buffer with 0,25 M sucrose and subsequently aliquoted and frozen in liquid 
nitrogen and stored at −80 °C until use. Golgi-enriched fractions purity was checked by 
Western Blot, measuring the enrichment of the Golgi marker GM130  
2.4.- Morphological analysis 
2.4.1.- Immunocytochemistry 
For morphological analysis, cells were grown on glass coverslips and fixed with 4 % 
paraformaldehyde (PFA) for 15 min at room temperature. After three washes with PBS, 
coverslips were treated for 20 min with 50 mM NH4Cl 50, to block PFA’s free reactive 
aldehyde groups. Coverslips were washed again three times with PBS and permeated 
with 0,1% saponin 1% BSA PBS for 10 minutes at room temperature. Primary 
antibodies were diluted in blocking solution (PBS 1% BSA) and coverslips incubated for 
1 hour at room temperature or overnight at 4 ºC. After three PBS washes, coverslips 
were incubated with secondary antibodies in the same blocking solution for 45 minutes 
at room temperature, washed again with PBS and mounted on slides with mowiol-
mounting media. Images were taken with an Olympus BX60 microscope coupled to an 
Orca-ER CCD camera (Hammamatsu Photonics, Japan). Confocal images were taken 
by a Leica TCS SL confocal microscope (Leica Microsystems, Heidelberg, Germany). 
Images were processed and quantified with Image J 1.43 (NIH, Bethesda, MD, USA). 
2.4.2.- Quantification of Golgi compactness 
To quantify Golgi compactness we measured the circularity of the Golgi as described 
before (Bard, 2003). 8 stacks of the Golgi area were taken by confocal microscopy and 
the mean of the Z projection of these stacks was analysed under a threshold between 
80 and 90. The perimeter and the area of Golgi particles bigger than 3 pixels were 
measured. The circularity of the Golgi apparatus was then computed according to the 
formula 4(sum (areas)/(sum(perimeters))^2). This dimensionless measurement varies 
from 0 to 1. The maximum value of 1 represents compacted, circular morphologies of 
the Golgi complex, while numbers below 0,1 represent fragmented structures. 
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2.4.3.- Electron microscopy 
For transmission electron microscopy, CHO-K1 and CHO-MT58 cells were rapidly fixed 
with 1.25% glutaraldehyde in PIPES buffer (0.1 M, pH 7.4) containing sucrose (2%) 
and Mg2SO4 (2 mM) for 60 min at 37 °C. Cells were then gently scraped, pelleted at 
100 × g for 10 min, rinsed three times in PIPES buffer, and postfixed with 1% (w/v) 
OsO4, 1% K3Fe(CN)6 in PIPES buffer for 1 h at room temperature in the dark. Cells 
were then treated for 5 min with tannic acid (0.1%) in PIPES buffer, rinsed in distilled 
water, block-stained with 1% uranyl acetate in 70% ethanol for 1 h, dehydrated with 
graded ethanol solutions, and finally embedded in Epon plastic resin (EMS, Hatfield, 
PA). Ultrathin sections (50–70 nm thick) were stained with lead citrate and observed on 
a JEOL 1010 electron microscope (Peabody, MA). Micrographs of randomly selected 
areas were obtained with a Gatan Bioscan digital camera (Pleasanton, CA) at the 
same final magnification (×50,000) and analysed using point-counting procedures. The 
minimum sample size of each stereological parameter was determined by the 
progressive mean technique with a confidence limit of 5%. 
2.5.- Lipid analysis 
2.5.1.- Determination of DAG in Lipid Extracts 
For DAG determination in lipid extracts cells were grown on 60-cm2 plates to 80% 
confluence, corresponding to 1,2 mg of protein, and were used as individual samples 
for the different conditions. After incubation, cells were placed on ice, incubation 
medium was removed, and 1 volume of methanol was added (2 ml for 60-cm2 culture 
dishes). Cells were then scraped and collected into glass test tubes containing 0.5 
volumes of chloroform. After 5 min on ice, phases were separated by adding 0.65 
volumes each of chloroform and distilled water. Tubes were vigorously vortexed and 
centrifuged at 3000 × g. The lower organic phase was washed in water/methanol (1:1) 
saturated with chloroform and evaporated under a stream of N2. To determine the total 
amount of DAG in the lipid extract, samples were incubated with DAGK and 
radiolabeled [32P]ATP, to phosphorylate DAG into [32P]PA, which will be measured as a 
product of the total DAG of the lipid extract. For this, the lipid extract of each sample or 
1,2-dioleoyl-sn-glycerol standards (in a range of 250–8000 pmol) were resuspended by 
sonication in 20 l of a mixture of cardiolipin 5 mM, 7.5% N-octyl glucoside and 1 mM 
DETAPAC. The lipid suspension was then incubated at 37 °C for 1 h in a final volume 
of 100 l with the reaction buffer (100 mM imidazole-HCl, 50 mM NaCl, 12.5 mM 
MgCl2, 1 mM EGTA, 0.5 mM DETAPAC, and 2 mM DTT), DAG kinase from 
Escherichia coli (0.022 unit) and 1 Ci of [32P]ATP (2 mM), to phosphorylate the DAG 
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of the sample to [32P]PA. The reaction was stopped by the addition of 0.6 ml of the 
mixture chloroform/methanol/HCl (100:200:1). After 15 min at room temperature, 0.25 
ml of chloroform and 0.25 ml of water were added to separate two phases. The tubes 
were then shaken vigorously and centrifuged at 3000 × g for 5 min. The upper aqueous 
phase was removed, and the lower organic phase containing 32P-lipids was washed in 
0.75 ml of methanol/H2O (1:1) saturated with chloroform. The washed organic phase 
was evaporated under a stream of N2. To separate [32P]PA from the rest of 32P-lipids, 
the lipid pellets were resuspended in 20 l of chloroform/methanol (4:1) and spotted 
onto silica gel plates (HPTLC silica gel-60 plates, 10 × 10 cm), which were developed 
with chloroform/acetone/methanol/acetic acid/H2O (10:4:3:2:1). The area 
corresponding to [32P]PA was identified by comigration with standards, counted for 
radioactivity with a PhosphorImager (Typhon TRIO, Amersham Biosciences), and 
analyzed with ImageQuant software (Amersham Biosciences). Standard values were 
plotted as counts of [32P]PA versus pmol of 1,2-dioleoyl-sn-glycerol (250–8000 pmol), 
and the amount of DAG in each sample was interpolated after linear regression of the 
data.  
2.5.2.- Determination of Major Phospholipid Classes and Triacylglycerol 
For determination of major phospholipid classes and triacylglycerol, cells were 
radiolabeled with [3H]choline (0,5 Ci/ml), [3H]myo-inositol (0,5Ci/ml), [14C]acetate 
(0,25 Ci/ml), or [3H]orthophosphoric acid (5 Ci/ml) for 24 h in F-12 Ham culture 
medium at the permissive growing temperature. Then cells were extensively washed to 
remove the radiolabeled precursors and incubated at different conditions. After 90 min, 
lipid extracts were obtained as described above. Individual lipid classes were 
separated by TLC, identified with authentic standards, and counted for radioactivity. 
[3H]PC in [3H]choline-labeled lipid extracts and [3H]PI in myo-[3H]inositol-labeled lipid 
extracts were separated in one-dimensional TLC with the mobile phase, 
chloroform/methanol/acetone/acetic acid/water (10:2:4:2:1 by volume). Major 
phospholipid classes (i.e. PE, PC, SM, PI, PS and PA in 32P-labeled lipid extracts were 
separated in two-dimensional TLC with the following mobile phases: first, 
chloroform/methanol/ammonia (65:35:10 by volume); second, 
chloroform/methanol/acetone/acetic acid/water (10:2:4:2:1 by volume). 
[14C]triacylglycerol in [14C]acetate-labeled lipid extracts was separated by one-
dimensional TLC with the mobile phase, hexane/diethyl ether/acetic acid (70:30:1 by 
volume). For the 3H- and 14C-labeled lipids, the area corresponding to authentic 
standards on the TLC was scraped and counted by scintillation. The 32P-labeled 
phospholipids were counted and analysed for radioactivity as described above.  
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2.5.3.- Lipid metabolism assays in Golgi-enriched membrane fractions 
2.5.3.1.- Measurement of CDP-choline:diacylglycerol phosphotransferase activity  
CDP-choline:diacylglycerol phosphotransferase (CPT) activity was measured in the 
presence of CMP to force the reaction to produce DAG and CDP-choline at the 
expense of endogenous Golgi membrane PC, which is the reverse of the reaction that 
takes place under physiological conditions. Golgi membranes (50 g of protein) 
isolated from Vero cells and rat liver were incubated in 100 mM Tris/HCl buffer 
containing 5 mM EDTA, 5 mM DTT, 10 mM MgCl2, pH 8.2, and, when indicated, 10 
mM CMP for 30 min at 37ºC. Incubations were stopped by adding 1 volume of 
chloroform/methanol (1:2) saturated with chloroform. Then, lipid samples were 
processed for determination of DAG as described previously. 
2.5.3.2.- [32P]PA production in Golgi-enriched membrane fractions 
Cytosol and PLC-dependent [32P]PA production was determined in Golgi-enriched 
membrane fraction. 25 g of Golgi-enriched membrane fractions from rat liver were 
resuspended  in 10 mM Tris/Maleate, 3 mM EGTA, 4 mM MgCl2  0,62 mM Ca2+
(100nM of free Ca2+) and 20 M GTPS in the presence of 1Ci of [32P]ATP in a final 
volume of 200 L, and incubated at 37 ºC for 30 minutes. 60 g/ml of cytosol, 6M 
U73122, 6 M U73343 or 0,3 U/ml of recombinant PLC  were added to the incubation 
when indicated, or Ca2+ and GTPS were not supplied as indicated. Reaction was 
stopped with chloroform/methanol (1:2) saturated with chloroform. The lipid phase was 
obtained as previously described and [32P]PA was separated from other lipids by one 
dimensional TLC with the mobile phase chloroform/methanol/acetone/acetic acid/water 
(10:2:4:2:1).The [32P]PA was identified by comigration with authentic standards and 
counted and analysed for radioactivity as previously described. 
2.5.3.3.- [32P]PIP metabolism in Golgi-enriched membrane fractions 
For measurements of [32P]PIP, 25 g of Golgi-enriched membrane fractions from rat 
liver were resuspended  in 10 mM Tris/Maleate, 3 mM EGTA, 4 mM MgCl2  0,62 mM 
Ca2+ and 20 M GTPS in the presence of 1 Ci of 0,5 M ATP in a final volume of 200 
L and incubated at 37. After 30 minutes, membranes were washed three times to 
remove the remains of [32P]ATP and incubated for other 30 minutes at 37 ºC in the 
presence of cytosol, Ca2+ and GTPS, as indicated. The reactions were stopped by the 
addition of 0.6 ml of the mixture chloroform/methanol/HCl (100:200:1, v/v/v), and lipid 
extraxts were taken and processed as previously described .[32P]PIP was separated 
from other lipids by one dimensional TLC treated with oxalate with the  mobile phase  
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chloroform/methanol/ammonia/water (18:18:2:3,8 by volume), identified with 
comigration of authentic standards and counted and analysed for radioactivity as 
previously described. 
2.5.4.- Determination of DAG and PI(4)P by its binding to lipid-sensor constructs 
For the analysis of DAG and PI(4)P levels at the Golgi complex, we used the 
constructs C1-PKC-GFP and PH-OSBP-GFP, respectively (Carrasco and Mérida, 
2004; Balla, 2005. The localization of these constructs at the Golgi complex is 
dependent on the amount of DAG and PI(4)P present at this organelle. HeLa cells 
grown on coverslips were transfected with cDNA of C1-PKC-GFP and PH-OSBP-GFP 
as previously described. After 12-16 hours of transfection, cells were fixed and 
processed for immunofluorescence and images were taken as previously described. To 
measure the localization of both constructs at the Golgi complex, cells were also 
stained for Golgin97 to define Golgi area. Localization of these constructs at the Golgi 
complex was expressed as the percentage of fluorescence of the construct in the Golgi 
area referred to the total fluorescence of the cell. To increase the resolution of DAG 
determination at the Golgi complex by the use of C1-PKC-GFP, 100 nM PMA was 
added to cells, in order to recruit C1-PKC-GFP to the plasma membrane, since it has 
been described that this construct also recognizes phorbol esters. 
2.6.- Trafficking assays 
2.6.1.- Transport of vesicular stomatitis virus G protein 
For the analysis of the trafficking assays of VSVG we transfected VSVG-YFP or VSVG-
cherry to CHO-K1 or we used HeLa cells that constitutively express VSVG-GFP. Cells 
were kept overnight at the restrictive temperature of 40ºC, where VSVG cannot fold 
properly and accumulates at the ER. Cicloheximide was added to the media (100 
g/ml) 30 minutes before the temperature shift to 32 ºC, in order to inhibit protein 
synthesis. Once at 32 ºC, the VSVG protein can fold properly and exits the ER, going 
through the Golgi complex and reaching the plasma membrane after 60 min. Cells 
were fixed at different times with 4% PFA and were processed for 
immunofluorescence. 
To quantify VSVG arrival at the plasma membrane we stained non-permeated cells 
with the anti VSVG-EctoDomain antibody, that only stained the VSVG protein that has 
reached the plasma membrane. Images of the ectodomain fluorescence (membrane 
VSVG) and YFP fluorescence (total VSVG) were taken by epifluorescence microscopy. 
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The arrival of VSVG at the plasma membrane was represented as the ratio between 
ectodomain fluorescence and total YFP fluorescence of each cell.  
To measure VSVG arrival at the Golgi complex we also used the endo--N-
acetylglucosaminidase H enzyme (Endo-H, New England Biolabs, Ipswich, MA, USA,). 
Endo-H is a recombinant glycosidase that cuts the mannose-rich residues that proteins 
have when exiting the ER, but cannot act on the more complex N-glycan residues that 
proteins acquire at the Golgi complex. The VSVG protein that has not reached the 
Golgi complex is sensitive to Endo-H, but it becomes resistant to it once its glycan 
residues are modified at this organelle. To analyse the acquisition of resistance to 
Endo-H of the VSVG protein, HeLa cells that constitutively express the termosensitive 
GFP-VSVG protein were incubated 24 hours at 40 ºC and shifted to 32 ºC to allow the 
exit of VSVG of the ER. Cells were lysed at different times after the temperature shift 
with 0,5 % SDS and denaturalyzed at 100 ºC for 10 minutes. 20 g of protein were 
treated with denaturing buffer and boiled again for 10 minutes at 100 ºC. After this step, 
the sample was incubated with 2L of Endo-H enzyme at 37 ºC for 1 hour and reaction 
was stopped with 5 L 5x loading buffer with 10% -mercaptoethanol. Samples were 
processed for WB and GFP-VSVG was identified blotting against GFP. The VSVG 
band with higher electrophoretic mobility is the one sensitive to Endo-H. Arrival at the 
Golgi complex is represented as the ratio between the resistant VSVG and total VSVG 
in the sample. 
2.6.2.- Secretion of a secretory form of horseradish peroxidase (ssHRP) 
To study the secretion of a soluble protein we used a secretory form of horseradish 
peroxidase (ssHRP) as a model. CHO-K1 cells were transfected with Flag-tagged 
ssHRP as prieviously described and after 24 hours media was washed to start the 
secretion assay. CHO-K1 cells were incubated in 1 ml of saline buffer with choline 200 
M and inositol 5 mM or without them with the presence of LiCl 5 mM. 100 L of media 
were collected and centrifuged for 5 minutes at 1000 g at indicated times. The 
enzymatic activity of ssHRP of the supernatants was measured with ECL detection, 
producing a chemical signal which was quantified with a Luminometer (Synergy 2 from 
Biotek). Cellular ssHRP was measured by chemiluminiscence after lysing cells with 
water or by Western Blot. 
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2.6.3.- Secretion of [35S] radiolabeled soluble proteins 
To study soluble protein secretion, we adapted the protocol from Cheong et al 2003. 
HeLa cells were silenced as described and grown on poli-D-lysine for 48 hours on 6-
well plates. Cells were starved for 30 minutes in DMEM without cysteine and 
methionine and radiolabeled with 20 Ci of EasyTag™ EXPRESS35S Protein Labeling 
Mix in 750 L of media for 10 minutes. After that, cells were washed twice with ice-cold 
DMEM and kept at 18 ºC for 3 hours, in order to accumulate newly synthetized 
[35S]proteins at the Golgi complex. Cells were washed twice with PBS 5%BSA and 1 
ml of DMEM per well was added to start secretion at 37 ºC. At indicated times, 100 l 
of culture media was collected, centrifuged and protein in the supernatant was 
precipitated with 200 l of 20% tichloroacetic acid. Pellets were washed twice with cold 
acetone, and left overnight with 500 l NaOH 1 M to resuspend pellets. 500 l of HCl 1 
M were added to neutralize the solution before being quantified by scintillation 
counting. To determine total incorporation of [35S]Met/Cys into cellular proteins, cells 
were lysed with 0.1 N NaOH in 0.1% sodium deoxycholate and quantified by 
scintillation counting.  
2.6.4.- STxBKDELr internalization 
To study retrograde transport we used the B fragment of the toxin of Shigella tagged 
with the KDEL sequence (STxB-KDEL). The KDEL sequence promotes the retention of 
this toxin in the ER, so we can monitor the transport of this toxin from the plasma 
membrane to the ER through the Golgi complex. For this purpose, HeLa cells grown on 
coverslips were washed with PBS and incubated without FBS for 30 minutes at 37 ºC. 
After this, 0,5 g/mL STxB-KDEL was added to the media and cells were kept at 4ºC 
for 1 hour, allowing the binding of the toxin to globotriaosylceramide. The next step was 
to wash cells with DMEM in order to remove the remaining unbound toxin. Cells were 
shifted to 37ºC to induce its internalization to the Golgi complex and finally to the ER. 
Cells were fixed at indicated times with PFA 4% and processed for 
immunofluorescence. 
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1.- Role of phospholipid synthesis in the regulation of DAG required for 
membrane trafficking at the Golgi complex 
1.1.- Cellular content of DAG can be controlled by PC and PI synthesis 
To study if phospholipid synthesis can control the formation of DAG at the Golgi 
complex and regulate trafficking at this organelle, we designed two strategies to inhibit 
phospholipid synthesis for a short time. The first one was using the mutant cell line 
CHO-MT58, which its CCT can not be folded properly at 40 ºC (Esko,1981). CCT is the 
rate limiting enzyme of the CDP-choline pathway, so when we shift CHO-MT58 cells to 
the non-permissive temperature, the cell’s main pathway for PC synthesis is inhibited. 
The second strategy that we have set up to inhibit phospholipid synthesis was 
providing or not choline and inositol, essential precursors of PC and PI, respectively. 
Since regular growth media contain both choline and inositol, we used a saline buffer in 
these assays. As a control we added 200 M choline chloride and 5 mM myo-inositol to 
the saline buffer. To inhibit phospholipid synthesis, we were not supplying choline and 
inositol and added 5 mM lithium to inhibit the recycling of inositol phosphates and 
deplete endogenous inositol. We expected that after a short time inhibition of 
phospholipid synthesis, DAG levels were increased in both experimental strategies. 
DAG levels in CHO-MT58 were increased after shifting the cells to 40 ºC. This increase 
was already seen at 30 minutes, reached a maximum at 60 minutes and remained 
constant for at least 3 hours (Fig. 16B). As a control we used the wild-type cell line 
CHO-K1, where PC synthesis should not be compromised when shifted to 40 ºC. CHO-
K1 DAG levels remained constant all the time that cells were at 40 ºC, being lower than 
those of CHO-MT58 from 30 minutes on (Fig. 16B). On the other hand, we observed 
that CHO-K1 and NRK cells incubated without choline and inositol for one hour had 
higher amount of DAG than those with choline and inositol (Fig. 16C). These results 
demonstrate that short time inhibition of phospholipid synthesis by our two different 
strategies increased cellular DAG.  
1.2.- Inhibition of PC and PI synthesis for a short time does not affect PC and PI, other 
major phospholipids or TAG levels 
To study the effects of DAG changes produced by inhibition of phospholipid synthesis, 
we first wanted to confirm that DAG was the only membrane lipid significantly altered 
in our experimental conditions. Since we are inhibiting PC and PI synthesis, a 
decrease of the amount of these phospholipids, and a possible increase of other lipids 
synthesised from DAG, such as TAG, could be expected. For this purpose, we 
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Figure 16. The cellular content of DAG can be regulated by PC and PI synthetic pathways. A, 
enzyme-catalyzed reactions for the synthesis of PC and PI from DAG and choline and inositol. B, CHO-K1 
and CHO-MT58 cells were grown at 33 °C and then shifted to 40 °C for the indicated times, lipids 
extracted and DAG mass determined. Results are from one experiment representative of three 
experiments. C, CHO-K1 and NRK cells were incubated for 1 h in saline buffer with 200 M choline and 5 
mM inositol (white bars) or without these substrates in the presence of 5 mM LiCl (black bars). Lipids were 
extracted and DAG mass determined. Results are mean ± S.D. of three experiments performed in 
duplicate. 
incubated the cells with different radioactive tracers for 24 hours until the isotopic 
equilibrium, where the amount of radioactive labelling is proportional to the total mass 
of the molecule. We labelled CHO-K1 and CHO-MT58 cells with [32P]orthophosphoric 
acid, [3H]choline, [3H]inositol or [14C]acetate for 24 hours, then washed out the 
radioactive tracer and incubated them for one hour  with our experimental conditions to 
inhibit PC and PI synthesis. We found that the relative amount of [32P]PC was 
unaltered by any of the experimental conditions (Fig. 17A, 17B). [3H]PC labelled with 
[3H]choline, which is incorporated to PC through the CDP-choline pathway, was not 
altered after inhibiting phospholipid synthesis by the absence of choline and inositol 
(Fig. 17C). The level of [3H]PC in CHO-MT58 cells at the permissive temperature was 
lower than in CHO-K1 (Fig. 17D), as previously described (Caviglia, 2004).  However, 
during one hour at the non-permissive temperature, the level of [3H]PC of CHO-MT58 
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remained stable, as it happened in CHO-K1 cells. These results confirmed that none of 
our strategies, which inhibit PC synthesis for a short time, changed significantly the 
total amount of PC. 
Figure 17. Modulation of PC and PI synthesis for a short time does not affect the cellular levels of 
PC or PI. CHO-K1 and CHO-MT58 cells were labeled with [32P]orthophosphoric acid (A, B, E, F), 
[3H]choline (C, D) or [3H]inositol (G, H)  for 24 h. Cells were then washed and incubated for 1 h in saline 
buffer with 200 M choline and 5 mM inositol (white bars), without these substrates in the presence of 5 
mM LiCl (black bars) (A, C, E, F), or with growth medium (F12) at the temperature indicated (B, D, F, H). 
Lipids were extracted, separated by TLC, and counted for radioactivity. Results are mean ± S.D. of two 
experiments performed in duplicate (A, B, E, F) or triplicate (C, D, G, H) 
. 
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 [32P]PI levels were not altered by any of our strategies used to inhibit phospholipid 
synthesis (Fig. 17E). The percentage of [32P]PI was slightly higher in CHO-MT-58 than 
in CHO-K1 cells at the permissive temperature, but in both cell lines [32P]PI levels 
remained unaltered after shifting to the non-permissive temperature (Fig. 17F). We also 
measured PI levels by labelling with [3H]inositol and found that in both experimental 
conditions, [3H]PI levels remained unaltered (Figs. 17G, 17H). These results showed 
that while DAG levels are increasing when we are inhibiting phospholipid synthesis for 
a short time, the total amount of PI is not significantly modified. 
Once we checked that short inhibition of PI and PC synthesis was not lowering these 
phospholipids, we wanted to check if other major phospholipid classes were altered or 
not. Following the same protocol described before, we analysed the amount of SM, PS, 
PE and PA. None of them were altered in both strategies used to inhibit phospholipid 
synthesis (Figs. 18A, 18C). 
Since DAG is a precursor of TAG synthesis, we also assessed if the amount of TAG 
was altered. For this purpose we labelled CHO-K1 and CHO-MT58 cells with 
[14C]acetate and measured [14C]TAG . The amount of [14C]TAG was not altered in any 
of the conditions used to inhibit phospholipid synthesis (Figs 18B, 18D). CHO-MT58 
had lower [14C]TAG than CHO-K1 at 32 ºC, but their amount remained similar after PC 
synthesis inhibition at 40 ºC (Fig. 18D). 
Altogether, these results showed that we have set up two different experimental 
conditions based in phospholipid synthesis inhibition for a short time, in which only 
cellular DAG levels increase, while other major membrane lipids remained unaltered. 
Then, the possible effects that we could see on the cell could be attributed to changes 
in DAG levels, rather than changes in other membrane lipids.  
1.3.- Phospholipid synthesis controls DAG levels at the Golgi complex 
Our next step was to check if the increase in DAG due to the inhibition of phospholipid 
synthesis for a short time could be taking place at the Golgi complex. For this purpose 
we wanted to confirm that DAG consuming reactions of phospholipid synthesis could 
take place in Golgi membranes. We isolated Golgi enriched fractions from Vero cells 
and rat liver and incubated them with or without 10mM CMP. CMP is one of the 
products of the last step of PC synthesis, a reaction catalysed by CPT that consumes 
DAG. CMP is also produced in the last reaction of PI synthesis, a reaction catalysed by 
the PIS. The addition of an excess of CMP to a Golgi membrane preparation will revert 
these PC and PI synthesis reactions if they are localized in the Golgi complex, and as a  
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Figure 18. Modulation of PC and PI synthesis for a short time does not affect the levels of other 
than PI and PC major 32P-labelled phospholipids or TAG levels. CHO-K1 and CHO-MT58 cells were 
labelled with [32P]orthophosphoric acid (A, C) or [14C]acetate (B, D) for 24 h. Cells were then washed and 
incubated for 1 h in saline buffer with 200 M choline and 5 mMm inositol (white bars), without these 
substrates in the presence of 5 mmM LiCl (−substrates) (A, B), or with F-12 growth medium (F12) for one 
hour at 40 ºC (C) or at the temperature indicated (D). Lipids were extracted, separated by TLC, and 
counted for radioactivity. Results are mean ± S.D. of two experiments performed in duplicate. 
 result, DAG will increase. We observed that the addition of CMP led to a two-fold 
increase in the amount of DAG of Vero cells Golgi-enriched fractions (Fig. 19A), and a 
three-fold increase of DAG in Golgi membranes from rat liver (Fig. 19B). Since 
phospholipid synthesis, and so these DAG consumption reactions, is mainly localized 
at the ER, the CMP induced DAG rising in Golgi enriched fraction could be a 
consequence of ER membrane contamination in our samples. We analysed the purity 
of our Golgi-enriched fractions from rat liver by Western Blot, by comparing it to the 
initial homogenate. The Golgi marker GM130 was enriched in our membrane 
preparation, while the ER marker calnexin dropped to 10% in our membrane fractions 
(Fig. 19C). Besides, considering that the Golgi complex is an organelle rich in DAG, 
with 70 ± 17 nmols DAG/ mg protein, compared to 1,3 ± 0,4 nmols nmols DAG/ mg 
protein in cell lysates, the three-fold increase in DAG after CMP addition is plausible to 
be taking place in Golgi membranes, rather than as a consequence of ER 
contamination. These results indicated that DAG consumption reactions of 
phospholipid synthesis are localized at the Golgi, and suggest that the rise in DAG that 
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we observed after inhibiting phospholipid synthesis could be taking place, at least in 
part, at the Golgi complex. 
Figure 19. The content of DAG in Golgi membranes can be regulated by phospholipid synthetic 
pathways. DAG production in the presence of CMP in isolated Golgi membranes from Vero cells (A) and 
rat liver (B). Golgi membranes (25 g of protein) were incubated in Tris-HCl buffer for 20 min with or 
without of 10 mm CMP. Lipids were extracted, and DAG was determined. Results are mean ± S.D. of two 
experiments performed in duplicate. C, Western Blot analysis for GM130 and calnexin of homogenate (H) 
or Golgi-enriched fractions (GM) from rat liver. 
To determine if DAG at the Golgi is increased after inhibition of phospholipid synthesis, 
we used the overexpression of the C1b domain of PKC tagged with GFP (C1-PKC-
GFP). This construct behaves as a sensor of DAG, that binds to the Golgi associated 
DAG pool (Carrasco and Mérida, 2004). We transfected CHO-K1 cells with C1-PKC-
GFP and incubated them with saline buffer with or without substrates for phospholipid 
synthesis for one hour. Inhibition of phospholipid synthesis led to a small increase in 
C1-PKC-GFP recruitment to the Golgi, although it was not statistically significant (Fig. 
20). 
To determine if the inhibition of phospholipid synthesis that leads to an increase in the 
DAG pool of the Golgi produces a functional effect at the Golgi level, we incubated 
CHO-K1 and CHO-MT58 with propanolol during the inhibition of PC and PI synthesis. 
Propanolol is a drug that inhibits the formation of DAG from PA, and this inhibition 
leads to a decrease of DAG and an increase of the number of Golgi associated buds 
as a consequence of an impairment of vesicle fission at the Golgi (Fernández-Ulibarri, 
2007). CHO-K1 and CHO-MT58 were incubated at 33 ºC or 40 ºC in the presence of  
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Figure 20. The recruitment of C1-PKC-GFP to the Golgi is slightly increased by inhibition of PC 
and PI synthesis. A, CHO-K1 cells with transiently transfected C1-PKC-GFP cells were incubated for 1 
h in saline buffer with 200 M choline and 5 mM inositol or without these substrates in the presence of 5 
mM LiC. Bar, 10 m. B, Quantification of C1-PKC-at the Golgi complex was represented as a percentage 
of total fluorescence in the Golgi area. Golgi area was defined using staining with GM130. Results are 
mean ± S.D of more than 20 cells per condition from two different experiments. 
60 M propanolol for the last 15 minutes and Golgi structure was analysed by electron 
microscopy. CHO-MT58 cells at 40 ºC prevented the increase in the number of Golgi-
associated buds induced by propanolol (Fig. 21), which indicates that the DAG 
increase produced by PC synthesis inhibition may compensate the decrease of DAG 
produced by propanolol.  
Figure 21. Inhibition of PC synthesis prevents the increase of Golgi-associated buds induced by 
propanolol. Representative ultrastructural images for the Golgi area of CHO-MT58 cells incubated at 33 
or 40 °C for 1 h with or without propanolol (60 M) during the last 15 min. Bar, 200 nm. 
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Quantitative analysis showed that propanolol induced an increase of the Golgi-
associated budding vesicular profiles per m2 from 0,8 ± 0,3 to 2,9 ± 1,5 in CHO-K1 
and from 0,7 ± 0,2 to 3,0 ± 1,4 in CHO-MT-58, at 32 oC. In CHO-MT58 cells at 40 ºC, 
where DAG is increased as a consequence of PC synthesis inhibition, the increase in 
the number of vesicular profiles after propanolol incubation was prevented(1,5 ± 0,7). 
In contrast, the rise to 40ºC in CHO-K1 did not prevent the propanolol effect in the 
number of vesicular profiles (0,9 ± 0,4 in control situation and 3,3 ± 1,6 with 
propanolol). This prevention of the propanolol effect on the Golgi ultrastructure 
suggests that PC synthesis leads to an increase of the Golgi-associated DAG pool, and 
that the experimental conditions that we had set up can control the level of DAG at the 
Golgi. 
1.4.- Phospholipid synthesis controls both retrograde and anterograde transport at the 
Golgi complex 
Once we confirmed that we are able to control the pool of DAG of the Golgi by tuning 
phospholipid synthesis, and this tuning had a structural effect on vesicle budding, we 
studied if this DAG plays a role in membrane trafficking at this organelle level. For this 
purpose we analysed three different models: the distribution of the endogenous 
KDELR, the transport of the VSVG protein and the secretion of ssHRP. 
We first analysed the subcellular distribution of the KDELR, a transmembrane protein 
that cycles between the Golgi complex and the ER. Luminal ER resident proteins 
contain the KDEL sequence at their C terminus. Once these proteins bind to the 
KDELR at the Golgi complex or at the intermediate compartment, they are brought 
back to the ER in a COP-I dependent manner. Once at the ER, the protein-KDELR 
complex is split and KDELR returns to the Golgi complex. So, KDELR could be found 
in the Golgi complex, in the ER or cycling between these organelles, seen by 
immunofluorescence as cytoplasmic particles. Thus, the subcellular distribution of the 
KDELR reflects the membrane trafficking between the Golgi complex and the ER. 
We analysed the number of KDELR particles by immunofluorescence in CHO-K1 and 
NRK cells after being incubated with saline buffer with or without substrates for 1 hour. 
The pattern of KDELR staining was different between these cell lines. CHO-K1 cells 
showed a strong Golgi staining and some particles in the cytoplasm, while NRK cells, 
although having a good Golgi pattern, presented more cytoplasm particles (Fig. 22A). 
In spite of this, both cell types had a higher number of KDELR positive structures per 
area when we deplete cells of choline and inositol to inhibit phospholipid synthesis (Fig. 
22B). CHO-MT58 cells incubated for one hour at 40 ºC had a higher number of KDELR 
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positive particles per area than CHO-MT58 at 33 ºC and CHO-K1 at both 33 or 40 ºC 
(Fig. 22C). All together these results showed that the inhibition for a short time of PC 
synthesis led to an increase of KDELR particles cycling between the Golgi complex 
and the ER and that the amount of KDELR particles correlated with DAG levels, 
previously shown in figure 16B and 16C. 
Figure 22. The number of KDELR particles per area is increased by the inhibition of PC and PI 
synthesis. A, representative images for KDELR staining in NRK and CHO-K1 cells for the results 
presented in (B). Bar, 10 m. B, NRK and CHO-K1 cells were incubated for 1 h in saline buffer with 200 
M choline and 5 mM inositol (white bars) or without these substrates in the presence of 5 mM LiCl (black 
bars).. C, CHO-K1 and CHO-MT58 cells were incubated for 1 h in growth medium at permissive (33 °C) or 
at non-permissive temperature (40 °C) for the PC-synthesis in CHO-MT58. Results are mean ± S.D. of 
three experiments performed in duplicate. 
To further analyse the dependence of KDELR distribution on DAG we tested a set of 
different experimental conditions and measured the number of KDELR positive 
particles and the amount of DAG. CHO-K1 and CHO-MT58 cells were incubated for 
one hour at 33 or 40 ºC, in saline buffer with or without substrates for phospholipid 
synthesis. The profile for the amount of DAG in the 8 conditions tested (Fig. 23A) was 
qualitatively similar to that for the KDELR particles per area (Fig. 23B). We next plotted 
the number of KDELR particles against the amount of DAG for each condition tested to 
characterize the correlation between these two parameters  The data points were fitted 
to a rectangular hyperbola for one binding site (Fig. 23C), suggesting that the 
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distribution of KDELR particles can be controlled by the interaction of DAG to one 
effector protein.  
Figure 23. The density of KDELR particles correlates with the DAG content. Shown are DAG levels 
(A) and density of KDELR particles (B) from a representative experiment. C, density of KDELR particles 
plotted against DAG for each different experimental condition tested in CHO-K1 and -MT58 cell lines 
incubated in saline buffer for 1 h. Data from individual experiments were normalized (the value for CHO-
K1 cells at 33 °C in the absence of substrates was taken as 100%) and represented are means ± S.D. of 
three experiments performed in duplicate. Data points were fitted by non-linear regression to a one-
binding site hyperbola (r = 0.896). 
We next studied the trafficking of VSVG to the plasma membrane after phospholipid 
synthesis inhibition. VSVG is a protein that is not folded properly at 40 ºC and is 
retained at the ER. After temperature shift to 32 ºC, it can fold and exit the ER, through 
the Golgi complex to the plasma membrane. Most protocols for VSVG synchronization 
keep VSVG expressing cells for at least 4 hours at 40 ºC, in order to accumulate VSVG 
at the ER. These protocols are incompatible with our strategy to inhibit PC synthesis in 
CHO-MT58 cells, because the restrictive temperature for PC synthesis is also 40 ºC. 
For this reason, we only analysed the trafficking in VSVG cells in CHO-K1 cells with or 
without choline and inositol. CHO-K1 cells transfected with VSVG were kept overnight 
at 40 ºC and its media was changed to saline buffer with or without substrates for 
phospholipid synthesis at the moment of the temperature shift to 32 ºC. Inhibition of 
phospholipid synthesis did not alter VSVG arrival at the Golgi complex (Figs. 24A, 
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24B). However, VSVG exited the Golgi complex faster in CHO-K1 cells incubated 
without choline and inositol than with them (Figs. 24A, 24B). In accordance with this 
result, inhibition of phospholipid synthesis by depletion of choline and inositol led to a 
faster VSVG arrival at the plasma membrane than in the presence of the substrates 
(Fig. 24C). Taken together, these results suggest that the increase of DAG in the Golgi 
complex due to phospholipid synthesis inhibition could be promoting the vesicle 
formation in the Golgi complex and its exit to the plasma membrane.  
Figure 24. Post-Golgi transport of VSVG is increased by the inhibition of PC and PI synthesis.
CHO-K1 cells transiently transfected with VSVG were incubated overnight at 40 °C to accumulate the 
unfolded VSVG at the ER. Cells were then shifted to 32 °C and incubated for 1 h in saline buffer with 200 
M choline and 5 mM inositol or without these substrates in the presence of 5 mM .A, representative 
images for the two conditions. Bar, 10 m. B, percentage of cells with VSVG at the Golgi for the times 
indicated. Results are mean ± S.D. of three experiments performed in duplicate. C, cells incubated for 60 
min as in B were then labeled with anti-VSVG ectodomain antibody without permeabilization. Results 
represent the ratio between VSVG at the plasma membrane and the total VSVG. Results are mean ± S.E. 
of five experiments performed in triplicate.
After analysing the traffic of KDELR and VSVG, both transmembrane proteins, we next 
wanted to check if the trafficking of soluble proteins could also be controlled by 
phospholipid synthetic pathways. For this purpose, we studied the secretion of a 
soluble form of the horseradish peroxidase (ssHRP). CHO-K1 cells were transfected 
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with ssHRP and incubated with saline buffer with or without choline and inositol. The 
amount of ssHRP was measured as the HRP activity accumulated in the media during 
every 30 minutes along 2 hours. CHO-K1 cells incubated without substrates for 
phospholipid synthesis had a higher HRP activity in the media than those cells where 
phospholipid synthesis was not inhibited (Fig. 25A). To ensure that the differences of  
Figure 25. ssHRP secretion is increased by the inhibition of PC and PI synthesis. CHO-K1 cells with 
transiently transfected ssHRP were incubated for the times indicated in saline buffer with 200 M choline 
and 5 mM inositol (white bars) or without these substrates in the presence of 5 mM LiCl (black bars). 
ssHRP in the incubation buffer (A) and in cell lysates (B, C ) was determined by a luminescent enzymatic 
assay  or Western blot, as indicated. Results are mean ± S.D. of eight experiments performed in duplicate 
in A and mean ± S.D. of two experiments performed in duplicate in B and C. A.U., arbitrary units. 
 HRP activity found in the media reflected changes in the rate of secretion of HRP and 
not a differential expression, we checked intracellular ssHRP. The amount of HRP 
measured by both luminescence assay of activity and Western blot, we found that just 
after changing the media to saline buffer, cells had the same amount of HRP (Figs. 
25B, 25C). We also observed that after 60 minutes of incubation, the levels of 
intracellular ssHRP were slightly higher on cells incubated with choline and inositol, 
indicating that the differences seen on the media were due to differential secretion in 
the presence of substrates for phospholipid synthesis. These results confirmed that 
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soluble protein trafficking, as it happened for transmembrane proteins, can be 
regulated by modulating the routes of phospholipid synthesis. 
Altogether, the results for the trafficking of these three proteins showed that 
phospholipid synthesis can regulate membrane trafficking at the Golgi complex by 
controlling DAG levels in this organelle, in both anterograde and retrograde directions 
and of both transmembrane and soluble proteins. 
2.- Role of PLC1 in the regulation of DAG required for membrane trafficking at 
the Golgi complex 
2.1.- PLC activity in Golgi-enriched membrane fractions 
In order to determine the role of PLC in the Golgi complex, we first studied if there was 
PLC activity in Golgi-enriched membrane fractions. For this purpose, we incubated 
Golgi-enriched membrane fractions with radiolabeled [32P]ATP and measured the 
production of [32P]PA. In this assay, if PLC and DAGK are present and their reactions 
coupled, then the production of [32P]PA can be a reporter of DAG production.  On the 
other hand, since most of PLC isoforms are found in a soluble form (Gresset, 2012; 
Kadamur and Ross, 2013), we also added cytosol to the reaction,. Little [32P]PA 
production was observed in Golgi membranes alone, but this [32P]PA production highly 
increased after cytosol addition (Fig. 26A). In order to evaluate if this experimental 
strategy was a good approach to measure PLC activity, we added recombinant PLC to 
the reaction. In the presence recombinant PLC, [32P]PA production increased almost 2-
fold, compared to the condition in the presence of cytosol (Fig.26A). To confirm that 
cytosol-induced [32P]PA production reflected PLC activity, we tested the effects of the 
PLC inhibitor U73122 in our experimental conditions. U73122 addition led to a 
decrease of [32P]PA production (Fig. 26B). U73343, a close analogue of U-73122 that 
does not suppress PLC activity (Smith, 1990); also decreased [32P]PA production, but 
its effect was lower than the inhibition by U73122 (Fig. 26B). These results showed that 
in our experimental strategy [32P]PA production may reflect PLC activity and that this 
activity could be taking place in Golgi-enriched membrane fractions after cytosol 
addition. 
All previous reactions were performed in the presence of Ca2+ and GTPS. Our next 
step was to study the effects of Ca2+ and GTPS on the cytosol-induced [32P]PA 
production. Ca2+ is needed for the action of all PLC isoforms (Gresset, 2010; Kadamur 
and Ross, 2013) and if this [32P]PA production is by the action of PLC we expect that 
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Ca2+ depletion would inhibit it. On the other hand, GTPS strongly activates the action 
of G proteins, which are localized at the Golgi complex and activate the PLC
isoenzymes (Gresset, 2010; Kadamur and Ross, 2013), suggested to be acting at the 
Golgi complex (Díaz-Añel, 2007). This way, if [32P]PA production is mediated by a 
PLC isoform, this should be sensitive to GTPS. We found that [32P]PA production 
was reduced in the absence of Ca2+ and also in the absence GTPS (Fig.27A).  
Figure 26. [32P]PA production in Golgi-enriched membrane fractions as a reporter of PLC activity. 
A 25 g of Golgi-enriched membrane fractions from rat liver were incubated with 10 mM Tris/Maleate, 3 
mM EGTA, 4 mM MgCl2, 0,62 mM Ca2+ (1 µM free Ca2+) and 20 M GTPS for 30 minutes at 37ºC in the 
presence of 1Ci of ATP. 60 g/ml of cytosol and 0,3 U/ml of recombinant PLC were added in the 
reaction when indicated. B, Golgi-membrane fractions in the presence of 60 g/ml cytosol were incubated 
in the presence of 6 M U73122 or 6 M U73343. Results are mean ± S.D.  of three or more experiments 
performed in duplicate. Statistical significance according to one-way analysis of variance using 
Bonferroni's multiple comparison test  compared to control (*, p  0.05; ***, p  0.001) and to Cytosol 
(++,p  0.01) in A. 
Next, we wanted to study the consumption of PIP in Golgi membranes, since this 
phosphoinositide is abundant in Golgi and can be a substrate for PLC to produce DAG 
and Inositol (1,4)P2. We also cheked whether the depletion of Ca2+ and GTPS affect 
the consumption of PIP. For this, we first incubated the Golgi-enriched membrane 
fractions with [32P]ATP in order to label [32P]PIP and, after [32P]ATP washout, measure 
the levels of [32P]PIP after cytosol addition. Cytosol addition led to a decrease of 
[32P]PIP, compared to those membranes incubated without cytosol (Fig. 27B). Ca2+
depletion prevented the cytosol-induced [32P]PIP consumption (Fig. 27B), indicating 
that this cytosol-induced [32P]PIP consumption was sensitive to Ca2+. However, cytosol-
induced [32P]PIP consumption was not altered by the absence of GTPS (Fig. 27B), 
suggesting that [32P]PIP consumption was independent of the action of G proteins. 
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Although not conclusively, these results allow us to hypothezise  that PLC can 
metabolize PIP at the Golgi complex in a manner  independent of G proteins. To 
pursue this hypothesis we then decided to focus our further investigations on the action 
of PLC on Golgi function and structure, since it is sensitive to Ca2+, but not to G 
proteins. 
Figure 27. PLC activity in Golgi-enriched membrane fractions requires Ca2+ but not GTPS. 25 g 
of Golgi-enriched membrane fractions from rat liver were incubated with 10 mM Tris/Maleate, 3 mM 
EGTA, 4 mM MgCl2,. 0,62 mM Ca2+ (1 µM free Ca2+) and 20 M GTPS for 30 minutes at 37ºC in the 
presence of 1Ci of ATP. 60 g/ml of cytosol, 0,62 mM Ca2+ and 20 and M GTPS and were added in 
the reaction when indicated.. D Golgi-membrane fractions were preincubated for 30 at 37ºC in the 
presence of 1Ci of ATP, washed and incubated with or without cytosol, Ca2+ or GTPS for 30 minutes at 
37ºC, as indicated. Lipids were extracted, separated by TLC, and PA and PIP were identified using lipid 
standars and counted for radioactivity. Results are mean ± S.D.  of three or more experiments performed 
in duplicate. Statistical significance according to one-way analysis of variance using Bonferroni's multiple 
comparison test  compared to control (*, p  0.05; **, p  0.01). 
2.2.- Characterization of PLC1 tools 
For the study of the role of PLC in the Golgi complex, we first characterized the PLC
tools that will allow us these studies in HeLa cells. We first wanted to confirm that HeLa 
cells express PLC1 and that could be recognized by Western Blot and silenced by 
siRNA. Anti-PLC1 antibody worked for WB, recognizing one band around 150 KDa, 
which fits with the molecular weight of PLC1 (Fig. 28A). This band recognized with the 
anti-PLC1 antibody was decreased to less than 10% after 72 hours treatment of 
siRNA against PLC1, but it remained unaltered when incubated against a non-
targeting siRNA or with a siRNA against PLC2, and it was also decreased after  
incubation with siRNA against PLC1 and PLC2 (Fig. 28A).  
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Moreover, the intensity of anti-PLC1 was higher after the overexpression of both wild-
type PLC1 and a construct of its catalytically inactive form, PLC1(H335Q), but not 
when overexpressing wild-type PLC2 or its catalytically inactive form, PLC2(H327Q) 
(Fig. 28B). These results showed that the PLC1 antibody specifically recognized  
Figure 28. Characterization of PLC silencing and antibodies in HeLa cells. A Western Blot analysis 
of HeLa lysates transfected with diferent siRNA for 72 hours. B Western Blot analysis of HeLa lysates 
transfected with diferent PLC plasmids for 34 hours. C Western Blot analysis of HeLa cells in control 
conditions or in the presence of 100 ng/mL EGF. 
PLC1 for WB and that the siRNA against PLC1 also worked properly. Moreover, the 
antibody against PLC1 phosphorylated in its tyrosine 783 (anti-phosphoPLC1), a 
phosphorylation related to PLC1 activation (Gresset, 2010); recognized a band 
around 150 kDa that increased after treatment with epidermal growth factor (EGF) (Fig. 
28C), one known activator of PLC1. This result also confirms that the antibody against 
the activating phosphorylation of PLC1 also works properly for WB. 
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The anti-PLC2 antibody did not seem to recognize any specific band around 150 KDa 
in HeLa cells lysates (Fig. 28A), where its molecular weight would fit. Moreover, 
treatments with siRNA against PLC1, PLC2 or both did not modify the pattern of anti-
PLC2 labeling (Fig.28A). However, anti-PLC2 antibody specifically recognized a 
band around 150 KDA when overexpressing wild-type PLC2 or its catalytically inactive 
form, PLC2(H327Q), but it did not recognize overexpression of both PLC1 constructs 
(Fig. 28B). These results showed that anti-PLC2 antibody works specifically for WB, 
since it recognizes the overexpression of its target protein. The lack of signal in lysates 
of HeLa cells for the anti-PLC2 antibody suggests that this cell line does not express 
this PLC isoform, which is in accordance with the literature, where PLC2 expression is 
described to be restricted to cells of the haematopoietic system (Gresset, 2012, 
Kadamur and Ross, 2013). 
Figure 29. Antibodies against PLC1 and pPLC1 do not work for immunocytochemistry. A HeLa 
cells transfected with control or PLC1 siRNA were stained with anti-PLC1 antibody. B HeLa cells in 
control conditions and incubated with EGF 100 ng/mL for 5 min were stained with anti-phospho-tyr783 
PLC1 antibody. Bar = 10 m. 
One of our goals was to study the subcellular localization of PLC1 and if this protein 
could be found, or temporally translocated, at the Golgi complex. However, the 
antibodies against PLC1 or phosphoPLC1 did not work for immunocytochemistry. 
Staining of HeLa cells with anit-PLC1 did not show any recognizable structure and 
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treatment with siRNA against PLC1, which, according to WB results, worked properly 
(Fig. 28A), did not change this staining pattern (Fig. 29A). Staining with anti-phospho-
PLC1 also did not show any recognizable structure, although in some cells it stained 
the nucleus (Fig. 29B). After stimulation with EGF the staining pattern of anti-
phosphoPLC1 did not change (Fig. 29B), suggesting that this antibody does not work 
properly for immunocytochemistry. 
Finally, we overexpressed PentaHis-tagged wild type PLC1  and its catalytically 
inactive form PLC1(H335Q), to study its subcellular localization and any possible 
translocation of this protein at the Golgi complex. Both constructs were localized at the 
cytoplasm, but addition of EGF, a known activator of PLC, did not alter this staining 
pattern (Fig. 30). Since we were unable to see any redistribution after stimulation with 
EGF, we ruled out the possibility to study any translocation to the Golgi complex by any 
other stimuli. However, we can identify cells that overexpress PLC1 to further analyse 
the effects of the overexpression of its wild-type or catalytically inactive forms on the 
Golgi complex. 
Figure 30. Overexpressed PLC1 localyzes at the cytoplasm of HeLa cells. HeLa cells transiently 
overexpressing PLC1 or its catalitically inactive form PLC1(H335Q) were fixed in control conditions or 
after 5 min incubation of 100 ng/mL and analysed by immunofluorescence. Bar = 10 m. 
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 With these tools, and because of the absence of PLC 2 in our cell system, we 
decided to focus the study in the role of PLC1 at the Golgi complex by using 
strategies based in PLC1 depletion by siRNA, since we could not study any possible 
localization of PLC1 on the Golgi complex or elsewhere by immunofluorescence.  
2.3.- Role of PLC1 in Golgi function and structure 
2.3.1.- Role of PLC1 in Golgi secretory function 
To study the role of PLC1 in the secretory function of the Golgi complex, we analysed 
the trafficking of VSVG along the secretory pathway. HeLa cells that constitutively 
express VSVG-GFP were silenced for PLC1 using siRNA. First, we studied the 
trafficking in the early secretory pathway from the ER to the Golgi complex, measuring 
the acquisition of resistance to the endoglicosylase-H (Endo-H) enzyme. The Endo-H 
enzyme cuts the glycosyl residues enriched in mannose that proteins possess when 
they exit the ER, but it cannot process the higher complex N-glican residues that 
proteins acquire at the mid-Golgi. This way, the acquisition of resistance to Endo-H will 
represent that proteins, in our case VSVG, have reached the medial region of the Golgi 
complex. The acquisition of Endo-H resistance is seen by a change in the 
electrophoretic mobility of the protein, being this lower once it has acquired the 
resistance (Fig. 31A). HeLa cells transfected with non-targeting (from now on control 
siRNA) or PLC1 siRNA were kept overnight at 40 ºC in order to accumulate VSVG at 
the ER and then shifted to 32 ºC to allow its exit from the ER to the Golgi complex. The 
resistance to the Endo-H enzyme at 30 min was  the same in cells silenced for siRNA 
against PLC1 and those treated with a control siRNA (Fig. 31A-B), suggesting that 
PLC1 silencing does not alter the transport of VSVG from the ER to the Golgi 
complex. 
Next, we measured the arrival of VSVG to the plasma membrane after PLC1 
silencing. Cells were kept overnight at 40 ºC to accumulate VSVG at the ER and then 
shifted to 32 ºC to allow VSVG transport from the ER to the plasma membrane. As 
seen by immunofluorescence, after 60 minutes at 32 ºC, cells silenced for PLC1 
presented less amount of VSVG at the plasma membrane compared to those 
transfected with control siRNA (Fig. 31C). Quantification of VSVG that has reached the 
plasma membrane with an antibody against the Ecto-Domain of VSVG confirmed that 
in cells silenced for PLC1 the trafficking of VSVG is slower than in control cells (Fig. 
31D). Since the transport of VSVG from the ER to the Golgi complex did not seem 
affected after PLC1 silencing, the delay in the arrival of VSVG at the plasma 
membrane in silenced cells suggests that PLC1 may be participating in the late  
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Figure 31. PLC1 silencing impairs post-Golgi trafficking. A-D HeLa cells constitutively expressing 
VSVG-GFP were transfected for 72h with siRNA control or against PLC1 and incubated at 40 °C 
overnight. 30 minutes after the temperature shift, cyclohexymide was added to inhibit protein synthesis. 
A-B, Biochemical transport assay for VSV-G-GFP using Endo H. After overnight incubation at 40 ºC and 
addition of CHX, cells were shifted at 32 °C to induce the transport of VSV-G from the ER, lysed at 
indicated times, and subjected to Endo H treatment. R and S indicate Endo H-resistant and -sensitive 
forms, respectively. B The ratio of the amount of Endo H-resistant form to that of total amount is plotted. 
Values are represented as the mean ± S.D. of three independent experiments.. C Cells were fixed after 
60 minutes at 32ºC and stained for VSVG ectodomain antibody without permeabilization. Bar = 10 m. D 
Results represent the ratio between the staining of VSV-G at the plasma membrane and the total cellular 
VSVG-GFP. E HeLa cells were transfected with control or PLC1 siRNA. 72 h after the transfection, cells 
were pulse labeled with [35S]Met/Cys, incubated at 19 °C for 3 h and then shifted to 37 °C. After 60 
minutes, proteins in the culture supernatants were precipitated and cell lysates were taken and both 
quantified by scintillation counting. . Results are mean ± S.D. of four independent experiments. Statistical 
significance according to Student’s t-test (**, p  0.01; (***, p  0.001). 
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secretory pathway. To confirm this result by studying other cargoes, we measured the  
post-Golgi secretion to the extracellular media of soluble proteins radiolabeled with 
[35S]cysteine/methionine. HeLa cells were silenced for PLC1 or treated with a control 
siRNA and pulse-labelled with a mixture of [35S]cysteine/ methionine. Then, cells were 
kept for 3 hours at 19 ºC, in order to accumulate newly synthesised [35S]proteins at the 
Golgi complex and then shifted to 37 ºC to allow its secretion to the extracellular media. 
After 60 min at 37 ºC, the amount of [35S]soluble protein secreted in the extracellular 
media was slightly, but significantly lower in cells silenced for PLC1 than in control 
cells (Fig. 31E), indicating that the post-Golgi trafficking of soluble proteins is slowed by 
PLC1 silencing. This result is in accordance with the delay of VSVG trafficking to 
plasma membrane (Fig. 31C,D), and confirms that PLC1 silencing impairs post-Golgi 
transport. 
We next assesed if PLC1 could also contribute to retrograde transport from the Golgi 
complex to the ER. To this end, we analysed the internalization of the Shiga toxin that 
contains in its carboxyl terminus the ER retention sequence KDEL conjugated with Cy3 
(STxB-KDEL). After binding to the plasma membrane, this toxin is transported to the 
Golgi complex and to the ER, where it is retained. HeLa cells transfected with control or 
PLC1 siRNA for 72 hours were incubated for STxB-KDEL at 4 ºC for one hour to allow 
the toxin binding and synchronize its internalization. After that, cells were washed in 
order to remove the remaining of unbound toxin and then shifted to 37 ºC to start its 
internalization through the Golgi complex to the ER.  After 30 minutes, almost all STxB-
KDEL was found at the Golgi complex and progressively reached the ER (Fig. 32). 
Although the arrival of STxB-KDEL at the ER and its exit from the Golgi complex was 
apparently delayed in cells silenced for PLC1, the quantification of STxB-KDEL 
dynamics  was not significantly different between control cells or cells silenced for 
PLC1 (Fig. 32), suggesting that PLC1 is not taking part in the retrograde transport 
from the ER to the Golgi complex. 
2.3.2.- Role of PLC1 in the maintenance of Golgi structure 
Since PLC1 controls post-Golgi membrane trafficking, but not the retrograde transport 
from the Golgi complex to the ER, we studied if the unbalance of membrane flux at the 
Golgi complex caused by PLC1 silencing could also lead to changes in the structure 
of this organelle. For this purpose, HeLa cells were transfected with non-targeting or 
PLC1 siRNA for 72 hours. Then, cells were stained for GM130, Golgin97 and TGN46, 
markers of cis-Golgi, trans-Golgi and TGN, respectively, in order to analyse the 
morphology of the different Golgi compartments. Cells silenced for PLC1 presented a  
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Figure 32. The retrograde transport of STxB-KDEL to the ER is unaltered after PLC1 silencing. A 
Immunofluorescence microscopy of the retrograde transport kinetics of the cy3-tagged Shiga toxin 
fragment B containing the ER-retention signal KDEL (STxB-KDEL) in HeLa with control or PLC1 siRNA. 
Plasma membrane internalization of bound STxB-KDEL at 4°C was performed at 37°C for different times 
until the arrival to the ER (identified by the reticular pattern and nuclear envelope staining), crossing firstly 
the Golgi (identified by the juxtanuclear staining). Bar = 10 m.B-C Quantification of cells with STxB-KDEL 
at the Golgi complex (B) and the ER (C). Values are the mean ± S.D. from three independent 
experiments.  
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 more compacted morphology of the Golgi complex, compared to control cells (Fig. 
33A). To quantify these morphological differences, we measured the compactness of 
the Golgi, a dimensionless number that represents circularity, which is a function of the 
area and perimeter of all Golgi particles (Bard, 2003). For all three Golgi markers, the 
value of Golgi circularity was higher in cells silenced for PLC1 than in control cells 
(Fig. 33B), which indicates that the Golgi morphology is more compacted in cells 
Figure 33. Cells silenced for PLC1 present a Golgi-compacted morphology. A HeLa cells 
transfected with control or PLC1 siRNA were stained with GM130, Golgin97 and TGN46. Bar = 10 m. B 
Golgi compactness was quantified as described in methods. More than 150 cells per condition in each 
experiment were computed and results from from three independent experiments were submitted to 
statistical analysis. Statistical significance according to Student’s t-test (**, p  0.01, ***, p  0.001).  
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depleted of PLC1. Since the morphology of the Golgi complex is highly dependent of 
alterations of the cytoskeleton (Egea, 2013), we checked if the effects of PLC1 
silencing on the Golgi morphology could be a consequence of changes in the actin 
cytoskeleton. Apparently, there were no differences in the actin stress fibers between 
silenced and control cells (Fig. 34), therefore the cause for changes in the Golgi 
morphology after PLC1 silencing were other than alterations in the actin cytoskeleton. 
Figure 34. PLC1 silencing has no effects on the actin cytoskeleton. HeLa cells transfected with 
control or PLC1 siRNA for 72 hours were fixed and stress fibers stained with TRITC-phalloidin. Bar = 10 
m. 
To further explore the effect of PLC1 on the Golgi structure, we next studied the Golgi 
morphology after overexpression of wild-type PLC1 or its catalytically inactive form 
PLC1(H335Q). After 48 hours of overexpression, cells were stained for GM130 and 
Golgin97 and Golgi compactness was measured as previously described. 
Overexpression of PLC1, but not PLC1(H335), led to a decrease in the compactness 
of the staining for GM130 (Fig. 35A-B). However, this effect was higher at the trans-
Golgi, where PLC1 overexpression, but not its catalytically inactive form, led to a 
fragmentation of the structures stained with Golgin97 (Fig. 35C), with the consequent 
decrease of the value of the Golgi compactness (Fig. 35D). These results confirmed 
that the catalytic activity of PLC1 has a role in the maintenance of the structure of the 
Golgi complex.  
2.4.- Role of PLC1 in the regulation of the Golgi-associated DAG pool 
All previous results show that PLC1 can be participating in different Golgi events, as 
the post-Golgi transport or in the maintenance of Golgi structure. The changes induced 
by PLC1 silencing or overexpression in Golgi function and structure can be a 
consequence of at least three different mechanisms. First, PLC1 depletion can alter a 
signalling cascade that could be originated in a location of the cell other than Golgi, as  
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Figure 35. PLC1 overexpression leads to fragmentation of the Golgi. HeLa cells were transfected 
with PLC1 or its catalitically inactive form for 48 hours. Cells were fixed and stained for GM130 and 
Golgin97, as a marker of cis and trans-Golgi, respectively. Golgi compactness was measured as 
previously described (Bard et al., 2003). Values are the mean ± S.D. from three independent 
experiments. Statistical significance according to one-way analysis of variance using Bonferroni's multiple 
comparison test (*, p  0.05; **, p  0.01). Bar = 10 m. 
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for example, the plasma membrane, that could control Golgi structure and function. In 
this case, as PLC1 would not be located at the Golgi complex would affect this 
organelle in an indirect way. Second, PLC1 depletion may lead to an unbalance of the 
total cell amounts of DAG, PI(4)P and PI(4,5)P2, its lipid product and substrates, 
respectively, that could in turn affect the composition of Golgi membranes, leading to 
the alterations of Golgi function and structure. The third hypothesis is that PLC1 is 
acting on the Golgi complex, where it controls the production of DAG required for 
membrane traficking, after being stimulated at this organelle. 
In order to analyse the mechanism used by PLC1 to participate in Golgi function and 
structure, we first determined if PLC1 depletion had an effect on the Golgi associated 
DAG pool. For this purpose, HeLa cells transfected with control or PLC1 siRNA were 
also transfected with C1-PKC-GFP, a construct that acts as a sensor of the Golgi 
associated DAG pool. In both control and silenced cells, C1-PKC-GFP mainly 
localized at the Golgi complex (Fig. 36A). No significant differences were found in the 
localization of C1-PKC-GFP at this organelle, although the amount present in the 
Golgi complex was slightly lower in cells silenced for PLC1 (Fig. 36A). In order to 
increase the resolution of this assay, we added PMA for 10 minutes, a compound that 
induces the recruitment of C1-PKC-GFP to the plasma membrane. This way, we 
could measure the kinetics of the recruitment of C1-PKC-GFP, which would depend 
on the DAG amount present at the Golgi complex. After 10 minutes of PMA incubation, 
almost all C1-PKC-GFP was localized at the plasma membrane in both conditions 
(Fig. 36A). However, after 5 minutes of PMA incubation, C1-PKC-GFP was mainly 
localized at the Golgi complex in control cells, while in cells silenced for PLC1 the 
presence of C1-PKC-GFP in the plasma membrane was more evident (Fig. 36A). 
Quantification of the amount of C1-PKC-GFP at the Golgi complex after 5 minutes of 
PMA treatment revealed that cells silenced for PLC1 had lower percentage of C1-
PKC-GFP at this organelle than control cells (Fig. 36B). This result suggests that 
PLC1 can control the amount of Golgi associated DAG pool. 
Once provided that PLC1 can regulate the Golgi associated DAG pool, we wanted to 
check if PLC1 could be involved in DAG production at the Golgi complex and in a 
manner triggered by cargo arrival. For this purpose, we first studied if the arrival of 
cargo at the Golgi complex increases the Golgi associated DAG pool, a hypothesis that 
has not been experimentally addressed before. To this end, HeLa cells were co-
transfected with C1-PKC-GFP and VSVG and kept overnight at 40 ºC, in order to 
accumulate VSVG at the ER. Then, cells were shifted to 32 ºC to allow VSVG arrival at 
the Golgi and fixed at different times. C1-PKC-GFP was mainly localized at the Golgi  
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Figure 36. Cells silenced for PLC1 have less recruitment of C1-PKC-GFP to the Golgi after PMA 
addition. HeLa cells transfected with control or PLC1 siRNA were also transfected with C1-PKC-GFP 
and incubated in the presence of 100 nM PMA. A, Cells were fixed before and 5 and 10 min after PMA 
addition and stained for Golgin97 to define Golgi region. B, Quantification of C1-PKC-GFP binding at the 
Golgi complex. Values are the mean ± S.D. from three independent experiments. Statistical significance 
according to two-way analysis of variance using Bonferroni's multiple comparison test (*, p  0.05). Bar = 
10 m. 
complex during all the time, but the GFP fluorescence intensity at this organelle was 
higher at 30 minutes, when VSVG has reached the Golgi complex (Fig. 37A). 
Moreover, in the presence of VSVG, the fluorescence intensity of C1-PKC-GFP at the 
Golgi complex constantly increased after the temperature shift, while in the absence of 
VSVG C1-PKC-GFP localization at the Golgi complex remained unaltered from 10 to 
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30 minutes (Fig. 37B). This result confirms, for the first time, that cargo arrival at the 
Golgi complex stimulates the production of DAG at this organelle. 
Once demonstrated that cargo arrival at the Golgi complex promotes DAG production, 
we studied if PLC1 could be the responsible of the increase of DAG at this organelle.  
Figure 37. Cargo arrival promotes DAG formation at the Golgi complex. A Hela cells were transfected 
with C1-PKC-GFP and VSVG-cherry and kept overnight at 40 ºC. After CHX addition, cells were shifted 
to 32 ºC and cells were fixed at indicated times and stained with Golgin97 to define Golgi area. B 
Quantification of C1-PKC-GFP localizatoin at the Golgi complex. Values are the mean ± S.D. from three 
independent experiments. Statistical significance according to two-way analysis of variance using 
Bonferroni's multiple comparison test (*, p  0.05). Bar = 10 m. 
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Figure 38. PLC1 silencing inhibits the increase of DAG at the Golgi induced by cargo arrival. A 
HeLa cells transfected with control or PLC1 siRNA were transfected with C1-PKC-GFP and VSVG-
cherry and kept overnight at 40 ºC. After CHX addition, cells were shifted to 32 ºC and cells were fixed at 
0 and 30 minutes after the temperature shift and stained with Golgin97 to define Golgi area. B 
Quantification of C1-PKC-GFP localizatoin at the Golgi complex. Values are the mean ± S.D. from three 
independent experiments. Statistical significance according to two-way analysis of variance using 
Bonferroni's multiple comparison test (*, p  0.05). Bar = 10 m. 
HeLa cells were transfected with control or PLC1 siRNA and co-transfected with C1-
PKC-GFP and VSVG, in order to measure the localization of C1-PKC-GFP at the 
Golgi complex after VSVG arrival. We found that before the temperature shift, control 
and silenced cells had the same amount of C1-PKC-GFP at the Golgi complex (Fig. 
38), but after 30 minutes at 32 ºC, when VSVG has reached the Golgi complex, control  
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cells showed higher levels of C1-PKC-GFP at the Golgi complex than cells silenced 
for PLC1 (Fig. 38). This result suggests that PLC1 is responsible, at least in part, of 
the DAG production at the Golgi complex induced by cargo arrival. 
In order to test if PLC1 was the responsible for this DAG production by metabolizing 
the main phosphinositide, PI(4)P, at the Golgi complex, we studied the distribution of 
PH-OSBP-GFP before and after cargo arrival at the Golgi complex. PH-OSBP-GFP is  
Figure 39. Cargo arrival does not alter the Golgi-associiated PI(4)P pool. A HeLa cells were 
transfected with PH-OSBP-GFP and VSVG-cherry and kept overnight at 40 ºC. After CHX addition, cells 
were shifted to 32 ºC and cells were fixed at indicated times and stained with Golgin97 to define Golgi 
area. Bar = 10 m.B Quantification of PH-OSBP-GFP localized at the Golgi complex. Values are the mean 
± S.D. from three independent experiments. 
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a construct that associates with the PI(4)P pool of the Golgi (Balla, 2005). We analysed 
PH-OSBP-GFP localization at the Golgi complex, following the same protocol for cargo 
arrival at the Golgi complex described for C1-PKC-GFP measurements. As previously 
described, we found PH-OSBP-GFP localized at the Golgi complex and also at the 
nucleus (Fig. 39A; Balla, 2005). Cargo arrival did not alter PH-OSBP-GFP localization 
at the Golgi complex (Fig. 39B), suggesting that the amount of PI(4)P pool of the Golgi 
complex is not significantly modified after cargo arrival at this organelle. 
Next, we wanted to study the mechanisms underlying PLC1 activation after cargo 
arrival at the Golgi complex. The most known mechanism of PLC1 activation is by 
phosphorylation of its Tyr783 (Gresset, 2010) and it has been suggested that cargo 
arrival induces an increase of phosphotyrosines at the Golgi complex (Pulvirenti, 2008). 
For these reasons, we checked if cargo arrival activates PLC1 by phosphorylation on 
its Tyr783. HeLa cells constitutively expressing VSVG were kept at 40 ºC and then 
shifted to 32 ºC, in order to promote VSVG arrival at the Golgi complex and measure 
the levels of phosphorylation of PLC1 in its Tyr783 (pPLC1). As a control, cells were 
incubated with EGF, to confirm that we are able to measure an increase of pPLC1  
Figure 40. Cargo arrival at the Golgi does not modify the levels of phospho-tyr783 PLC1. HeLa 
cells constitutively expressing VSVG-GFP were incubated at 40 ºC for 5 hours without FBS and then 
shifted to 32 ºC. Lysates were taken at indicated times and were processed for WB (A) or 
immunoprecipitated for PLC1 (B) and blotted against phospho-tyr783 PLC1 or total PLC1 (L= lysates, 
P=pellet). 100 ng/mL of EGF were added for 5 minutes as a positive control for detection of phospho-
tyr783 PLC1.
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levels. However, the levels of pPLC1 were unaltered after the temperature shift in 
both cell lysates (Fig. 40A) and immunoprecipitated PLC1 (Fig. 40B). This unexpected 
result suggests that cargo arrival is activating PLC1 by another mechanism than 
phosphorylation on its Tyr783. 



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1.- Role of phospholipid synthesis in the regulation of the DAG needed for 
membrane trafficking at the Golgi complex 
In the first part of this work, we postulate that the DAG-consuming steps of 
phospholipid synthetic pathways present at the Golgi contribute to the regulation of 
DAG needed for membrane traffic at this organelle. 
1.1.- Role of DAG-consuming pathways in the control of cellular DAG 
To study the contribution of DAG-consuming pathways in the regulation of DAG levels, 
we set up two different strategies to inhibit phospholipid synthesis. Our main aim was 
to design an experimental approach that, by inhibiting phospholipid synthesis, allowed 
us to change the total amount of DAG, but, at the same, was not inducing changes in 
other membrane lipids. Since DAG is a metabolic intermediate present in lower 
amounts than the other phospholipids, we thought that a quick and short tuning of the 
rate of phospholipid synthesis could be more likely regulating the amount of DAG than 
the end products of these biosynthetic pathways. We then hypothesised that the cell 
can take advantage of its own mechanisms to regulate the phospholipid synthetic 
pathways in order to control the DAG required for membrane trafficking at the Golgi 
complex. We have proven that short time inhibition of PC and PI synthesis, which was 
60 min long in most of our experimental approaches, leads to an increase of cellular 
DAG. Moreover, as we hypothesized, our experimental design did not significantly 
affect the total mass of PC and PI, the end products of the metabolic pathways that we 
were inhibiting. This way, we defined a temporary window where, by inhibiting PC and 
PI synthesis, the amount of cellular DAG is increased, but PC and PI are not yet 
altered.  
The importance of the duration of the inhibition of phospholipid synthesis to regulate 
DAG can be seen in other studies, where different results were obtained with similar 
experimental designs. It has been reported that PC synthesis inhibition in CHO-MT58 
cells at the restrictive temperature, the same strategy used in our work, leads to an 
inhibition of protein transport at the Golgi complex (Testerink, 2009). In that study, the 
authors conclude that PC is needed for protein secretion at the Golgi complex, while 
we suggest that an inhibition of PC synthesis increases it. These apparently 
contradictory results are explained because in that work PC inhibition lasted 24 hours, 
while in our conditions was just for one hour.  After a long time inhibition of PC 
synthesis not only the amount of PC is affected, but also the amount of other lipids of 
this synthetic pathway as DAG. In fact, it has also been reported that a 24 hour 
inhibition of PC synthesis in CHO-MT58 cells not only decrease PC levels, but also 
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produces a reduction of DAG (Van der Sanden, 2004), which correlates with and 
highlights our hypothesis that lower amounts of DAG impair protein transport from the 
Golgi complex. These results also reflect that long-time inhibition of a metabolic 
pathway can lead to changes not only in its end product, but also can affect its 
metabolic intermediates, as well as other synthetic pathways. For this reason, in this 
part of the work, we discarded silencing of regulatory enzymes of PC and PI synthesis. 
Silencing protocols usually last for a minimum of 72 hours, and along this time the lipid 
intermediate metabolites, as DAG, can be altered and/or diverted into other metabolic 
pathways, thus complicating the interpretation of the results obtained. 
As described previously, DAG is an intermediate metabolite and its accumulation could 
lead to changes in the metabolic pathways and alter other classes of membrane lipids. 
Provided that our experimental conditions do not alter PC and PI, we measured other 
major phospholipid classes, such as PE, SM, PS, PA and the neutral lipid TAG. We 
found that at the permissive temperature CHO-MT58 cells present some inhibition of 
PC synthesis and also have different amounts of phospholipids and TAG than CHO-
K1, the wild type control cells, which is in accordance with published results (Caviglia, 
2004). We therefore wanted to make sure that our experimental conditions did not 
significantly alter the amount of phospholipids and TAG of both cell lines. Apart from 
the basal differences between CHO-K1 and CHO-MT58, we found that our 
experimental conditions did not modified neither phospholipids nor TAG, indicating that 
only the amount of cellular DAG is changing. However, we can not rule out that, by 
inhibiting phospholipid synthesis for a short time, there is a local increase of PA, any 
other phospholipid or TAG, undetectable by the measurement of the composition of the 
whole cell lipid extract. So, since DAG is the only measured lipid that is altered by our 
experimental conditions, we correlated all the changes measured in trafficking to this 
metabolite. Nonetheless, the results obtained for PA were unexpected. Because PA is 
also a lipid intermediate metabolite present at much lower levels than other 
phospholipids and a direct product of DAGK action on DAG, we expected an increase 
of PA concomitant to the DAG accumulation. However, the amount of PA was 
unaltered by our conditions, which could mean that PA is rapidly consumed to other 
metabolic pathways or that the particular DAG accumulated in our strategies is not a 
good substrate for DAGK. 
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1.2.- Role of DAG-consuming pathways in the control of the Golgi-associated DAG 
pool 
It is widely accepted that the major site for PC and PI synthesis is the ER, but it is 
becoming accepted that DAG-consuming steps of phospholipid synthesis are also 
relevant at the Golgi complex (Chen, 2011). Since we designed our experimental 
conditions in order to regulate DAG at the Golgi complex, we wanted to confirm that, at 
least in part, the observed changes in the amount of DAG were taking place at this 
organelle. However, we were unable to resolve any increase of DAG at the Golgi 
complex after phospholipid synthesis inhibition. We discarded the option to isolate 
Golgi-enriched membrane fractions from CHO cells after phospholipid inhibition. The 
isolation of Golgi-enriched membrane fractions needs several washes and 
homogenization of both the composition of the buffer and the temperature, the factors 
that allowed us modify the rate of phospholipid synthesis. And besides, even if we were 
able to maintain the experimental conditions during the procedure, the time it takes is 
too long. Thus, this protocol will not ensure the preservation of the previously induced 
DAG alterations during membrane isolation. We also measured the localization of the 
DAG sensor C1-PKC-GFP at the Golgi complex after phospholipid synthesis inhibition 
by depletion of its substrates. Inhibition of PC and PI synthesis led to a small increase 
in C1-PKC-GFP localization at the Golgi complex, although this was not significant. 
One possible explanation is that the changes in DAG at the Golgi induced by 
phospholipid synthesis inhibition could be small and beyond the resolution of this 
assay. We ruled out the measurement of localization of C1-PKC-GFP in CHO-MT58 
cells because temperature shift to 40 ºC reduced its localization to the Golgi complex 
and thus complicates data interpretation. 
Although we could not resolve significant changes in DAG at the Golgi complex 
induced by the inhibition of phospholipid synthesis, we studied if it could have a 
functional effect. Our group previously reported that inhibition of DAG production by 
propanolol, which inhibits LPPs, increased the number of Golgi-associated buds. This 
effect could be reverted by exogenous addition of 2-dioctanoyl-sn-glycerol (DOG), a 
short chain DAG that could be incorporated into the Golgi complex, where it 
compensates the lowered DAG levels induced by propanolol (Fernández-Ulibarri, 
2007). Inhibition of PC synthesis in CHO-MT58 cells had the same effect as DOG 
addition, preventing the increase of the Golgi-associated buds induced by propanolol. 
This results shows that most likely PC synthesis inhibition is increasing DAG at the 
Golgi complex, since it is able to compensate the effects produced by the reduction of 
DAG by propanolol. 
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This last result shows that phospholipid synthesis inhibition counteracts an effect that 
was produced by a reduction of DAG at the Golgi complex, but it does not specifically 
demonstrate that the reactions that consume DAG for phospholipid synthesis are 
taking place at this organelle. Phospholipid synthesis takes place mainly at the ER and 
the changes in DAG at the Golgi complex could be a reflex of an increase of DAG that 
is taking place at the ER and then is transported to the Golgi complex. TAG levels were 
unaltered after phospholipid synthesis inhibition, indicating that the increase of DAG 
was not diverted into neutral lipid synthesis. In spite of this, the addition of excess CMP 
induces a robust increase of DAG in Golgi-enriched fractions, suggesting that reactions 
of phospholipid synthesis are taking place at this organelle. We think that the chance 
for DAG to accumulate at the Golgi complex is higher than in the ER, because at the 
ER DAG can be more easily diverted to other metabolic pathways, like neutral lipid 
synthesis (Coleman, 2004). However, TAG levels were unaltered after phospholipid 
synthesis inhibition, indicating that the increase of DAG was not diverted significantly 
into neutral lipid synthesis in 1 h incubation time. All together these results strongly 
reinforce the hypothesis that the increase of DAG seen on cellular extracts is taking 
place at the Golgi complex.  
1.3.- Role of DAG-consuming pathways in the regulation of membrane trafficking at the 
Golgi complex 
Our first evidence that DAG-consuming pathways can be involved in membrane 
trafficking was the alteration that its regulation caused in the subcellular distribution of 
the KDELR at the ER-Golgi interface, where KDELR is continuously cycling. The 
reduction of KDELR positive particles cycling between these organelles when DAG 
was reduced by being consumed for PC and PI synthesis suggests an impairment of its 
trafficking, that could be caused at the generation of COPI transport carriers at the 
Golgi complex or at the biogenesis of COPII transport carriers at the ER. Some data 
support that the alteration in the biogenesis of KDELR-containing transport carriers is 
localized at the Golgi complex. First, we monitored the trafficking of VSVG from the ER 
to the Golgi complex in the same experimental conditions and no alteration was found. 
This result suggests that anterograde transport from the ER to the Golgi complex is not 
altered in our experimental conditions and, therefore, the impairment in KDELR traffic 
would likely be localized at the Golgi complex, where we showed that our experimental 
conditions can modify the amount of DAG. Moreover, the generation of COPI transport 
carriers has been reported to require DAG, but anterograde transport from the ER to 
the Golgi complex seems to be unaffected by DAG depletion (Fernández-Ulibarri, 
2007). 
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Moreover, we found that the inhibition of phospholipid synthesis increased the post-
Golgi trafficking of two different cargoes, VSVG and ssHRP; confirming the functional 
effects of DAG alterations in membrane trafficking by our experimental conditions at 
the Golgi complex. We observed that VSVG transport to the plasma membrane was 
blocked at the Golgi complex; but we did not know the precise subcellular location 
along the secretory pathway where the delay of ssHRP secretion took place. However, 
the transport of VSVG indicates that DAG regulated by phospholipid synthesis affects 
the exit from the Golgi but not from the ER, and this could also be suggested for 
ssHRP secretion. 
The cycling of KDELR at the ER-Golgi interface allowed us to establish a correlation 
between the amount of cellular DAG and the number of KDELR transport carriers. We 
found that the correlation between these two parameters followed a hyperbola-shaped 
function. In this approach we measured cellular DAG, while it would have been more 
appropiated to measure DAG at the Golgi complex, since is at this organelle where 
DAG regulates the formation of KDELR transport carriers. However, since this 
organelle has abundant DAG content compared to the total cellular membranes, we 
suggest that changes in total cell DAG can well reflex changes in DAG at the Golgi 
complex. We counted the total of KDELR containing transport carriers, because we 
were unable to distinguish those trafficking from the ER to the Golgi complex from 
those who were trafficking retrogradely. In spite of these limitations, we found that the 
number of KDELR particles increased with the DAG content and the data matched with 
a hyperbola-shaped correlation. This correlation indicates that the number of KDELR 
transport carriers depends on the amount of DAG that can be consumed in 
phospholipid synthesis, in a manner that fits with an interaction of DAG with an effector 
molecule, as it could be for PKD for TGN-to-plasma membrane transport carriers 
(Baron and Malhotra, 2002). Such result would also be in accordance with the 
requirement of DAG as a membrane component that facilitates the curvature needed 
for the generation of transport carriers (Semesh, 2003).  
1.4.- Physiological implications of the regulation of DAG at the Golgi complex by DAG-
consuming pathways  
Our results highlight the role of DAG-consuming pathways in the regulation of DAG at 
the Golgi complex. Most studies focus in the regulation of this metabolite by metabolic 
pathways that produce it (Baron and Malhotra, 2002; Fernández-Ulibarri, 2007; 
Subathra, 2011). Here, we have shown that the amount of DAG at the Golgi complex, 
and membrane trafficking at this organelle, can be also regulated by DAG-consuming 
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pathways. At the Golgi complex, a local inhibition of PC and PI synthesis can produce 
an increase of DAG at this organelle in order to promote membrane trafficking. 
Interestingly, one of the regulatory mechanisms of CCT, the regulatory enzyme of the 
CDP-choline pathway, relies on its ability to sense the elastic stress of a membrane. 
CCT increases its activity on membranes with relatively low PC and enriched with DAG 
(Fagone and Jackowski, 2013). This regulatory mechanism suggests that the action of 
the CCT at the Golgi complex could be the resetting of the elastic stress of the 
membrane, by consuming DAG and restoring basal DAG levels, which could have 
been increased for transport carrier formation. CCT would produce again PC, which 
could by consumed for DAG production by the SMS at the trans-Golgi, thereby 
producing a “wave”’ of DAG all through the Golgi complex. Moreover, it has been 
described that an increase of Ca2+ promotes CCT ubiquitinization at the Golgi complex 
(Chen, 2011) that promotes CCT degradation and therefore inhibit PC synthesis, a 
process previously seen and proposed to maintain high DAG levels in pancreatic acini 
(Matozaki, 1991). Cargo arrival at the Golgi complex triggers an increase of Ca2+ 
(Micaroni, 2010). Thus, a Ca2+ increase induced by cargo arrival would inhibit PC 
synthesis in order to maintain a temporary increase of DAG, which in turn would 
promote the generation of transport carriers to facilitate cargo exit at the Golgi complex. 
2.- Role of PLC in the regulation of the DAG needed for membrane trafficking at 
the Golgi complex 
2.1.- PLC activity in Golgi-enriched membrane fractions 
As a first screening for the study of the role of PLC in the Golgi complex, we tried to 
measure PLC activity in Golgi-enriched membrane fractions. For this purpose, we 
measured the production of [32P]PA in the presence of [32P]ATP in Golgi-enriched 
membrane fractions, which reflects the rate of its production by DAGK from DAG, 
together with the changes of [32P]PIP. In this context, the amount of [32P]PIP depends 
on the activity of the enzymes that first incorporate the radiolabeled [32P]ATP to 
[32P]PIP, as the PI(4)K, and the enzymes that could metabolise [32P]PIP, such as PLC 
or the phosphatase Sac1.  
In these experiments, [32P]PA production is in part indicative of DAG formation, since 
DAG is rapidly converted into PA by the action of DAGK. Production of [32P]PA was 
dependent on the presence of cytosol. This could be explained because DAGKs, the 
enzymes that incorporate [32P]ATP to [32P]PA, are cytosolic. To confirm that this 
experimental design allowed the measurement of PLC activity coupled to DAGK, we 
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added recombinant PLC from B.cereus as a positive control. We observed that the 
addition of recombinant PLC led to a high increase of the labelling of [32P]PA, 
confirming that in these experimental conditions the measurement of [32P]PA could be 
a reporter of PLC activity. However, in these experiments we could not specify if any 
regulated increase of [32P]PA production induced by cytosol addition is caused by 
DAGK alone or by PLC coupled to DAGK. To discriminate the action of PLC and DAGK 
in [32P]PA production in Golgi-enriched membrane fractions with added cytosol, we 
used the general PLC inhibitor U73122 (Bleasdale, 1989). U73122 had an inhibitory 
effect on [32P]PA production, although we could not absolutely trust the specificity of 
this compound for PLC, since a study published while we were realizing this work 
showed that U73122 had non-specific effects in vitro, where it can even increase PLC 
activity instead of inhibit it (Klein, 2011). 
To further analyse the possibility that PLC could be acting on Golgi-enriched 
membrane fractions we analysed the dependence of [32P]PA production in the 
presence of Ca2+ and GTPS. Ca2+ is required for all PLCs to be active, while we 
expect that GTPS stimulates the activity of PLC isoforms by the action of G proteins. 
In parallel, we analysed the consumption of [32P]PIP in the same conditions. We 
observed that Ca2+ depletion impaired [32P]PA production and [32P]PIP consumption, 
while GTPS depletion only impaired [32P]PA production. These results are not 
conclusive, but allow us to suggest that if there is any PIP consuming PLC activity after 
the addition of cytosol to Golgi-enriched membrane fractions this PLC would  be 
sensitive to Ca2+, but independent of G protein activation. 
However, the interpretation of the results from Golgi-enriched membrane fractions is 
not straightforward. Of note, another study used the same experimental conditions to 
measure [32P]PA production in Golgi membranes by Arf stimulation, and concluded that 
ARF-stimulated [32P]PA production was a result of the action of PLD (Godi, 1999). 
Although this was their interpretation, the incorporation of [32P]Pi to [32P]PA requires the 
action of DAGK, since PLD conversion of PC to PA does not incorporate a phosphate 
group of [32P]ATP to [32P]PA. Moreover, the inhibition of [32P]PA production and of 
[32P]PIP consumption caused by Ca2+ depletion that we hypothesise that could be PLC 
activity, could also be  mixed up with the direct effect of Ca2+ on DAGKs or on the Sac1 
phosphatase. 
In spite of all these limitations, we felt courageous to focus in the possible action of 
PLC1 on the Golgi complex, rather PLC isoforms, which are activated by G proteins. 
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2.2.- Role of PLC1 in the regulation of Golgi secretory function and structure 
Some previous studies involved PLC1 in Golgi events. First, it was reported that 
PLC1 is required for Ras activation at the Golgi complex (Bivona, 2003). More 
recently, it has been described that in keratinocytes PLC1 participates in Ca2+ uptake 
at this organelle (Tu, 2007). We found that PLC1 silencing led to an inhibition of the 
post-Golgi membrane trafficking of both soluble and transmembrane cargo, and led to 
a reduction of the Golgi-associated DAG pool. Since DAG is required for the formation 
of transport carriers at this organelle (Baron and Malhotra, 2002) and PLC1 silencing 
reduces it, with this data, we can suggest that PLC1 is involved in anterograde 
membrane trafficking at the Golgi complex by regulating DAG levels at this organelle. 
Whether the reduction of Golgi DAG reflects the reduction of DAG elsewhere in the cell 
after 72 h of PLC1 silencing or it is a consequence of a reduced PLC1 activity 
directly at the Golgi complex was still not resolved at this point.   
PLC1 silencing or overexpression led to changes in the Golgi complex structure. 
PLC1 silencing led to a slight, but significant compactation of all Golgi compartments, 
from cis-Golgi to the TGN. Overexpression of PLC1, but not its inactive form, had the 
contrary effect, leading to a fragmentation of the trans-Golgi and to a less extent of the 
cis-Golgi. Interestingly, the Golgi fragmentation induced by PLC1 overexpression is in 
accordance with other studies that by overactivating the fission machinery also produce 
a fragmentation of this organelle. This effect was firstly seen by the action of IQ, which 
led to the fragmentation of the trans-compartments of the Golgi complex (Takizawa, 
1993). The overexpression of a constitutively active form of PKD also promotes 
vesiculation of the Golgi complex (Bossard, 2007). The similarity of these effects to the 
fragmentation of the Golgi complex seen after PLC1 overexpression suggests that 
PLC1 could be part of the machinery for transport carrier formation at the Golgi 
complex. In this context, activation of the Src kinase also promoted fragmentation of 
the Golgi, which was shown to be dependent of dynamin 2 phosphorylation by Src 
(Weller, 2010). Taking into account that first: PLC1 could be activated by 
phosphorylation of its tyrosine 783; second: Src could act as an activator of PLC1 
(Bivona, 2003), and third: the phosphorylation and dephosphorylation cycle in tyrosines 
can regulate the structure of the trans-Golgi with an increase in phospho-tyrosines 
leading to a fragmentation of the trans-Golgi, but not of the cis compartments (Webb, 
2005), it is tempting to propose that PLC1 could act downstream of the Golgi 
fragmentation induced by Src (Weller, 2010). To confirm this, it would be interesting to 
check the phosphorylation state of PLC1 in cells with an overactivated Src. However It 
is not known why the trans-Golgi is more sensible to fragmentation than the cis-Golgi 
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under these conditions. One possible explanation relies on our results concerning the 
role of PLC1 in membrane trafficking, which affected the anterograde transport, but 
not the retrograde. Since the generation of transport carriers for anterograde transport, 
where we have observed that PLC1 participates, takes place at the TGN, which is in 
close proximity to the trans-Golgi, the overactivation of the fission machinery is more 
likely to alter the trans-Golgi rather than the cis-Golgi. Moreover, PLC1 has been 
localized at the TGN, where it is found to be part of a complex with TGN38, SPCA and 
CaR in keratinocytes (Tu, 2007), which could also explain the higher fragmentation of 
the TGN and the trans-Golgi in cells that overexpress PLC1 or present higher levels of 
phosphotyrosines. 
2.3.- Role of PLC1 in the production of DAG after cargo arrival at the Golgi complex 
The main physiological relevance of the finding that PLC1 could be regulating 
membrane trafficking at the Golgi complex is that PLC1 activation could be coupled to 
a potential signal triggered earlier in the secretory pathway. As previously proposed, 
but not addressed, the arrival of cargo at the Golgi could be the signal that triggers a 
signalling cascade at the Golgi complex to produce DAG for transport carrier formation 
(Bard and Malhotra, 2006). Recently, the basis of this hypothesis was strengthened by 
the finding that cargo arrival is triggering a signalling circuit at the Golgi complex that 
involves the KDELR and Src (Pulvirenti, 2008). To further investigate this, we studied if 
this signalling cascade triggered by cargo arrival could be promoting DAG production. 
We demonstrated for the first time that cargo arrival at the Golgi complex promotes 
DAG production. This finding shows that some of the metabolic pathways that control 
the amount of DAG at the Golgi complex are responding to a stimulus, the presence of 
cargo, in order to promote an increase of DAG at this organelle, probably for the 
generation of transport carries. Thus, it is tempting to propose that one goal of the 
signalling pathway involving the KDELR and Src at the Golgi complex, is the production 
of DAG, since inhibition of Src leads to an inhibition of the exit of cargo from this 
organelle (Pulvirenti, 2008). 
Once found that DAG production at the Golgi complex is stimulated by cargo arrival, 
we assessed the role of PLC1 in this process. Silencing of PLC1 impaired the 
increase of DAG at the Golgi complex triggered by cargo arrival. This result not only 
involves PLC1 in the signalling cascade triggered by cargo at this organelle, but also 
highlights its role in the regulated DAG production for transport carrier formation. To 
date, some studies showed that a reduction of DAG production led to an inhibition of 
membrane trafficking at the Golgi complex, but none showed that the DAG-producing 
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pathway that was inhibited was the one stimulated by the cell in the need of transport 
carrier formation at the trans-Golgi (Baron and Malhotra, 2002; Fernández-Ulibarri, 
2007; Subathra, 2011; Gutiérrez-Martinez, 2013). Thus, cargo-triggered PLC1-
dependent production of DAG that we describe here is the first evidence of a regulated 
DAG production at the Golgi complex for the generation of transport carriers. 
Other enzymes than PLC1 should be involved in this event. If DAG production for 
transport carrier formation was only dependent on PLC1, we would expect a complete 
inhibition of transport at the Golgi complex after PLC1 silencing. However, in our 
trafficking assays after PLC1 silencing we observe an inhibition, but not a complete 
block of the anterograde trafficking. This effect suggests that PLC1 is required for a 
quick and efficient production of DAG for transport carrier formation, but other DAG 
producing mechanisms can also contribute to this process. Another interpretation of 
our data could be that PLC1 responds to cargo arrival producing DAG, which recruits 
PKD, and then PKD activates a signalling pathway to efficiently produce DAG by SMS 
to generate transport carriers, as was previously suggested (Malhotra and Campelo, 
2011). In the absence of PLC1, the generation of the DAG that recruits PKD could be 
diminished, thus reducing but not totally impairing the PKD localization at the Golgi 
complex. However, as said before, DAG generated by other mechanisms, either 
regulated or not, could also promote PKD recruitment and DAG formation downstream 
of PKD. The idea that the DAG produced by PLC1 have a signalling role to recruit 
PKD and trigger the machinery required for transport carrier formation downstream of 
PKD is reinforced by the results of our studies with the StxBKDEL, where we could not 
observe any significant change in the retrograde trafficking of StxBKDEL from the Golgi 
complex to the ER after PLC1 silencing. If the role for DAG produced by PLC1 at the 
Golgi complex is to recruit PKD, it could explain why PLC1 silencing has no effect on 
retrograde trafficking, since this transport pathway is independent of PKD. To confirm 
this hypothesis would be really interesting to measure PKD recruitment at the Golgi 
complex after cargo arrival and the involvement of PLC1 in this process. 
Strikingly, the levels of phosphoPLC1 were unaltered after cargo arrival at the Golgi 
complex. Phosphorylation of the 783 tyrosine is the most common mechanism to 
activate PLC1 (Gresset, 2010). At the plasma membrane, PLC1 can be activated by 
Src (Bivona, 2002), which is activated after cargo arrival at the Golgi complex 
(Pulvirenti, 2008). Since we have observed a DAG production at the Golgi complex 
after cargo arrival that was dependent on PLC1, we expected that PLC1 could be 
activated by phosphorylation after cargo arrival. However, we did not observe changes 
in the amount of phosphorylation of the 783 tyrosine of PLC1, and therefore we could 
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not confirm the PLC 1 activation by its classical way. But still, the action of PLC1 in 
DAG production after cargo arrival at the Golgi complex is clear. We have no result-
based rationale for this observation, but we attempt some explanations, although 
speculative, for this finding. One possibility is that the changes of the amount of 
phosphorylated PLC1 were smaller than the resolution of the assay.  Another 
explanation is based in the possibility that other mechanisms, different from 
phosphorylation, could be activating PLC1 after cargo arrival at the Golgi complex. In 
this context, it has been reported that an increase of Ca2+ is sufficient to activate both 
PLC1 and PLC2, independently of its phosphorylation state (Piechulek, 2005). After 
cargo arrival, the peri-Golgi Ca2+ concentration increased (Micaroni, 2010) and can 
affect the activities of Golgi-associated proteins (Micaroni, 2012), as could be 
happening with PLC1. We propose that the increase of the peri-Golgi Ca2+
concentration triggered by cargo arrival activates PLC1, promoting DAG formation for 
the generation of transport carriers at this organelle. To test this hypothesis, it would 
have been interesting to study the effects of Ca2+ chelation by BAPTA on DAG 
production after cargo arrival at the Golgi complex, but we ruled out the possibility to 
test this, since it has been previously described that BAPTA impairs protein transport 
from the ERGIC to the Golgi complex (Chen, 2002), making incompatible the arrival of 
cargo at the Golgi complex with Ca2+ chelation. Interestingly, BAPTA also impairs the 
exit of cargo from the Golgi complex (Chen, 2002). This effect of Ca2+ chelation on the 
post-Golgi transport would fit with a reduction of PLC1 activity and DAG production 
required for membrane trafficking at the Golgi complex. Moreover, it has been 
described that an increase of Ca2+ promotes DAG production at the Golgi complex and 
enhances PKD recruitment to this organelle (Kunkel and Newton, 2010). In this study, 
the authors rule out that the increase of DAG seen after Ca2+ stimulation could be 
produced by the action of PLC, since edelfosine does not inhibit DAG production at the 
Golgi complex, but inhibits DAG accumulation at the plasma membrane. However, the 
precise mechanism of action of edelfosine it is not known. It has been shown that after 
interaction with PI(4,5)P2 at the plasma membrane, the substrate of PLC, it interferes 
with PLC activity (Powis, 1992). But, to date, it is not known if edelfosine can inhibit 
PLC activity by interfering on phosphoinositides found in endomembras, such as PI(4)P 
at the Golgi complex. So, if edelfosine were not interacting with PI(4)P still PLC could 
be the responsible for the described DAG production at the Golgi stimulated by Ca2+.  
We then measured the levels of PI(4)P at the Golgi complex after cargo arrival with the 
localization of PH-OSBP-GFP at this organelle. PI(4)P is the principal phosphoinositide 
at the Golgi complex and can also be metabolised by PLC (Claro, 1993). We did not 
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find a decrease on PI(4)P that matched with the observed increase of DAG. This 
apparently contradictory observation has some possible explanations. The first one is 
based on the resolution of the assay. Although we have seen changes in DAG by using 
the localization of C1-PKC-GFP at the Golgi complex, the resolution of these two 
constructs may be different. Thus, a significant increase of DAG by PLC1 activity by 
measurement of C1-PKC-GFP localisation has not necessarily be paralleled with a 
significant decrease in the localisation of PH-OSBP-GFP. Moreover, as we propose, 
DAG production after cargo arrival could not be only from PLC activity and other 
mechanisms could act downstream of PLC1, thus increasing the difference between 
the relative changes of DAG and PI(4)P at the Golgi complex. Another possibility is that 
we do not observe changes in the localisation of PH-OSBP-GFP because PLC1 
hydrolyses PI(4,5)P2, its most common substrate, which is proposed to be also found at 
the Golgi complex (Godi, 1999). It would be interesting to determine which 
phosphoinostide is the substrate of PLC1 at the Golgi complex to know how this can 
affect Ca2+ signalling. Hydrolysis of PI(4,5)P2 generates DAG and IP3, which promotes 
the release of Ca2+ from cellular stores as the Golgi complex and the ER. However, if 
PLC1 hydrolyses PI(4)P the products of the reaction will be DAG and IP2, which does 
not affect Ca2+ release. Since Ca2+ may be playing a critical role in PLC1 activation at 
the Golgi complex, it would be important to know if PLC1 is coupled to an increase of 
Ca2+, which would feedforward the signal to sustain PLC1 activation.  If PI(4)P is the 
substrate in PLC1 at the Golgi complex, this Ca2+ would not take place and the 
physiological relevance of PLC1 action would only relay on DAG production. 
3.- Summary 
In this work, we show that DAG-consuming pathways and PLC1 can regulate the 
DAG required for membrane trafficking at the Golgi complex, but with different 
relevance for anterograde and retrograde transport. An integration model of the action 
of both processes could be as follows. For the generation of post-Golgi transport 
carriers, cargo arrival, by increasing the peri-Golgi Ca2+ concentration, activates PLC1 
which produces a signalling DAG that recruits PKD. Then, PKD promotes DAG 
formation by indirect stimulation of SMS, which could facilitate the fission of transport 
carriers. DAG produced by this with pathway could be accumulated because, at the 
same time, Ca2+ inhibits PC synthesis by promoting CCT degradation, thus inhibiting 
DAG consumption. After the Ca2+ increase and cargo passage through the Golgi, the 
remaining CCT at the Golgi complex could be activated by sensing the increase of 
DAG on Golgi membranes, thus restoring DAG and PC levels at the Golgi complex, 
leaving the system ready for another round of cargo arrival (Fig.41). 
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Figure 41. Proposed model for the generation of post-Golgi transport carriers. A) In the absence of 
cargo, KDLER remains unactivated and the CDP-choline pathway maintain the levels of DAG. B) Cargo 
arirval triggers the activation of the KDELR, which, by unknown mechanisms, promotes Ca2+ release from 
the Golgi Complex, thus increasing the peri-Golgi Ca2+ concentration. This increase of Ca2+ activates 
PLC1 at the Golgi complex. C) PLC1 produces DAG, which recruits and activates PKD at the Golgi 
complex, stimulating DAG production by SMS. At the same time, the CDP-choline pathway is inhibited by 
the increase of the Ca2+ concentration, allowing the accumulation of DAG necessary for the formation of 
transport carriers. D) After fission of the transport carrier and passage of cargo, Ca2+ concentrarion is 
restored and the CDP-choline pathway consumes the excess DAG in order to reset the Golgi membrane 
compostion for another round of transport carrier formation.
On the other hand, retrograde membrane trafficking could be also regulated by an 
increase of Ca2+ triggered by cargo arrival at the Golgi complex. This increase of Ca2+
would inhibit the CDP-choline pathway as described before, but would have no effect 
on the activity of PLC1 or one of its downstream targets. LPP3 could be producing 
DAG and its accumulation by the inhibition of PC synthesis would be sufficient to 
promote the formation of transport carriers that travel from the Golgi complex to the 
DISCUSSION 
144 

ER. After fission of the transport carrier and the decrease of Ca2+, the system could be 
restored by the activation of CCT by sensing the increase of DAG on Golgi 
membranes, as proposed for post-Golgi trafficking (Fig.42). 
Figure 42. Proposed model for the generation of retrograde transport carriers.A) In the absence of 
cargo, KDLER remains unactivated and the CDP-choline pathway maintain the levels of DAG. B) Cargo 
arirval triggers the activation of the KDELR, which, by unknown mechanisms, promotes Ca2+ that inhibits 
the CDP-choline pathway. C) The inhibition of the CDP-choline pathway leads to DAG accumulation,
which can be produced by LPP3,  that promotes the formation of transport carriers from the Golgi complex 
to the ER. D) After fission of the transport carrier and passage of cargo, Ca2+ concentrarion is restored 
and the CDP-choline pathway consumes the excess DAG in order to reset the Golgi membrane 
compostion for another round of transport carrier formation. 
VI. CONCLUSIONS  
  
  
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1.- Metabolic pathways for the synthesis of phospholipids that consume DAG regulate 
its levels at the Golgi complex. 
2.- Phospholipid synthesis controls the levels of DAG needed for both retrograde and 
anterograde trafficking at the Golgi complex. 
3.- Cargo arrival at the Golgi complex promotes DAG production. 
4.- PLC1 is involved in the production of DAG triggered by cargo arrival at the Golgi 
complex. 
5.- PLC1 is needed for post-Golgi transport and maintenance of the structure of the 
Golgi complex.
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